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Abstract 
Self-assembly is a powerful method for producing controlled morphologies at the 
nanometre scale. Peptides are biomolecules capable of self-assembly and have the 
potential for use in a variety of applications such as emulsion and foam stabilisation, 
wound healing and drug delivery. The investigation of peptide sequence-structure 
relationships is a rapidly advancing field of study, which in many cases now allows 
the targeted design of self-assembling peptides.  
While self-assembling peptides show potential in several fields, their large-scale 
adoption is limited by the high production expenses associated with conventional 
solid-phase synthesis. A potentially cheaper and more renewable approach to 
peptide production is bacterial expression. However, the bioproduction of peptides is 
a non-trivial process, and generally involves the expression of peptides as part of a 
fusion protein in which the target peptide is only a small portion of the expressed 
product. An alternate approach involves peptide concatemers, in which the target 
peptide makes up the majority of the expressed construct. 
The work reported in this thesis focused on the design, characterisation and 
bioproduction of self-assembling α-helical peptides. It was particularly focussed on 
the development of amphiphillic α-helical peptides with applications as surfactants 
and hydrogelators. The aim of this work was to further the field of de novo peptide 
design, while also investigating an approach for peptide bioproduction. This work 
aimed to combine the requirements for peptide bioproduction with end-use 
functionality. 
Chapter 2 details successful bioproduction of an anionic helical surfactant peptide 
EDP-11, as part of a charge-paired heteroconcatemer with the cationic expression 
partner RDP-4. The method utilised designed assembly of the constituent α-helical 
peptides to generate a stably folded coiled-coil concatemer. The polypeptide 
sequence was further optimized for molecular charge, hydropathy and predicted 
protease resistance. This process allowed expression of a soluble concatemer that 
accumulated to high levels (22% of total protein) in E. coli. The expressed 
concatemer possessed extreme stability to heat and proteases,  allowing isolation by 
simple heat and pH precipitation, yielding concatemer at 130 mg per gram of dry cell 
weight and >99% purity. Key parameters used in designing the heteroconcatemer 
were then compared to those of all open reading frames of several reference 
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proteomes in an attempt to gain insight into the mechanistic basis for the high 
stability of the designed miniprotein. 
Following bioproduction using this concatemer approach, further processing was 
required to produce monomeric peptides for use in surfactant applications. The 
design of acid-cleavable aspartate-proline sites within the concatemer sequence 
allowed for simple heat- and acid-mediated cleavage to give constituent peptides. 
Chapter 3 details characterization of cleavage of the expressed concatemer by 
coupled liquid chromatography-mass spectrometry and includes modelling of the 
kinetic pathways involved. Chemical denaturation studies showed that cleavage 
decreased the stability of the coiled coil from 38.9 to 32.8 kcal mol-1. Both intact and 
cleaved concatemer possessed surfactant functionality, with each giving an 
equilibrium interfacial pressure of 29 mN m-1 at the air-water interface. Both 
concatemer cleavage and addition of guanidinium chloride to partially denature 
coiled-coil structure resulted in enhanced rates of adsorption to the interface. The 
cleaved products were also used to prepare heat-stable oil-in-water emulsions with 
droplet sizes in the nanometre range. 
Chapter 4 describes the design and characterisation of peptide AFD19, which was 
designed as part of ongoing work on amphiphilic α-helical peptides. AFD19 self-
assembled to form fibrils and hydrogels at weight fractions below 0.1%. Gelation 
occurred in a pH-dependent manner, which was attributed to changes in molecular 
charge. AFD19 gave free-flowing solutions at high molecular charge, gel formation 
where the peptide charge was close to ±1, and precipitation when the charge 
approached zero. Characterisation of AFD19 self-assembly indicated the peptide 
assembled to give coiled-coil fibrils of approximately a hexamer in cross-section that 
formed physical cross-links below a critical molecular charge. While AFD19 
precipitated at close to neutral pH, redesign of the peptide sequence gave AFD36, 
which underwent gelation at physiological pH and salt, increasing utility in the 
biomaterial field. Small-angle X-ray scattering showed AFD36 to form fibrils of 3.8-
3.9 nm diameter at pH 4.0-7.0. Coiled coils of both peptides possessed high 
thermodynamic stability, with ΔG(H2O) values of 9.3-9.5 kcal mol-1 per monomer. 
Chapter 5 details the investigation of α-helical peptide hydrogels as cell scaffolds 
and therapeutic delivery vehicles. Rheological measurements of an AFD36 hydrogel 
showed viscoelastic properties with an elastic modulus of 350 Pa. Further peptide 
iii 
 
design gave the sequence AFD49, and hydrogels formed by either this peptide or 
AFD36 supported the growth of NIH/3T3 fibroblasts at levels similar to controls of 
tissue culture polystyrene. AFD49 hydrogels also supported the proliferation of 
encapsulated fibroblasts over several weeks, but were unable to support the growth 
of induced pluripotent stem cells in the absence of coating with Matrigel. The ability 
of AFD49 hydrogels to incorporate and release the hydrophobic drug all-trans 
retinoic acid was also demonstrated. 
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1   Literature Review 
1.1 Molecular self-assembly 
Self-assembly is the spontaneous organisation of components into larger assemblies 
based only on local interactions. In the case of molecular assembly this process is 
governed by non-covalent forces that can include electrostatic, hydrophobic and van der 
Waals interactions, metal-ligand and hydrogen bonds, as well as aromatic π-stacking.1-3 
Although these interactions are individually weak, the sum of multiple interactions can 
generate highly stable and defined assemblies at the nanometre scale. Molecular self-
assembly is common in both natural and synthetic systems, ranging from the assembly of 
lipid bilayers4 and actin protein filaments5 to the designed assembly of supramolecular 
polymers6-8 and virus-like particles.9, 10 
In recent years the targeted design of self-assembling molecules has become a 
burgeoning field of study. This has rapidly enhanced understanding of the factors 
governing the assembly of monomeric building blocks to give structurally well-defined 
architectures.11, 12 Understanding of these factors has assisted in the development of self-
assembling materials with potential in many applications such as drug delivery,13 tissue 
engineering14 and targeted diagnostic imaging.15 Advantages of self-assembling materials 
relative to covalently bonded equivalents include the responsive nature of the self-
assembly process, as well as the ability to tune the properties of the assembled material 
for individual applications by modification of the assembling monomers, and potential for 
multiple functionalities to be incorporated through the combination of varied monomers.11 
Self-assembling biomolecules, such as nucleic acids, carbohydrates, polypeptides and 
lipids, are of particular interest in many applications due to their higher biocompatibility and 
biodegradability in comparison to synthetic materials.16, 17 
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Designed peptides are particularly attractive components for the self-assembly of 
supramolecular structures, with potential in applications such as emulsion and foam 
stabilisation,18, 19 wound healing20, 21 and drug delivery.22, 23 These informational polymers 
may be produced with specific sequences, generally using synthetic methods based on 
solid-phase synthesis.24 Molecular complexity may be engineered into these molecules by 
producing sequences of amino acids of varied properties. The ease of access to 
oligopeptides of defined sequence has enabled investigation of sequence-structure 
relationships.25 While the precise link between molecular architecture and assembled 
supramolecular structure is still an area of ongoing study, in many cases it is now possible 
to use established design principles to produce peptides that self-assemble to form 
specific structures. This self-assembly is often highly dependent on the peptide 
environment and may be responsive to external stimuli such as changes in solvent,26 
solution pH,26, 27 temperature,28 salt concentration29, 30 or chelating metals.18, 31  Designed 
peptides also possess the advantage of being amenable to bioproduction, making them a 
potentially renewable material for large-scale applications.32, 33 
 
Figure 1-1. Classes of self-assembling peptides. A) Peptide amphiphiles, B) β-sheet forming 
peptides, C) α-helix forming peptides. Dashed bonds indicate peptide backbone hydrogen 
bonding pattern. Purple shading highlights secondary structures of β-sheet and α-helix. The 
dashed box in A and C highlight hydrophobic regions of the peptides. In B the hydrophobic 
region extends out of the image towards the viewer. Atoms are coloured according to element; 
carbon (grey), oxygen (red), nitrogen (blue) and hydrogen (white). 
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Self-assembling peptides may be classified by the types of structures they form. Three of 
the most common classes of self-assembling peptides are peptide amphiphiles, β-sheet 
forming peptides and α-helix forming peptides (Figure 1-1). A key driving force for self-
assembly in aqueous environments is the hydrophobic interaction. This drives hydrophobic 
moieties to segregate so as to minimise contact with the bulk aqueous phase.34 In peptide 
self-assembly, this driving force for association is generally opposed by the solvation of 
polar moieties and, where they are charged, electrostatic interactions.35 The self-
assembling peptides discussed in this review are relatively short amphiphilic sequences 
(Figure 1-1). Design of these amphiphilic peptides allows for forces favouring and 
disfavouring association to be controlled, and in turn direct peptide self-assembly. Section 
1.2 of this review gives an overview of the three self-assembling peptide classes and 
discusses key examples of each. Many self-assembling peptides have potential for use 
across a variety of applications. Section 1.3 focuses on the use of these self-assembling 
peptides as surfactants, cell scaffolds and therapeutic delivery vehicles. One of the 
barriers to the adoption of self-assembling peptides in many applications is the cost of 
production. Section 1.4 discusses production methodologies for designed self-assembling 
peptides, with a focus on bioproduction techniques. 
1.2 Peptide self-assembly 
1.2.1 Peptide amphiphiles  
Peptide amphiphiles (PAs) are a structurally simple class of self-assembling peptides that 
are designed to possess a lipid-like structure comprising a hydrophilic head and 
hydrophobic tail. The hydrophilic head is composed of one or more charged amino acids, 
while the tail can be either a string of hydrophobic amino acids or an alkyl chain.36 PAs 
assemble similarly to lipid molecules, with hydrophobic tails associating to minimize 
exposure to water, and have well-defined critical aggregation concentrations.37 Self-
assembly of PAs has been reported to produce well-ordered nanostructures such as 
bilayers,38, 39 micelles,40 vesicles,37 nanotubes,37 nanorods39 and nanofibres.41  
In PAs composed only of amino acids, the hydrophobic tail generally comprises 3-9 
hydrophobic residues such as alanine, valine or leucine.36 The hydrophilic head group is 
composed of one or more charged amino acids with lysine or aspartate being the most 
common. The hydrophilic head group is generally at the C-terminus of these peptides and 
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the terminal carboxylate may be either uncapped or capped, depending on the desire for 
an anionic charge. The hydrophobic tail is generally at the N-terminus, with the terminal 
amino acid capped to prevent interruption of hydrophobic interactions. However, the 
orientation of the hydrophobic and hydrophilic moieties can be swapped, in some cases 
without any significant effect on nanostructure assembly.42 PA self-assembly into defined 
nanostructures is pH dependent due to changes in the protonation state of charge-carrying 
residues. In highly charged states, electrostatic repulsion prevents self-assembly.37 As this 
charge is decreased, PA solubility is lowered and the electrostatic repulsion between 
peptides is lessened, allowing self-assembly. Further decreases in charge then leads to 
amorphous aggregation.39, 42  
The assembly of PAs occurs similarly to that of lipid molecules, where hydrophobic tails 
associate away from water, leaving the charged groups facing the bulk aqueous solution. 
However, unlike alkyl chain surfactants, the hydrophobic amino acids may form 
intermolecular hydrogen bonds as well as hydrophobic interactions. This leads to 
assembled PAs adopting a higher degree of organisation than would be present in lipid 
assemblies.37, 39 
PA self-assembly has been well characterised in solution. Studies by the Zhang group and 
others have shown PAs of six to twelve amino acids, including one to two anionic or 
cationic residues with the remainder being hydrophobic residues, to assemble into ordered 
nanotubes and vesicles at neutral pH.37, 42-45 A preference for formation of vesicles over 
nanotubes was seen with increasing PA hydrophilicity,37 however in changing PA 
hydropathicity, the peptide residue composition is modified. In doing so, other factors such 
as the size of the hydrophilic head group likely also play a role in structure determination. 
The assembly of these varied PAs illustrates that peptides with a similar distribution of 
hydrophobic and hydrophilic amino acids may self-assemble into comparable structures, 
even when their primary sequence varies. Further studies have shown longer PAs of ~ 30 
amino acids, with a higher proportion of charged residues, to form core-shell micelles at 
neutral pH.40 These micelles show potential in gene delivery applications, as is discussed 
in Section 1.3.3. 
In addition to characterisation of PAs in solution, studies of their assembly at interfaces 
have been reported. For example, the peptides Ac-V6K1-2-CONH2 were reported to form 
predominantly bilayer structures at the silica-water interface.38, 46, 47 These adsorbed 
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cationic peptides also bound DNA, demonstrating their potential for gene delivery 
applications.46 Xu et al.39 studied the assembly of the peptide series (Ac-AnK-NH2, n = 3, 6, 
9) at solid surfaces and showed that increasing the length of the hydrophobic tail gave 
changes in assembled nanostructures from stacked bilayers to nanotubes and nanorods. 
These transitions between structures were attributed to changes in the packing of the 
hydrophobic tails and interactions of the charged head groups. Some reports such as this 
have correlated observed transitions in assembled PA nanostructures with molecular 
architecture using adaptations of the packing parameter48 commonly used to describe 
conventional surfactant assembly.39, 45 However, these studies are so far limited, and 
require further experimental work to allow prediction of assembled structures. 
Rather than a series of hydrophobic residues, PAs may incorporate alkyl chains of typically 
12-16 carbon atoms in length at the N-terminus (Figure 1-2A).41, 49-52 Alkyl-tail PAs 
assemble in a similar manner to the PAs previously discussed, with the hydrophobic 
moiety segregating away from water and driving assembly. Assembly of alkyl-tail PAs has 
been reported to produce structures such as monolayers,50 spherical micelles49 and 
cylindrical micelles (nanofibres).41, 52  
Of the alkyl-tail PAs, those that form nanofibres have been particularly well studied.41, 52-58 
A key structural component of these PAs is the presence of a β-sheet forming region 
adjacent to the alkyl-chain tail (Figure 1-2B). Intermolecular hydrogen bonding between 
these first few residues occurs primarily down the longitudinal axis of the nanofibre, and 
stabilises the fibre arrangement relative to a spherical micelle structure.54 The interactions 
of this region also affect the ultimate mechanical properties of assembled structures, with 
less twisted β-sheet structures generating stiffer materials.53 Reversible cross-linking may 
be incorporated into alkyl-tail PAs by including cysteine residues adjacent to the alkyl 
chain. The formation of intermolecular disulfides stabilises nanofibres to disassembly.41  
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The incorporation of one or more charged residues in the hydrophilic head provides both 
solubility and electrostatic interactions that influence structure formation.41, 52 Nanofibre-
forming PAs with either cationic or anionic charges can be triggered to self-assemble by 
lowering the electrostatic repulsion between charged PAs. This can be achieved by 
adjusting pH to partially neutralise charge, charge-screening through the addition of 
electrolyte solutions such as cell culture media, or in the case of anionic PAs, the addition 
of divalent metal ions.41, 55, 56 Furthermore, mixed systems of oppositely charged PAs 
assemble under conditions where both species possess charge.57 In some cases, 
assembled nanofibres are able to form physical cross-links, resulting in hydrogel 
formation.55, 57, 58 Hydrogels formed by these peptides have potential use in several 
biomedical applications as is discussed in Section 1.3. 
In PAs, residues further away from the core are less involved in nanostructure formation. 
Alkyl-tail PA self-assembly tolerates a range of amino acids to be incorporated within the 
hydrophilic head, and allows greater sequence variation to be incorporated into alkyl-tail 
  
Figure 1-2. Example chemical structures of A) an alkyl-tail PA and B) a nanofibre forming alkyl-
tail PA. 
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PA design compared to amino acid only PAs. This has been used for the incorporation of 
functional motifs for specific applications.41, 54 For example, PAs have been designed as 
mineralisation templates and cellular scaffolds by incorporation of crystal nucleation and 
cellular recognition motifs respectively.41, 52 In some cases, incorporation of functional 
motifs partially destabilises PA self-assembly, likely by altering the length of the 
assembling peptide and disrupting peptide-peptide interactions.59 However, by including a 
proportion of non-functionalised PA, self-assembly can be restored. The functionalization 
of alkyl-tail PAs for specific applications has been well studied by both the Stupp group 
and others, and is discussed further in Section 1.3.  
Peptide amphiphiles are a structurally simple class of self-assembling peptide. The 
potential for modification of their structure is relatively limited due to requirements for self-
assembly. However, functionality is able to be integrated into many of these designs by 
incorporation of functional motifs within the hydrophilic head. Several such PAs, 
predominantly alkyl-tail PAs, have found utility in a range of applications as is discussed in 
Section 1.3. Peptides designed to assemble to form secondary structures such as β-
sheets or α-helices are more complex in design and are discussed in the following 
sections.  
1.2.2 β-sheet peptides 
The β-sheet structure was discerned from studies of proteins such as silk fibroin and β-
keratin, which contain a high proportion of this secondary structure.60-62 Structural 
assignment based on X-ray diffraction data and theoretical calculations allowed the 
conformation of polypeptides in β-sheets to be proposed. β-sheets are comprised of 
multiple polypeptide β-strands positioned in either parallel or anti-parallel configurations, 
with hydrogen bonding between backbone amide groups of neighbouring β-strands (Figure 
1-1B). In β-strands, polypeptides adopt an almost fully extended conformation. In this 
arrangement the side chains of sequential amino acids will be oriented alternating above 
and below the plane of the β-sheet.62 These early studies also indicated lamination of β-
sheet structures to occur, with interactions between laminated sheets dictated by the 
properties of residues at each face.62 
In early attempts to produce peptides that adopted stable laminated β-sheet structures, 
oligopeptides with repeating hydrophilic-hydrophobic sequences were investigated. 
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Studies of oligopeptides such as poly(VK),63 poly(EA),64 poly(KF)65 and poly(YK)66 showed 
these sequences to form β-sheet structures under conditions where the charge on the 
peptide was lowered by adjusting pH or screened by the addition of salt to reduce 
repulsive electrostatic interactions. This was attributed to the formation of β-sheet bilayers, 
in which hydrophobic interactions between non-polar residues stabilise association, and 
hydrophilic amino acids are displayed on the exterior (Figure 1-3).63 
 
Figure 1-3. Schematic representation of amphipathic β-sheet and bilayer assembly. A) β-strand, B) 
β-sheet in which hydrogen bonding occurs parallel with the plane of the page (as in Figure 1-1B), 
C) β-sheet bilayer. Hydrophobic and hydrophilic residue side chains are represented as red and blue 
spheres respectively. For simplicity the polypeptide backbone is represented as a line. 
Amino acids have distinct conformational preferences that influence their propensity to 
adopt secondary structures such as α-helices and β-sheets.67 Notably, the cyclic structure 
of proline makes this residue incompatible with the formation of either of these secondary 
structures. The propensity of amino acids for β-sheet formation has been studied by 
statistical analysis of residue composition of proteins with known structure68-70 and host-
guest studies,71 resulting in thermodynamic scales for β-sheet propensity. While there is 
some variation across the different studies, residues such as tyrosine, threonine, 
isoleucine and valine are seen to have high β-sheet propensity, while glycine, aspartate 
and alanine do not.68-71 The design of β-sheet forming peptides often targets the 
incorporation of high β-sheet propensity residues as well as hydrophobic-hydrophilic 
residue patterning consistent with the desired assembled structure. 
The advent of solid-phase peptide synthesis enabled investigation of short designed 
peptides of defined sequence. Short peptides composed of alternating hydrophobic-
hydrophilic residues showed a high tendency for β-sheet formation, similar to earlier 
oligopeptides, and allowed better study of factors influencing self-assembly. For example 
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the peptide length is a key determinant of self-assembly.72-75 Although some variation was 
seen with amino acid composition and solution conditions, a minimum peptide length of 
approximately 12 residues is observed for β-sheet formation. Typical designed β-sheet 
forming peptides are between 12-20 residues in length.76  
A complete understanding of the factors influencing the assembly of β-sheet forming 
peptides is yet to be achieved. However, the influence of assembly-stabilising and -
destabilising interactions has been the focus of significant research. Several studies have 
investigated the balance between stabilising hydrophobic interactions and hydrogen 
bonds, and destabilising electrostatic interactions.77-81 For example, studies have shown 
that increasing the hydrophobicity of the non-polar residues in alternating hydrophobic-
hydrophilic β-sheet forming peptides favoured self-assembly due to increased stabilising 
hydrophobic interactions.77, 78 Additionally, Dong et al.79 developed a series of “frustrated” 
amphiphilic peptides, in which the lengths of a central β-sheet forming domain and flanking 
cationic destabilising domains were varied. At neutral pH the peptide Ac-K2(QL)6K2-
CONH2 assumed a β-sheet secondary structure and formed nanofibres consistent with β-
sheet bilayers. Addition of salts lowered electrostatic repulsion and increased fibre lengths, 
while assembly in phosphate-buffered saline gave self-supporting hydrogels. Decreasing 
the length of the central domain lowered the number of stabilising interactions, while 
increasing the length of the flanking domains increased destabilising electrostatic 
interactions, such that in either case β-sheet and fibre formation was largely inhibited. 
These reports exemplify the fine balance between hydrogen bonding and hydrophobic 
effects that promote self-assembly and electrostatic repulsive effects that oppose self-
assembly.  
Many β-sheet peptides such as Ac-K2(QL)6K2-CONH2 assemble to form fibrils due to the 
repeating nature of their intermolecular hydrogen bonding network. Hydrogel formation 
occurs above a critical concentration for some of these peptides under appropriate solution 
conditions due to the formation of physical cross-links between fibrils.26, 82-88 Several 
research groups have developed series of β-sheet and hydrogel forming peptides based 
on successive modifications of β-sheet forming peptide designs and are now discussed. 
The series of fibril and hydrogel forming peptides reported by the Zhang group are some of 
the most studied in the literature. The first of these peptides, EAK16 (Ac-((AEAEAKAK)2)-
CONH2)) was designed based on a repeating AEAEAKAK sequence of the Z-DNA binding 
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protein Zuotin.89 EAK16 self-assembly gave a β-sheet structure at low concentrations that 
was extremely stable to thermal and chemical denaturation, as well as insensitive to 
changes in pH.30  Addition of NaCl to peptide solutions produced a macroscopic 
membrane composed of interwoven fibres with diameters corresponding to approximately 
the length of one peptide, consistent with individual peptides being oriented 
perpendicularly to the fibre axis.30, 75 The substitution of arginine for lysine and aspartate 
for glutamate in EAK16 gave the peptide RAD16-II (Ac-((RARADADA)2)-CONH2), which 
displayed self-assembly similar to EAK16. This outcome highlighted the importance of 
charged residue distribution rather than specific residue composition in these peptides.85 
Shortening of the repeating unit of RAD16-II gave the peptide RAD16-I (Ac-((RADA)4)-
CONH2), which maintains the alternating hydrophilic-hydrophobic amino acid sequence 
and assembles similarly to EAK16 and RAD16-II peptides.84 For these three peptides, 
assembly was proposed to proceed through formation of anti-parallel β-sheet bilayers due 
to intermolecular electrostatic repulsive interactions in the parallel arrangement.90 All three 
peptides readily self-assemble to form hydrogels when introduced into a solution of 
monovalent salt, physiological buffer or cell culture media, giving these peptides potential 
utility in several biomedical applications, as is discussed in Section 1.3.84, 85 As with many 
physical hydrogels, these peptide hydrogels are self-healing following mechanical 
disruption due to the non-covalent nature of fibre formation and fibre cross-links.90 
Peptide self-assembly can also be linked to conformational changes in the monomer 
structure. An example of this is the series of β-hairpin forming MAX peptides such as 
MAX1 (H2N-VKVKVKVKVDPPTKVKVKVKV-CONH2) developed by Schneider and 
colleagues.87 The design of these 20-residue peptides was based on two arms that 
possess a high tendency for β-sheet formation due to their alternating hydrophobic-
hydrophilic residue composition, similar to the EAK and RAD designs discussed 
previously. These arms flank a central tetrapeptide (VDPPT) that is designed to adopt a 
type II′ turn structure to enable β-hairpin formation. The ability of the two arms to form 
intramolecular hydrogen bonds is dependent on reducing the electrostatic repulsion 
between lysine residues by adjusting pH or increasing ionic strength.87, 91 β-hairpin folding 
occurs simultaneously with the formation of single monomer wide bilayer fibrils via lateral 
β-sheet formation and hydrophobic facial association. Several variants of MAX1 have been 
reported in which effects of residue substitution in the hydrophobic and hydrophilic faces 
have been studied.92-94 For example, the replacement of one lysine with a glutamate 
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residue gave the peptide MAX8, which showed self-assembly that was faster and occurred 
at lower pH values than that of MAX1 due to decreased levels of repulsive positive 
charge.92, 94 Both MAX1 and MAX8 peptides self-assemble to form hydrogels on addition 
of cell culture media,87, 95, 96 and have potential in several biomedical applications, as is 
discussed in Section 1.3.  
Polypeptide sequences with glutamine repeats possess a high tendency for β-sheet 
formation. Aggregates formed by these polyQ tracts have been linked to 
neurodegenerative diseases such as Huntington’s disease and Kennedy disease.97, 98 This 
predisposition for β-sheet formation is attributed to the ability of glutamine to form inter-
chain hydrogen bonds via both backbone amides and their polar side chains.98, 99 The 
design of peptides P11-2 (originally named DN1; Ac-QQRFQWQFEQQ-CONH2)26, 100 by 
the Aggeli group and Q11 (Ac-QQKFQFQFEQQ-CONH2)83 by the Collier group used the 
β-sheet forming tendency of this amino acid to direct peptide assembly. The alternating 
hydrophobic-hydrophilic residues in the centre of the peptides were included to promote β-
sheet assembly, while the inclusion of cationic and anionic residues near opposing peptide 
termini were used to dictate an antiparallel β-sheet alignment due to inter-molecular 
charge-charge interactions. The positioning of the three hydrophobic residues towards the 
centre of the peptides provided a hydrophobic driving force for assembly as well as 
intermolecular recognition via π-π interactions. 
Peptide Q11 assembled to form a β-sheet structure in solution at low concentrations, and 
electron microscopy revealed fibrils that were a single peptide in diameter.83 Increased 
ionic strength enhanced β-sheet assembly, with aqueous solutions of Q11 undergoing 
rapid hydrogel formation in monovalent and divalent salts or phosphate buffered saline. 
Fibrils and hydrogels of Q11 have shown utility in several biomedical applications as is 
discussed in Section 1.3. 
Peptide P11-2 also formed β-sheet structures in solution at low concentrations, with 
thermostable gels formed at acidic pH.26, 82, 100 A series of P11 class peptides were 
subsequently produced using similar design principles, but incorporated alternate charge 
carrying residues to give changes in the pH dependence of assembly.82, 101 For these 
peptides, assembly followed a nucleated pathway; above a critical concentration peptide 
monomers assembled into β-sheet tapes with further increases in concentration leading to 
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higher-order structures of ribbons (pairs of tapes stacked back to back via hydrophobic 
interactions), fibrils (bundles of stacked ribbons) and fibres (entwined fibrils).102  
The effect of peptide charge on β-sheet self-assembly has been investigated by the Aggeli 
group. Characterisation of a series of P11 gelling peptides capable of carrying either one or 
multiple charges allowed the proposal that in solutions of low ionic strength, a charge of ±1 
per peptide was required to decrease electrostatic repulsion and allow fibril formation and 
physical cross-linking interactions, while also maintaining peptide solubility.82  This 
provided pH responsive self-assembly as the charge carrying groups on self-assembling 
peptides were titrated. Increased ionic strength decreased electrostatic interactions via 
charge screening and altered the pH of gelation. This is exemplified by peptide P11-4 (Ac-
QQRFEWEFEQQ-CONH2), which transitions from a fluid to a gel phase at pH 6.0 upon 
the addition of salt.82 More recent experimentation by the Aggeli group has generated a 
much larger number of P11 peptides,101, 103  some of which are capable of gelation in cell 
culture media. One key observation was that in cell culture media, which possesses a high 
ionic strength, a charge per peptide of ±2 was required to maintain solubility. This is due to 
the screening of molecular charge and stronger hydrophobic driving force for assembly. 
These experiments also showed P11-4 to be capable of gel formation at physiological pH in 
cell culture media, making this peptide amenable to use in tissue culture models as is 
discussed in Section 1.3. Hydrogels formed by peptide P11-4 have also been demonstrated 
to promote remineralisation and hydroxyapatite nucleation. This has shown utility in the 
treatment of dental caries,104 and formulations involving P11-4 have progressed to clinical 
safety trials with promising results.105 
As well as assembly in solution, β-sheet peptides may be designed to assemble at 
interfaces. Rapaport et al.106 reported ordered monolayers of designed β-sheet peptides 7 
to 17 amino acids in length at the air-water interface as confirmed by grazing-incidence X-
ray diffraction. These peptides were of the form H2N-PE(FE)nP-COOH (PFE-n), where n = 
2-7. This series of peptides form anti-parallel β-sheets where the phenylalanine residues 
adsorb to the interface while the glutamate residues face the bulk aqueous solution. Lower 
solution pH leads to protonation of acidic side-chains, which decreases peptide aqueous 
solubility and increases the potential for intermolecular hydrogen bonding of the carboxyl 
groups. Both of these factors result in a more stable association at the interface. 
Monolayers of these peptides were both compressible and elastic, with recovery of original 
13 
 
structure following compression attributed to a reversible buckling of the peptide 
backbone.107, 108  
Further experimentation by the same group has generated several designs that direct the 
assembly of other molecules. The peptide PFD-5 assembles to give both monolayers and 
bilayer fibrils, of which the fibrils are able to form hydrogels at neutral pH.88 This peptide 
was also shown to template calcium phosphate mineralisation, making it potentially 
applicable in bone tissue regeneration. Vinod et al.109 recently reported the peptide PFK-5, 
which incorporated the cationic lysine as the charged hydrophilic residue. This peptide 
assembled at air-water interfaces and was able to template gold nanofibre film formation. 
Finally, by selective placement of residues on the hydrophilic face of the β-sheet peptides, 
catalytic arrangements of residues were formed.110 This enabled the direction of small 
molecule adsorption at peptide monolayers with potential in detection applications. 
Larger β-sheet forming polypeptides may also be designed using similar principles to 
those discussed above. A 30-residue peptide BS30 was designed as a triple-stranded β-
sheet peptide that formed a monolayer at the air-water interface.111 In this design, 8-
residue repeating sequences, following the hydrophobic-hydrophilic residue pattern 
(above), were linked via proline-alanine dipeptides. These dipeptides were designed to 
form type II β-turns, which resulted in an anti-parallel arrangement of adjacent β-strands. 
The triple-stranded peptide assembled into extended hydrogen bonded ribbons, with 
several packing configurations possible between triple-stranded units. 
The design of monomeric β-sheet based structures has been hindered by the tendency of 
this secondary structure for aggregate and fibril formation. However, there has been some 
progress in the design of small β-sheet units.112-118 For example, the 20-residue peptide 
Betanova was designed to adopt an antiparallel three-stranded β-sheet motif using two-
residue β-turn linkers.113 This peptide formed a discrete, well-folded conformation despite 
the absence of any covalent crosslinking. Several designs reported by multiple groups at 
almost the same time utilised similar design principles and also gave discrete 3-stranded 
β-sheet motifs.114-116 Ongoing work in this area has produced β-structured mini-proteins 
based on both naturally occurring motifs stabilised by disulfide bonds117 and modification 
of amyloid forming β-hairpin sequences.118 Investigation of such discrete β-sheet 
structures may increase understanding of complex interactions in native and designed 
proteins, as well as enabling de novo design of structures with increased complexity. 
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Peptides designed to adopt β-sheet conformations have been well studied, and as 
discussed above, several research groups have developed series of peptides based on 
particular designs. The rationale behind the design of these peptides generally focuses on 
a combination of residue patterning and the selection of amino acids that have high β-
sheet propensity. Studies of β-sheet forming peptides have predominantly focused on 
those capable of fibril formation. This is likely due in part to the tendency of β-sheet 
peptides to form these extended structures owing to the repeating nature of their 
intermolecular hydrogen bonding network. β-Sheet forming peptides show utility in many 
applications, as is further discussed in Section 1.3. An alternate secondary structure 
commonly targeted in peptide design is the α-helix, as is now discussed. 
1.2.3 α-Helical peptides 
The α-helical secondary structure was first proposed based on X-ray scattering studies of 
α-keratin, myosin and other fibrous proteins,119-121 as well as synthetic polypeptides122 
found to be rich in helical structure. In an α-helical conformation, the polypeptide backbone 
is folded into a right-handed helix where each amino acid corresponds to an approximately 
100° turn in the helix (Figure 1-1C). This results in 3.6 residues per helix turn and a 
periodicity of 5 turns or 18 residues (Figure 1-4A). In this arrangement the backbone 
amide groups are aligned axially and hydrogen bonds form between amides spaced four 
residues apart (i, i + 4).  
Further studies of helices in proteins suggested that many of these helices are in coiled-
coil arrangements.123, 124 In a coiled coil, two or more helices associate by wrapping 
around one another in a left-handed coil in either a parallel or anti-parallel arrangement. 
This arrangement results in a smaller 3.5 residues per helix turn, and a periodicity of 7 
residues, referred to as a heptad, in which positions are labelled a, b, c, d, e, f, and g 
(Figure 1-4B). Stabilisation of helix association was proposed to be due to hydrophobic 
interactions between the helices.124 A repeating periodicity of hydrophobic residues 
(conventionally at positions a and d) produces a hydrophobic face on each helix 
compatible with coiled-coil formation. 
Similar to studies of β-sheet forming peptides, the advent of solid-phase synthesis allowed 
studies of short defined peptide sequences, and investigation of factors influencing the 
folding of peptides into α-helical structures. Isolated α-helices tend to be 
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thermodynamically unstable in solution.125 However, it was found that α-helical structure in 
peptides could be stabilised by intramolecular constraints such as covalent bonds between 
i and either i + 4 or i + 7 residues126, 127 or metal ion coordination between residues at i and 
i + 4 positions.128, 129 In addition to these intramolecular constraints, helices may also be 
stabilised by association with interfaces. If hydrophobic residues are placed at alternating i 
+ 3 and i + 4 positions (residues 1, 4, 8, 11, 15 and 18 in Figure 1-4A) and hydrophilic 
residues at the remaining positions, a facially amphiphilic helix is generated that can 
associate laterally at air/oil-water interfaces.130 Over short distances of 1-3 heptads, the 
positioning of hydrophobic residues in helices for coiled-coil formation are also compatible 
with the hydrophobic residue positioning for facially amphiphilic helices capable of 
association with interfaces. One well studied facially amphiphilic peptide is Lac21 (Ac-
MKQLADS LMQLARQ VSRLESA-CONH2), which was derived from the coiled-coil forming 
domain of the Lac repressor protein131 and assembles at air-water interfaces.132 Several 
modifications to this peptide have been made to investigate their effect on assembly at 
interfaces and are discussed in Section 1.3.1.  
Similar to amino acid β-sheet propensity, statistical analysis of proteins of known 
structure,68-70 and host-guest studies using both protein and peptide sequences67, 133, 134 
led to the development of thermodynamic scales for the helix-forming propensity of each 
amino acid.  While some variation is present across these studies, residues such as 
alanine, arginine, lysine and leucine are considered to have high α-helix propensity, while 
glycine, cysteine and aspartate have low propensity for such structures. The design of α-
helix and coiled-coil forming peptides generally targets a combination of sequences with 
hydrophobic-hydrophilic residue patterning compatible with the desired structure, as well 
as selection of amino acids of high α-helix propensity. 
The study of peptides that assemble to form discrete coiled coils has been the focus of a 
large body of research. This work initially used peptides with sequences taken from 
leucine zipper motifs of native proteins such as GCN4,135, 136 and the paired Fos and 
Jun,137, 138 which were known to adopt coiled-coil structures. This work has led to an 
understanding of many factors affecting coiled-coil assembly such as peptide length, 
hydrophobic residue identity and the placement of charged residues, as is discussed 
below. Following on from this work has been the design of de novo peptides that adopt α-
helix and coiled-coil structures as is also discussed. 
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Figure 1-4. Representations of periodicity of α-helices in A) isolated and B) coiled-coil 
arrangements, and C) schematic illustrating interactions between helices in a parallel dimeric 
coiled coil. 
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As found for β-sheet structures (Section 1.2.2), coiled-coil stability is strongly dependent 
on the length of the constituent α-helical peptides.131, 139, 140 For example, Fairman et al.131 
showed that increasing the length of the Lac21 peptide to the four-heptad Lac28 or the 
five-heptad Lac35 increased coiled-coil stability by approximately 4 kcal mol-1 monomer-1 
per added heptad. This is attributed to increased numbers of stabilising interactions as well 
as lowering the proportion of amino acids in less stabilised positions at helix termini that 
take part in coiled-coil end-fraying.139, 141 Designed α-helix and coiled coil forming peptides 
are generally of three to six heptads, or 21 to 42 residues in length.142 
The identity of hydrophobic residues at heptad a and d positions also influences coiled-coil 
assembly due to packing of residues within the hydrophobic core. Hodges and colleagues 
investigated the effect of residue substitutions at positions a and d of the central heptad of 
a five-heptad dimeric coiled coil.143, 144 These studies showed a correlation between 
residue hydrophobicity and the resulting coiled-coil stability. This highlights the importance 
of hydrophobic interactions in stabilising coiled-coil assembly. While some variation was 
seen between positions, these studies showed the highest coiled-coil stability for peptides 
in which residues such as leucine, isoleucine or methionine were substituted at a and d 
positions. The packing of residues in the hydrophobic core also influences the 
oligomerization state of the coiled coil. By varying combinations of isoleucine, leucine or 
valine at a and d positions of the dimeric leucine zipper peptide GCN4-p1, Harbury et al.145 
showed transitions between dimeric, trimeric and tetrameric coiled coils. The general 
relationships between hydrophobic residue identity, coiled-coil stability and oligomerization 
state are likely to be complex, and vary between individual peptides. However, these 
results suggest that the packing of residues within the hydrophobic core of peptide coiled 
coils is an important factor in coiled-coil assembly. 
In both native proteins and designed coiled coils, positions e and g that flank the 
hydrophobic residues are often occupied by ionisable amino acid residues. In an 
assembled coiled coil, residues at positions e and g of constituent peptides will be brought 
into close proximity and interactions between them can dictate oligomerization selectivity 
(Figure 1-4C).142 This is exemplified in homo-dimerization, where placement of oppositely 
charged residues at e and g will destabilise the anti-parallel arrangement of helices, and 
favour parallel dimerization due to electrostatic interactions.146, 147 Similarly, the selective 
placement of charged residues at e and g positions can provide specificity in hetero-
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oligomerization interactions.137, 139, 140, 148, 149 The electrostatic interactions between helices 
can also confer pH-responsive coiled-coil assembly. Repulsion of like-charged residues at 
e and g positions of two helices will destabilise coiled-coil assembly, therefore allowing 
assembly only at pH values where charge on these residues is decreased.149, 150 
The hydrophobic core may also be expanded from positions a and d to include flanking 
positions e and g. This expansion is associated with an increase in the oligomerization 
state of coiled coils due to the larger hydrophobic face for association. For example, a 
change from a dimeric to a tetrameric coiled coil was reported on replacement of the three 
charged residues at g positions of the GCN4-pR peptide with hydrophobic alanine or 
valine.151 Further expansion of the hydrophobic core to include the e position gave the 
peptide GCN4-pAA, which assembled to form a heptameric coiled coil.152 More recently, 
Zaccai et al.153 utilised the relationship between expansion of the hydrophobic core and 
higher oligomerization state to design the hexamer forming peptide CC-Hex by placing 
hydrophobic residues at a, d and e positions. In coiled-coil forming peptides, the selective 
placement of charged or hydrophobic residues at positions e and g allows a degree of 
control over assembly to be engineered into the design. 
Designed coiled coils have been extensively utilised as polypeptide scaffolds for the 
production of catalytically active protein “maquettes”.154, 155 These structures generally 
involve the assembly of tetrameric coiled coils 4-5 heptads in length that are designed 
utilising similar principles to those already discussed, where hydrophobic interactions drive 
helix association.156, 157 Control over helix orientation is generally provided by covalent 
linkage of helix termini through disulfide bonds154, 158 or short polypeptide linkers.159-161 
Functionality is incorporated by including residues within the core of the coiled coil that 
bind redox-active metal ions or cofactors.154, 158, 160-163 Membrane association and 
integration may also be designed into these maquettes. This is achieved by increasing the 
hydrophobic residue content on the exterior of the coiled coils, and allows investigation of 
trans-membrane processes in simple designed systems.164 While natural protein 
engineering is hindered by a high degree of structural complexity, the simplicity of 
maquette design facilitates easier and more rapid investigations of structure-function 
relationships in molecular binding and catalysis. 
In addition to the discrete peptide coiled coils discussed so far, several examples of coiled-
coil fibrils have been reported. In these systems, coiled-coil forming peptides associate 
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with end-to-end overlaps to give longitudinal assembly (Figure 1-5). In some systems the 
formation of physical cross-links between these coiled-coil fibrils can produce hydrogels, 
similar to those of PA and β-sheet designs discussed previously. The majority of published 
work on fibril forming α-helical peptides has been completed by the Woolfson group,28, 165-
172 however these peptides predominantly form insoluble fibrils rather than hydrogels. The 
Woolfson group’s fibril forming designs are based on assembly of paired 28-residue 
peptides such as SAF-p1 (H2N-K IAALKQK IASLKQE IDALEYE NDALEQ-COOH) and 
SAF-p2 (H2N-K IRALKAK NAHLKQE IAALEQE IAALEQ-COOH). These peptides were 
designed with an asymmetric distribution of charged residues at e and g positions along 
the helix axis to promote staggered assembly. An asparagine residue was also included in 
an a position of each peptide, which is only able to form structure-stabilising intermolecular 
hydrogen bonds in an offset arrangement of helices (Figure 1-5A).165 SAF-p1/p2 peptides 
and several subsequent generations of designed sequences self-assembled at neutral pH 
to give insoluble rigid fibres of micrometres in length and ≥45 nm in width. These fibres 
were highly ordered and resulted from the lateral association of peptide coiled-coil 
filaments that were each expected to be ~ 2 nm in diameter.165, 166 The presence of salts 
inhibited peptide assembly, demonstrating the importance of electrostatic interactions in 
the design.165 Due to the destabilising placement of polar residues in the coiled-coil core, 
peptide fibrils were thermally unstable and required low temperatures for assembly.165, 167 
Assembled morphology was controlled by the addition of modified peptides designed to 
introduce kinks168 and branches169 into the fibrils. More recent work by the same group has 
given the peptides hSAFAAA-p1 and hSAFAAA-p2.28 These peptides follow the same basic 
design as the SAF sequences, except that b, c and f positions of both peptides are 
populated with alanine residues to reduce electrostatic interactions and promote 
hydrophobic interactions between peptide fibrils. Assembly of these peptides gave thinner, 
more flexible fibrils that were thermally stable and produce hydrogels at physiological pH 
and salt. These hydrogel forming peptides have been investigated for biomedical 
applications as is discussed in Section 1.3.2. 
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Figure 1-5. Schematic showing three design approaches for coiled-coil fibril formation: A) forced 
offsetting of helices by placement of hydrogen bonding residues within the hydrophobic core and 
asymmetric charged residue distribution,27, 28, 31, 165, 166, 168-173 B) end-to-end stacking of coiled coils 
with offset helices,174 C) forced offsetting of helices by non-continuous hydrophobic faces of 
helices.29, 175 Hydrogen bonds within the hydrophobic core are shown as lock-and-key 
arrangements; horizontal lines within each peptide mark the ends of heptads. 
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A similar approach to specify helix offsetting and fibril formation was used in the peptide 
designs of the Conticello group.27, 31, 173 The peptides YZ1 (Ac-E IAQLEKE IQALEKE 
NAQLEKK IQALRYK IAQLREK NQALRE-CONH2) and TZ1H (Ac-E IAQHEKE IQAIEKK 
IAQHEYK IQAIEEK IAQHKEK IQAIK-CONH2) were designed to form dimeric and trimeric 
coiled-coil fibrils respectively. Both peptide designs utilised asymmetrical charge 
distribution along the helix axis as well as multiple polar residues within the hydrophobic 
core to specify helix offsetting. In the case of TZ1H, assembly was designed to be pH 
dependent, with protonation of histidine residues at d positions causing assembly inhibition 
at low pH.27 Further experiments showed these internal histidine residues to coordinate 
silver ions that stabilised coiled-coil assembly.31 Assembly of both YZ1 and TZ1H gave 
insoluble fibrils of ≥20 nm, showing a high degree of lateral association similar to the SAF 
peptide designs. 
Another system showing offsetting of helices was reported by Liu et al..152 The peptide 
GCN4-pAA was observed to form a heptameric coiled coil with a single-residue shift in 
registry between adjacent helices, resulting in an offset of a full heptad between helices 1 
and 7. Helix offsetting was hypothesised to be driven by preferential packing of 
hydrophobic residues at positions a, d, e and g as well as a ring of hydrogen-bonding 
residues within the coiled-coil core. Xu et al.174 recently reported redesign of this peptide to 
give 7HSAP1 (H2N-KLAQA VEKLARA VEKLAYA NEKLARA VEKLAQA VE-COOH). Self-
assembly of 7HSAP1 resulted in staggered coiled coils that were stacked via end-to-end 
overlap of helices (Figure 1-5B) to give thermostable coiled-coil fibrils that did not laterally 
associate in solution. At lower concentrations, fibrils formed from 7HSAP1 were seen to be 
unstable and showed breaks and partial dissociation. This is likely to be due to the small 
amount of overlap afforded between coiled coils in this arrangement. 
In another approach to helix offsetting, the Fairman group has reported the development of 
peptides that use non-continuous hydrophobic faces to dictate end-to-end overlap (Figure 
1-5C).29 This design utilised two copies of the first two heptads of the GCN4 sequence 
separated by a two alanine residue linker to give the peptide CpA (Ac-CKQLEDK IEELLSK 
AA CKQLEDK IEELLSK-CONH2). Incorporation of the alanine spacer results in an 
approximately 200° rotational offset between the two-heptad modules, making these 
peptides only able to assemble into a staggered conformation rather than flush-ended 
coils. Addition of salts to enhance hydrophobic interactions was required for assembly of 
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these coiled coils. This was due to the short two-heptad overlap providing only a weak 
driving force for association. Assembly in NaCl solutions gave nanofilaments of only a few 
nm in diameter with lengths of several hundred nm, while addition of the divalent anion 
sulfate gave laterally associated filaments. Further experimentation showed that 
substitution of isoleucine at the first a positions of the CpA peptide increased the 
hydrophobic driving force for association and promoted coiled-coil assembly at lower NaCl 
concentrations.175 
Several coiled-coil fibril forming peptides have also been reported in which no attempt was 
made to specify helix offsetting in the original design. These designed peptides all have a 
high degree of self-similarity in the constituent heptad repeats. For example, peptide α3 
(H2N-(LETLAKA)3-COOH) reported by Kojima et al.176 and Takei et al.177 comprises three 
exact heptad repeats, peptide αFPP (H2N-QLAREL(QQLAREL)4-COOH) and derivatives 
reported by Potekhin et al.178 and Melnik et al.179 comprise four exact and one incomplete 
heptad repeat, while Peptide 1 (H2N-EIKQLES EISKLEQ EIQSLEK-COOH) and 
derivatives reported by Dong et al.180 possess three heptads with a slightly lower degree of 
self-similarity. These peptides all form thin fibrils of <10 nm in diameter, with self-assembly 
of peptides αFPP and Peptide 1 producing hydrogels at acidic pH. In studies of αFPP and 
Peptide 1 derivatives, replacement of charged residues with uncharged residues in solvent 
exposed positions resulted in laterally aggregated fibrils, likely due to reduced 
intermolecular repulsive forces.179, 180 No detailed study has been made of the mechanism 
of fibril formation in these peptides. However, one consequence of the self-similar heptads 
is that helices shifted out of register by increments of a heptad will have similar inter-helical 
interactions as those in an in-register arrangement. This may lower the energetic barrier to 
end-to-end overlaps, possibly promoting fibril formation.178 
α-Helix and coiled-coil forming peptides have been well studied, and many of the factors 
affecting their assembly, such as residue patterning and α-helix propensity, have been 
investigated. In many cases, this now allows for the de novo design of α-helix and coiled-
coil forming peptides. This is demonstrated by the growing number of reported surfactant 
peptides, protein maquettes and fibril forming peptides, as discussed above. Compared to 
PA and β-sheet forming peptides, α-helix forming peptides that assemble to give fibrils and 
hydrogels are less well developed. However, as described in this section, this is an area of 
study attracting recent attention. α-Helix forming peptides, as well as PAs and β-sheet 
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forming designs, have demonstrated utility in several applications as surfactants, cell 
scaffold materials and therapeutic delivery vehicles, as is now discussed. 
1.3 Applications of peptide self-assembly 
1.3.1 Surfactants 
There has been growing interest in biosurfactants as alternatives to conventional 
surfactants that are derived from petrochemicals. This interest is due to biosurfactants 
lower toxicity, higher biodegradability and potential for renewable production.181, 182 
Peptides in particular are of interest due to their stimuli responsiveness and designable 
assembly.183 Due to the amphiphilic structure of the peptide designs discussed in Section 
1.2, many of these peptides associate at protein surfaces and air/oil-water interfaces. 
Peptide self-assembly at these surfaces and interfaces shows utility in applications such 
as protein, foam and emulsion stabilisation, which are now discussed. 
Amino-acid only PAs have been investigated for their ability to solubilise and stabilise 
membrane proteins in solution. PAs such as Ac-A6K-CONH2 stabilised the photosynthetic 
complex photosystem I for several weeks, thereby increasing its potential utility in devices 
such as photodetectors and photovoltaic cells.184-186 Similar PAs were used to stabilise E. 
coli glycerol-3-phosphate dehydrogenase187 and G-protein coupled receptor bovine 
rhodopsin188 without causing structural damage or loss of activity. PAs increased protein 
stability over several days relative to many conventional detergents such as the commonly 
used octyl glucoside.187 The increased stability of membrane proteins solubilised by PAs 
may potentially be due to the more membrane-like environment produced by the assembly 
of these lipid-like peptides compared to conventional detergents. This increased protein 
stability may accelerate study of membrane protein structure. More recent work has used 
similar PAs to solubilise and stabilise membrane proteins such as olfactory receptors189 
and several G-protein coupled receptors190 during cell-free production, enhancing the 
yields of these otherwise difficult to produce proteins. 
Lac21 is a facially amphiphilic α-helical peptide (Section 1.2.3) that associates at air/oil-
water interfaces and lowers interfacial tension.132 The surfactant properties of a series of 
reversibly cross-linkable α-helical peptides based on the sequence of Lac21 has been well 
studied, predominantly by the Middelberg group.18, 19, 191, 192  Peptide AM1 was designed 
based on the sequence of Lac21, where residues 9 and 20 were replaced with histidine 
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residues.18, 191 This positioning leaves the histidine residues facing the aqueous phase, but 
oriented towards neighbouring helices at the interface. At neutral pH in the presence of 
metal ions such as Zn(II), these histidine residues form intermolecular cross-links, resulting 
in a mechanically strong interfacial film that stabilises emulsions and foams.18, 191 The 
addition of two more histidine residues at positions 13 and 17 produced the peptide AFD4. 
This resulted in histidine residue spacings of i + 3 and i + 4, which are compatible with 
both intermolecular and intramolecular metal ion cross-linking.19 Under identical cross-
linking conditions AFD4 gave stronger interfacial films and improved emulsion and foam 
stability compared to AM1.19, 192 Film formation by both AM1 and AFD4 was reversible 
through the addition of chelating agents or lowering pH to inhibit intramolecular cross-
linking. Loss of film cross-linking resulted in rapid emulsion coalescence or foam 
collapse.18, 19, 191, 192 Neutron reflectometry showed AM1 concentration at the interface is 
not significantly altered by film formation or loss. This indicated that the switching of 
emulsion and foam stabilisation is due to loss of the mechanical properties of the 
interfacial film rather than surfactant desorption.18, 19, 192  
The functionality of α-helical surfactant peptides possessing a high carboxylate content 
has also been investigated. The peptide Lac21E was designed based on the Lac21 
sequence,193 with the substitution of glutamate at positions 2, 3, 9, 10, 16 and 17 that are 
oriented towards bulk aqueous solution. This peptide adsorbed to the air-water interface 
and lowered interfacial tension as a function of molecular charge.194 At low pH, where 
glutamate residues are partially neutralised, Lac21E readily adsorbed to the interface, 
lowering interfacial tension and forming an interfacial film. Conversely, at high pH, where 
glutamate residues are deprotonated, peptide desorbed from the interface and film 
formation was lost.  
The rate of adsorption of surfactant peptides at interfaces is dependent on the assembled 
state of the peptide in bulk solution. As discussed in Section 1.2.3, the peptide Lac28 
assembles into a tetrameric coiled coil more readily than the shorter Lac21. Middelberg et 
al.132 reported that at moderate to high surface coverage of the octane-water interface, 
Lac28 showed slower adsorption kinetics than Lac21 due to the requirement for Lac28 
tetramer dissociation. Similarly, DAMP4, which was designed as a tetrameric miniprotein 
of DAMP1 repeats, displayed much slower adsorption to the air-water interface than the 
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monomeric DAMP1 surfactant peptide. This was attributed to the requirement for 
rearrangement of the larger and more structured DAMP4.195 
There have been few studies of PA or β-sheet peptide assembly at air/oil-water interfaces, 
with most reports instead focusing on their assembly in solution (Sections 1.2.1 and 1.2.2). 
The few reports on the assembly of these peptides at interfaces are generally focused on 
the formation of monolayers rather than their surfactant functionality.46, 50, 106 One report by 
Dexter196 investigated the surfactant properties of a series of β-sheet peptides based on 
the designs of Rapaport et al.106 with the sequence Ac-PX(FX)3P-CONH2, where X was an 
ionic residue. By varying the charged residue composition and solution pH, the assembly 
of these peptides at molecular-charge values of ±4 to 0 was assessed. At low molecular 
charge, peptides adsorbed readily at the interface and formed interfacial films, presumably 
by assembly of an ordered β-sheet. Lower peptide adsorption but better emulsification was 
seen at higher molecular charge. This suggests these β-sheet peptides stabilise emulsions 
primarily by conferring a high droplet surface charge rather than the film-formation 
mechanism seen for the AM1 and AFD4 α-helical peptides.  
The responsive self-assembly at interfaces of both the α-helical and β-sheet forming 
peptides discussed here allow surfactant functionality to be rapidly “switched”. This can be 
achieved by adjusting solution pH or the addition of a chelating agent, depending on the 
peptide. This provides stimuli-responsive control over emulsion or foam stability, which is 
of growing interest for many applications ranging from oil recovery and demulsification to 
cosmetics and textile treatment.197, 198  
As discussed here, designed self-assembling peptides show potential utility in several 
applications such as protein, emulsion and foam stabilisation. One of the benefits of these 
peptides over alternate biosurfactants is their designable and responsive assembly. These 
peptides also possess the potential for renewable production using bacterial expression, 
as discussed in Section 1.4. As well as assembly at interfaces, many self-assembling 
peptides are capable of fibril and hydrogel formation (Section 1.2). These hydrogel forming 
peptides have shown utility in several biomedical applications and are now discussed. 
1.3.2 Cell scaffolds 
Matrices that support cell growth are of interest for applications such as wound healing,199 
tissue engineering200, 201 and modelling disease states in vitro.202 Commonly used cell 
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growth matrices are naturally sourced and include decellularised extracellular matrices,203, 
204 collagen gels205, 206 or secreted protein mixtures such as Matrigel.207, 208 However, these 
naturally-sourced matrices have several drawbacks such as the high potential for 
immunogenic rejection, batch-to-batch variability and a lack of the ability to modulate their 
characteristics.202, 209, 210 The use of defined synthetic matrices such as polymer- or 
peptide-based hydrogels offers the potential to overcome many of these issues.206, 209, 210 
Peptide-based materials are particularly appealing due to their biocompatibility,84, 85 stimuli 
responsiveness211 and the ability to rationally design and control their self-assembly.28, 86 
Hydrogels formed by PA and β-sheet peptides in particular have been well characterised 
as cell scaffolds and are now discussed in detail. 
Several peptide hydrogels based on β-sheet structures have been demonstrated to 
support cellular attachment and growth in the absence of any further functionalization.84, 85, 
95, 212 For example, hydrogels of the peptides EAK16 and RAD16-II supported the 
attachment of a variety of primary cells and cell lines including fibroblasts and 
keratinocytes.85 In subsequent experiments, hydrogels of RAD16-II and RAD16-I 
supported extensive neurite outgrowth and active synapse formation by several neuronal 
cell types.84 Additionally, hydrogels of the peptides PFD-5 and MAX1 were reported to 
support the attachment and proliferation of osteosarcoma and fibroblast cells 
respectively.95, 212 Furthermore, MAX peptides are also antibacterial, with efficacy against 
both gram positive and negative bacteria, potentially increasing the utility of these peptides 
as wound dressings.213, 214  
To date, the most widely studied self-assembling peptides for cell culture matrices are the 
RAD16 peptides developed by Zhang and colleagues. RAD16-I peptide hydrogels have 
now been commercialised and are sold under the trade name Puramatrix by Corning. This 
has expanded the ease of access to this defined substrate for ongoing research. 
In a cells native environment within the body it is surrounded by the extracellular matrix 
(ECM). The ECM is a complex material composed primarily of a mixture of proteins and 
polysaccharides that provides structural support as well as cell signalling and adhesion 
domains.215, 216 Common components of the ECM include fibronectin, laminin, collagen 
and vitronectin.216 These macromolecules include specific integrin recognition motifs 
involved in cellular attachment. While some peptide hydrogels are able to support cellular 
attachment and proliferation with no further functionalization (above), others such as those 
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formed by PAs55 and peptide Q11217 show poor cellular attachment and proliferation. One 
common strategy used to improve cellular interactions with scaffold materials such as 
peptide hydrogels is to functionalise these materials with cell-recognition motifs such as 
the fibronectin-derived RGD and RGDS or the laminin-derived YIGSR and IKVAV 
sequences.21, 55, 59, 217-225  
The functionalization of alkyl-tail PA nanofibres by incorporating RGDS and IKVAV 
sequences in the hydrophilic head has been extensively explored.21, 55, 59, 218-221 For 
example, PAs functionalised with a variety of RGDS ligands supported the attachment and 
proliferation of fibroblasts, with the more mobile branched RGDS motifs showing enhanced 
cell adhesion and migration.219 As discussed in Section 1.2.1, the functionalization of PAs 
partially destabilises assembly, however mixtures of PAs functionalised with RGDS motifs 
and non-functionalised PAs gave recovery of material properties and supported the 
proliferation of bone marrow derived stem cells.221 
Hydrogels of functionalised Q11 peptide have also been investigated as defined 
substrates for cell culture. Incorporation of Q11 peptides functionalised at the N-terminus 
with RGD or laminin-derived IKVAV and YIGSR motifs did not significantly affect the 
assembly of the peptide at all ratios investigated. While poor cellular attachment and 
proliferation was seen on hydrogels of Q11 alone, hydrogels that incorporated 
functionalised peptide supported the attachment and proliferation of fibroblasts and human 
umbilical vein endothelial cells.217, 223-225 
The effect of functionalising the C-terminus of RAD16-I with a variety of biologically active 
motifs has been assessed for several cell lines.222, 226-228 While the functionalization of 
RAD16-I with short motifs did not interfere with self-assembly, longer sequences of more 
than 6 residues significantly decreased assembly and required the incorporation of non-
functionalised peptide to recover material properties.226 The functionalization of RAD16-I 
with several physiologically relevant motifs enhanced the attachment and proliferation of 
murine neural stem cells227 and precursor osteoblasts.222 Additionally, primary human 
fibroblasts proliferated and were stimulated to produce their own ECM when cultured on 
hydrogels of RAD16-I functionalised with RGD and laminin adhesion motifs.228 In each of 
these examples, cells seeded on hydrogels of functionalized RAD16-I infiltrated the 
peptide scaffold, demonstrating the potential of these gels in wound healing applications 
where cells from surrounding tissues may migrate into the peptide matrix.222, 227, 228  
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Modification of peptide hydrogels can also be targeted towards controlling material 
degradation rates. For example a series of MAX peptides were designed to include 
metalloproteinase cleavable sites to allow cellular degradation of the gels over time, which 
enhanced cell proliferation and migration into the gels.229 Variation of the cleavage 
susceptible site gave altered rates of digestion, allowing materials to be designed with 
specific rates of degradation. Notably, incorporation of cleavable sites also decreased 
peptide self-assembly, and it is likely that the folded or partially unfolded state of the 
peptide will also influence proteolytic degradation. 
There has been significant work done towards the functionalization of peptides to enhance 
cellular interactions. However, it is still unclear as to why some peptide systems such as 
PAs and Q11 peptides appear to require this functionalization for cellular attachment and 
proliferation, while others do not. It is expected that materials will become non-specifically 
functionalised with adsorbed proteins when they are exposed to biological systems such 
as serum containing media used in tissue culture experiments.201 These adsorbed proteins 
may facilitate cellular attachment in lieu of any specific functionalization. It is therefore 
possible that protein adsorption, and consequently cellular attachment, occurs less readily 
on the materials that require specific functionalization. However further experimentation 
will be required to determine the exact reason for poor cellular attachment to these 
surfaces. 
The hydrogels of modified PA, RAD16-I, Q11 and MAX peptides discussed here highlight 
the potential for design of these self-assembling peptides to give enhanced cellular 
interactions with these defined cell scaffold materials. Appropriate biologically active 
sequences are able to be selected to enhance interactions with specific cell types (above). 
In some cases the incorporation of biologically relevant motifs can interfere with peptide 
self-assembly. However, it is possible to overcome this by incorporating a proportion of 
non-functionalised assembling peptide.219, 221, 222, 226, 228 The optimal proportion of non-
functionalised peptide is a factor that is expected to be sequence dependent and will likely 
need to be optimised empirically for each self-assembly peptide and functional motif. 
The cell microenvironment can play an important role in determining cellular proliferation, 
morphology and response to therapeutic drugs.230-234 The culture of cells in 2D or 3D 
environments is a strong influence in determining cell responses and proliferation rates 
due to factors such as drug penetration, nutrient diffusion and cell-cell contacts. The 
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culture of cells within 3D matrices rather than on 2D substrates is therefore an important 
step in providing in vitro models that better mimic the conditions experienced by cells 
within their native environment, as well as characterising cellular responses to scaffold 
materials in 3D prior to in vivo work.202 
The culture of cells encapsulated within self-assembling peptide hydrogels has been a 
target of ongoing research. For example, RAD16-II peptide gels stimulated angiogenesis 
of encapsulated human micro-vascular endothelial cells,235 while studies of RAD16-I 
hydrogels showed them to support the growth and differentiation of encapsulated neuronal 
stem cells236, 237 and hepatocyte progenitor cells.238 Hydrogels of alkyl-tail PAs 
functionalised with RGDS or IKVAV recognition sequences supported the proliferation of 
encapsulated bone marrow derived stem cells221 or mouse neural progenitor cells55 
respectively. In separate studies, hydrogels of MAX8 supported the growth of 
encapsulated primary bovine chondrocytes.239 Furthermore, redesign of MAX8 to give 
peptides with lower positive charge produced similar hydrogel assembly, but enhanced 
growth of encapsulated cells, indicating that a less charged matrix may benefit cellular 
proliferation.239 Collier and colleagues have also reported hydrogels of the peptide Q11 to 
support the encapsulation and growth of fibroblasts, as well as murine stem cells when 
functionalised with RGD motifs.240 Hydrogels of several P11 type peptides, including P11-4, 
were reported to support the growth of encapsulated fibroblasts.241, 242 Additionally, due to 
the benign methods used to trigger crosslinking in these peptide systems, gel formation is 
generally able to occur in the presence of cells. This allows the cells to be homogeneously 
distributed throughout the gel matrix, producing a more uniform material and cellular 
environment.55, 86, 235-240 These results demonstrate hydrogels formed by designed self-
assembling peptides to be promising materials for the culture of several cell types with 
potential as both in vitro model systems and in regenerative medicine applications. 
However, further clinical studies will be required to determine how these materials may 
translate to model systems and human treatments. 
It has been shown that cell growth and function are impacted by the mechanical properties 
of the underlying substrate.243-246 Peptide hydrogels are generally relatively weak 
compared to chemically cross-linked materials and have elastic moduli in the range of 
pascals to kilopascals,28, 87, 91, 247  which may limit their utility to soft tissue applications.248, 
249 The network density and resulting hydrogel mechanical properties can be controlled by 
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the concentration of self-assembling peptide.236, 250, 251 This is exemplified by peptide 
MAX1, which at concentrations of 0.7, 1.4 and 2.1 wt% produced hydrogels with elastic 
moduli of approximately 0.25, 1.6 and 4 kPa respectively.250 These moduli are comparable 
to soft tissues of the body such as the lymph node and brain, and approach the moduli of 
liver and breast tissue at higher concentrations.248 Solution conditions such as pH, ionic 
strength and temperature may also be used to control hydrogel mechanical properties.87, 91  
However, these factors are generally pre-determined by requirements for cell growth and 
are therefore less useful for specifying mechanical properties of cell scaffold materials.  
The type of cross-links between fibrils can influence the resulting mechanical properties. 
For example, hydrogels formed by hSAF peptides designed to form fibril-fibril hydrogen-
bonds melted on warming to physiological temperature, while those stabilised by 
hydrophobic interactions were strengthened.28 Additionally, the formation of more specific 
interactions between fibrils can increase mechanical strength. For example, the elastic 
modulus of hydrogels formed by the peptide PLE-5 at 1.8% (w/v) was as high as 60-90 kPa 
when Ca2+ was included at the time of gelation, likely due to the formation of coordinated 
ion crosslinks.212 Covalent cross-linking of peptide hydrogels by chemical217, 252or 
enzymatic253 means can also be used to increase mechanical strength. Jung et al.217 
showed cross-linking of 4.6 % (w/v) Q11 peptide hydrogels using native chemical 
ligation254 to increase elastic moduli approximately five-fold. The mechanical properties of 
peptide hydrogels may therefore be selected for individual applications by adjusting 
peptide concentrations or by forming more stable cross-links between assembled fibrils. 
The physical nature of the cross-links in non-covalently cross-linked peptide hydrogels 
also means they are generally shear thinning and self-healing, meaning these materials 
are injectable, enabling simpler delivery in biomedical applications.86, 87, 90 
The success of peptide hydrogels in in vitro studies has led to interest in their use for 
tissue engineering applications. However, few of these systems are yet to be 
characterised in vivo. For example, while in vitro characterisation of MAX1 and MAX8 
showed these peptides to be non-cytotoxic and not elicit macrophage activation,96 to date 
no in vivo testing of these hydrogels has been reported. In comparison, the EAK16 and 
RAD16 peptides developed by Zhang and colleagues have been much better 
characterised in vivo. Preliminary studies showed that injection of EAK16 and RAD16-II 
peptide hydrogels into rabbits and rats gave no toxic effects or immunological response, 
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indicating high biocompatibility.84, 85 This led to further studies of these hydrogels in several 
in vivo models.  
Studies of RAD16-II and RAD16-I hydrogels in burn and diabetic wound models showed 
hydrogels to enhance angiogenesis and wound closure, demonstrating the potential of 
these hydrogels in wound healing applications.255, 256 Characterisation of RAD16-I 
hydrogels in neural injury and spinal cord damage models showed improved tissue and 
axon regeneration while also reducing scar formation.20, 247, 257 In one study of damage to 
the optic tract of hamsters, axon growth through hydrogels at the wound site gave 
functional recovery in the majority of treated animals.20 Furthermore, encapsulation and 
delivery of neuronal stem cells inside RAD16-I hydrogels enhanced regeneration of 
damaged rat brain tissue.247 These studies demonstrate the potential of these peptide 
hydrogels to both enhance tissue regrowth and deliver stem cells in neural wound healing 
applications, however further clinical studies will be required to determine how this efficacy 
may translate to humans. Alkyl-tail PAs have also been characterised by the Stupp group 
for their utility in neural wound healing models. Hydrogels of these peptides showed 
promising results in a murine spinal cord damage model21 and also delivered encapsulated 
neural progenitor cells to these injury sites to enhance tissue regeneration.218 The utility of 
peptide hydrogels is increased in many of these tissue engineering models by the ability to 
shear thin preformed hydrogels or trigger gel formation in situ. This facilitates the injection 
of the peptide material in a liquid state allowing the material to fill gaps and enhance 
subsequent integration with host tissue.21, 86, 257 
Despite the success of RAD16 hydrogels in in vivo trials, the progression of this material to 
clinical trials has been limited, with only one reported study investigating this materials 
efficacy as a haemostatic agent.258 One potential reason for this slow progression may be 
that there remain concerns about the applicability of β-sheet based materials for clinical 
use. One reason for this is that β-Sheet fibrils possess structural and potentially 
pathological similarities with misfolded protein aggregates implicated in several 
neurodegenerative and amyloid diseases such as Alzheimer’s disease, Parkinson’s 
disease and prion diseases including spongiform encephelopathies.259-261 Progression of 
several of these diseases appears to involve the induction of native protein unfolding by a 
β-sheet template, and there exists the potential for materials formed by β-sheet peptides to 
initiate such misfolding. Indeed, experiments by Westermark et al.262 showed induction of 
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AA-amyloid deposits in mice during inflammation following subcutaneous injection of 
amyloid-like fibril forming peptides, including RAD16-I. While these experiments 
demonstrate the potential for amyloid nucleation by these peptides, how these results may 
translate to human risks is currently unknown. Furthermore, the long lead time for many of 
these neurodegenerative diseases will make such health risks difficult to rule out.263, 264  
In addition to their implicated role in disease pathogenesis, recent studies have also 
shown several examples in which the formation of amyloid structures is part of normal 
biological functions for many organisms, ranging from micro-organisms to humans. 
Examples of functions carried out by amyloid structures include biofilm formation, 
regulation of catabolic pathways and sequestration of toxic intermediates.265-267 Given the 
diverse roles played by amyloid structures, exactly how amyloid structures formed or 
nucleated by peptides may induce disease or influence native biological processes is likely 
a complex question which will require further study to gain a better understanding. While 
there still remains questions regarding the clinical application of amyloid-like fibril-forming 
peptides, one alternate, and possibly safer, route to self-assembling peptide hydrogels is 
to avoid these peptides and instead utilise α-helical peptides that form coiled-coil fibrils. 
A limited number of hydrogels formed from the assembly of α-helical peptides have been 
reported to date (Section 1.2.3). Of these, few have been assessed for their ability to 
support cell growth, largely due to hydrogel assembly not occurring under physiological 
conditions. The hSAFAAA peptides designed by the Woolfson group form hydrogels under 
conditions of physiological pH and salt.28 However, these hydrogels were unstable in cell 
culture media. A substitution of one alanine residue for a tryptophan residue was required 
to increase hydrophobic interactions to produce gels stable enough for cell culture 
experiments. These hydrogels supported the growth of rat adrenal pheochromocytoma 
cells at levels similar to that of Matrigel controls. While this demonstrated the potential for 
α-helical peptide hydrogels to support mammalian cell growth, this tumour-derived cell line 
is likely to be less demanding in terms of growth conditions than non-tumour-derived 
alternatives.268 Investigation of the growth of cells with a more native phenotype will be 
required to better determine the utility of these materials for many applications. More 
recently, a cyclic coiled-coil peptide Cycl_one was reported that utilises a similar approach 
to helix offsetting as the SAF peptides. Assembly of this peptide gave mesoscopic fibrillar 
networks that did not gel but supported the growth of human dermal fibroblasts. 
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Proliferation on these surfaces was further enhanced by the incorporation of the laminin-
derived YIGSR recognition motif.269 
Hydrogels of self-assembled peptides have demonstrated utility as cellular scaffolds for 
both in vitro and in vivo use. As discussed in this section, several alternate peptide 
designs, which are predominantly PA and β-sheet based, have been investigated with 
promising results. However, there is no standard approach to testing these materials and a 
variety of cell types, indicators of cytocompatibility and measures of proliferation have 
been used that complicate comparisons between systems. The general outcomes from 
this body of work suggest that these relatively weak matrices are best suited to soft tissue 
applications, with several reports showing promising results for neural tissue engineering 
in particular. In addition to their use as cell scaffold materials, self-assembling peptides 
have shown utility in other biomedical applications such as therapeutic delivery, as is now 
discussed. 
1.3.3 Therapeutic delivery 
There is a large body of ongoing research towards the development of more effective, 
targeted and controlled therapeutic delivery systems.270-272 Self-assembling peptides are 
promising materials for therapeutic delivery vehicles. They possess advantages due to 
their biocompatibility,84, 85, 96 stimuli responsiveness31, 40 and the possibility to rationally 
design their assembly.23, 28 
Their amphiphilic structure and tendency to form micelles and liposomes make PAs 
attractive targets for therapeutic delivery systems.23, 40, 273-275  An example of this are PAs 
with an alanine tail and the cationic H5K15 head group that form micelles capable of binding 
DNA for gene delivery applications and show similar efficacy to polyethylenimine.40 In this 
design the lysine residues are utilised to bind DNA, while histidine residues are included to 
provide pH-responsiveness upon endosomal uptake, causing DNA release. Incorporation 
of the more hydrophobic residue phenylalanine in the PA tail gave peptide FA32, which 
assembles into micelles that are also capable of loading the chemotherapeutic 
doxorubicin.23 Micelles of FA32 co-delivered both encapsulated doxorubicin and bound 
DNA in in vitro studies. This demonstrates the potential for these PAs to be used as a dual 
therapeutic delivery system.23, 40 However, to date little work has been done towards 
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functionalization of such micelles for targeted delivery, which would enhance their 
specificity and efficacy for in vivo applications.270 
Peptide-based scaffolds are well suited for the delivery of therapeutics and can be 
designed to give controlled release of proteins and small molecules. The ability to 
assemble peptide scaffolds in situ also enables co-injection of bioactive molecules and 
self-assembling peptides to achieve localised delivery of therapeutics. Hydrogels formed 
by functionalised alkyl-tail PAs have been developed for growth factor and small molecule 
delivery. For example, heparin-binding PAs were produced by incorporation of the binding 
sequence (LRKKLGKA) in the hydrophilic head.276 Heparin is a natural biopolymer known 
to interact with several growth factors, and when bound to PA nanofibres may present and 
release these molecules to promote bioactivity. Hydrogels formed by heparin-binding PAs 
have been characterised in both in vivo and in vitro studies on angiogenesis,276, 277 islet 
transplantation278, 279 and cardiovascular disease280 with positive results. In another 
approach for therapeutic delivery from PA hydrogels, attachment of the anti-inflammatory 
drugs nabumetone or dexamethasone to PA nanofibres through a degradable hydrazone 
linkage gave slow controlled release under physiological conditions281, 282 and showed 
promise in in vivo testing.282 
Nanofibres formed by an alkyl-tail PA have also been used to physically encapsulate the 
chemotherapeutic doxorubicin for delivery.283 In this case, nanofibre disassembly and 
therapeutic release was triggered via enzymatic modification of the PA by an extracellular 
cancer biomarker. Doxorubicin was also reported to associate with the β-sheet peptide 
PFD-5 designed by the Rapaport group.284 Doxorubicin enhanced folding of PFD-5 in 
solution and was incorporated into peptide hydrogels. Sustained release of the 
chemotherapeutic occurred over several days with demonstrated cytotoxicity to an 
osteosarcoma cell line. Macroscopic disintegration of the hydrogels was observed in some 
cases, possibly due to the Ca2+ used to trigger gelation leaching from the gel. This gel 
instability is a barrier to the application of these gels in vivo, where reproducible material 
stability is required.  
Hydrogels of the fibril-forming RAD16 and MAX peptides have also been investigated for 
therapeutic delivery.22, 251, 285-289 For example, it was shown that the release of physically 
encapsulated small molecules from RAD16-I hydrogels was dependent both on peptide 
concentration and the strength of electrostatic interactions between model compounds and 
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the peptide scaffold.285  Similar gels also showed controlled release of physically 
entrapped proteins such as lysozyme, trypsin inhibitor, bovine serum albumin and 
immunoglobulin G without causing denaturation of loaded biomolecules.286 The rate of 
biomolecule release was dependent on both protein size and peptide scaffold 
concentration. Furthermore, Gelain et al.287 showed that the addition of C-terminal charged 
sequences to RAD16-I peptides altered electrostatic interactions with loaded molecules. 
Design of such peptide-therapeutic interactions was utilised to give controlled release of 
active cytokines from hydrogels over several days. More recently, Koutsopoulos et al.288 
reported the long-term release of human antibodies from layered peptide scaffolds of 
RAD16-I and the related peptide Ac-(KLDL)3-CONH2.  
MAX peptide hydrogels showed controlled release of positively charged and neutral 
biomolecules such as lysozyme and immunoglobulin G, with the rate of release governed 
by steric interactions with the network.251, 289  Conversely, negatively charged biomolecules 
interacted strongly with the positively charged peptide matrix and were released at much 
lower levels.289 Altunbas et al.22 have also reported the controlled release of the anti-
tumorigenic molecule curcumin from MAX8 peptide hydrogels. Released therapeutic was 
demonstrated to maintain bioactivity in in vitro assays. These examples demonstrate that 
the control of interactions between loaded molecules and peptide hydrogels may be used 
to regulate release rates. This has the potential for future applications where therapeutic 
release may be modulated depending on specific clinical requirements. 
Nanofibres formed by the β-sheet peptide Q11 have been investigated as vaccine delivery 
vehicles.290-294 In these systems, covalent linkage of epitopes or whole proteins to a short 
linker sequence at the termini of the peptide allowed display of these molecules at high 
density on peptide fibres. Importantly, the attachment of these molecules did not inhibit 
Q11 peptide assembly. When investigated in vivo the peptide fibres were seen to act as an 
adjuvant, generating strong immune responses to displayed vaccine molecules such as 
malarial epitopes290 that in some cases lasted for over one year, while no immune 
response was seen to the peptide itself.291  
The use of α-helical peptides in therapeutic delivery applications has been less well 
studied than PA or β-sheet peptides. However, their designable assembly as well as the 
potential for hydrophobic drug encapsulation295-297 make α-helical peptides attractive 
targets for therapeutic delivery. For geometric reasons, higher-order coiled coils contain an 
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internal tubular cavity, as observed in heptamer,152, 174 hexamer,153 pentamer298 and even 
tetramer structures.145, 298 The binding of hydrophobic biologically active molecules all-
trans retinoic acid, vitamin A and vitamin D3 has been shown within such a hydrophobic 
channel of the COMPcc pentameric coiled coil.295, 296 This demonstrates the potential for 
encapsulation and delivery of these molecules utilising coiled-coil forming peptides. 
Coiled-coil forming peptides have also been investigated as epitope presenting molecules 
for vaccines. For example the Burkhard group has reported peptides that consist of two 
linked coiled-coil domains that assembled into peptide nanoparticles.299-301 Similar to the 
Q11 fibres discussed previously, the functionalization of these peptides with epitopes 
elicited specific immunogenic response to the repetitively displayed antigens. This 
demonstrates the potential of this system for use in vaccine production. 
Self-assembling peptides show potential in applications for therapeutic delivery both as 
small micelle delivery vehicles and scaffold materials for controlled release. These scaffold 
materials also have demonstrated applications as epitope presenting materials for 
vaccines. Similar to the trends observed in cell-scaffold materials, the majority of work in 
this space has utilised either PAs or β-sheet forming peptides, with few α-helix forming 
peptide systems thus far reported. However interest in α-helical based systems is 
expanding. 
While this section has outlined potential applications of self-assembling peptides ranging 
from emulsion and foam stabilisation to tissue engineering and therapeutic delivery, there 
still remain limitations in translating these materials to commercial products. One key 
limitation to the adoption of these materials in many applications is the cost of peptide 
production. Current production methods are centred on high-cost solid-phase synthesis 
methods. However the biological expression of designer peptides may offer a cheaper and 
more renewable alternative, as is discussed in Section 1.4. 
1.4 Peptide production 
1.4.1 Chemical synthesis 
The majority of peptides reported to date for practical applications have been prepared by 
solid-phase chemical synthesis. This technique was originally introduced by Merrifield and 
involves the stepwise addition of amino acids to a surface bound oligopeptide.302 The 
current state of development of these techniques has been reviewed extensively24, 303 and 
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only a brief summary is included here as a complete review of this field falls outside the 
focus of this project. In a typical solid-phase synthesis process, each amino acid is 
temporarily protected at the N-terminal amino group. In each step the N-terminal protecting 
group of the bound oligopeptide is removed before the next sequential amino acid is 
introduced for addition. Amino acid side chains are also protected during synthesis in order 
to avoid undesired side reactions and are deprotected following recovery of the peptide 
from the resin. The surface attachment of the growing peptide chain allows removal of 
non-reacted derivatives and coupling reagents via simple washing procedures. Solid-
phase peptide synthesis is generally straightforward and may be automated to enable the 
synthesis of desired peptide sequences by non-specialist chemists. 
While this technique offers versatility in the range of sequences able to be synthesised, it 
does possess several key drawbacks. For example, there still exist technical difficulties in 
synthesising long oligopeptides (>20-30 amino acids) at large scale.24 Additionally, large-
scale production of peptides is expensive and has the potential for significant 
environmental impact due to the generation of toxic by-products and large volumes of 
chemical waste.24, 304, 305 While high-value products such as pharmaceuticals and 
biomedical devices can be feasibly produced by solid-phase synthesis, adoption of 
peptides for large-scale material applications is only viable if they can be produced at low 
cost. Biological expression of designed peptides offers a production methodology that may 
be able to achieve renewable and economically viable production at large scale.306 
1.4.2 Biological expression 
While bioproduction is an appealing method for peptide production, the expression of short 
peptides is a non-trivial process.  Peptides that are expressed in isolation are generally 
unstructured and therefore susceptible to proteolysis in the intracellular environment.32, 307 
One common approach to producing a more stable construct for expression is to couple 
peptides to a larger carrier protein. This approach facilitates expression of the peptide as 
part of a folded fusion protein and minimises proteolysis.32 Several detailed reviews exist 
of available fusion protein partners of which only a few are highlighted here.308, 309 
Commonly used fusion partners for soluble product expression include glutathione s-
transferase (GST, 26 kDa), maltose-binding protein (MBP, 42kDa), thioredoxin A (12 kDa) 
and small ubiquitin-related modifier (SUMO, 12 kDa). These highly expressed proteins 
enhance production, protect the fused peptide from proteolysis and increase product 
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solubility. Peptides may also be attached to a carrier protein such as ketosteroid 
isomerase (KSI, 13 kDa), which forms insoluble inclusion bodies that protect products from 
intracellular degradation and can simplify recovery after expression. One strategy to 
enhance recovery following expression is to incorporate short sequences such as 
polyhistidines, antibody epitopes or streptavidin binding tags as part of the fusion protein 
construct.308 These tags enhance product recovery by enabling the use of affinity 
chromatography to recover the fusion construct. The fusion partners GST and MBP also 
possess the added advantage that these facilitate the use of affinity chromatography 
directly, without the need for additional affinity tags.308 
Expression of peptides as fusion proteins is an easily adaptable method that enables 
biological production of short peptides. However, due to the relatively small size of most 
peptides compared to the carrier proteins, the target sequence only comprises a small 
portion of the expressed product (ca. 3-15% by weight for a typical 2 kDa peptide). As the 
total amount of heterologous protein that can be produced by a cell is finite, this low weight 
fraction becomes a limiting factor in production yields. One effective approach used to 
increase the proportion of target peptide in the expressed product is the incorporation of 
multiple copies of the target sequence.310-313 However, the number of incorporated repeats 
cannot be increased indefinitely, and the higher repeat number constructs tend to display 
lower expression.310-313 The optimal repeat numbers for expression must therefore be 
determined empirically for each expression system. The exact reason for decreased 
expression of higher repeat number constructs is not clear. However, it may relate to the 
instability of high repeat number expression plasmids and long RNA transcripts in the 
cell.312, 314  
To further enhance potential bioproduction yields, peptides may be expressed as tandem 
repeats or “concatemers” in the absence of a fusion partner.313 In this approach the target 
peptide comprises almost the entire expressed product. Similar to multiple copies in fusion 
proteins, this approach also requires empirical optimisation of repeat numbers.313-315 
Furthermore, expression of such designed constructs will generally succeed only if the 
resulting concatemer can form a stably folded structure. Targeted design approaches such 
as those outlined in Section 1.2 may be utilised to give peptide and concatemer 
sequences that will fold into stable structures for expression.316-318 Both theoretical 
considerations and a lack of examples in the literature suggest tandem expression of 
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highly cationic or anionic peptides to be unfavourable. Expression of these highly charged 
sequences is constrained by charge destabilisation preventing stable folding within the 
cell, and potential host toxicity in the case of cationic sequences.315, 319  At the same time, 
highly charged peptides are valuable targets as functional surfactants and antimicrobial 
peptides. In some cases the pairing of highly-charged peptides with oppositely-charged 
expression partners to form a less charged complex has been used to overcome these 
effects.315, 319  
Several factors influencing expression in the host organism can also be accounted for in 
the design of expression constructs and their coding sequences.320, 321 Variation in residue 
composition to avoid overloading amino acid biosynthesis pathways can enhance the 
potential for protein overexpression.322, 323 Optimisation of the nucleic acid sequence 
coding for the expression construct may be used to avoid undesired restriction, promoter 
or ribosomal binding sites,320 while balancing of relative nucleotide content can also be 
used to enhance oligonucleotide construct stability.320 Heterologous protein expression 
may also be enhanced by matching codon usage frequency to the host expression 
organism, as rare codon usage may decrease translation rates.324 Avoiding sequence 
repeats can also reduce undesired nucleic acid structure that may otherwise lower 
expression.320 Several algorithms exist for optimisation of nucleic acid sequences that 
greatly simplify this process when designing expression construct coding sequences.320, 324  
In both fusion protein and concatemer expression, cleavage of the expressed construct is 
required to give functional monomeric peptides. This can be accomplished by either 
enzymatic or chemical cleavage methods. Table 1-1 lists common cleavage approaches 
and their associated cleavage sites. Both enzymatic and chemical cleavage methods 
require design of the expression construct sequence to both include targeted cleavage 
sites, and avoid undesired cleavage within the target peptide. The functionality of the 
peptide target is generally highly dependent on amino acid sequence (Sections 1.2 and 
1.3). The selection of cleavage methods that minimise the required sequence 
modifications are therefore necessary to preserve functionality of the expressed peptide.  
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Table 1-1. Cleavage sites and resulting peptide terminus modifications of common enzymatic 
and chemical cleavage methods 
Cleavage agent Type Cleavage site Terminus modifications 
Enterokinasea Enzymatic DDDDK|X - 
Factor Xab Enzymatic I(E/D)GR|X             
(X≠R or P) 
- 
SUMO proteasec Enzymatic (SUMO protein)|X        
(X≠P) 
- 
Tobacco etch virus 
(TEV) proteased 
Enzymatic ENLYFQ|(S/G) - 
Thrombine Enzymatic LVPR|GS - 
3C proteasef Enzymatic ETLFQ|GP - 
Hydroxylamineg Chemical N|G C-terminal 
hydroxamate 
CNBrh Chemical M|X 
(X≠S or T) 
C-terminal homoserine 
lactone 
CDAP/NTCBi Chemical X|C Iminothiazolidine 
modified cysteine 
Acid and heatj Chemical D|P - 
Where | represents cleavage location and X represents any amino acid except as noted. a Hosfield 
and Lu.328 b Nagai and Thogersen.329 c Malakhov et al..330 d Dougherty et al.331 and Carrington 
and Dougherty.332 e Chang.333 f Cordingley et al..334  g Bornstein and Balian335 and Smith et al..336 
h Kuliopulos and Walsh310 and Riley et al..311 i Tang et al.337 and Wu and Watson.338 j Li et al.339 
and Zhang et al.340 
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Enzymatic methods are generally higher cost and require the incorporation of longer 
recognition sequences than chemical cleavage alternatives (Table 1-1). Furthermore, 
proteases such as enterokinase and factor Xa can give non-specific cleavage, thereby 
lowering peptide recovery.325, 326 However, enzymatic cleavage generates free amino acid 
termini and requires relatively benign cleavage conditions, thereby limiting amino acid 
modifications during processing. Chemical cleavage is generally a simpler and cheaper 
option; however, cleavage agents such as hydroxylamine, cyanogen bromide (CNBr), 1-
cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) and 2-nitro-5-
thiocyanobenxoic acid (NTCB) produce non-native amino acid termini (Table 1-1). 
Furthermore, side-reactions and the harsher conditions used in chemical cleavage 
methods can result in amino acid modifications such as deamidation and oxidation.327 
Environmental concerns with toxic waste production can also limit the use of reagents 
such as CNBr in large-scale production. The scale of production, requirements for product 
peptide sequence and sensitivity to chemical modifications will therefore influence 
cleavage method selection during expression construct design. 
Purification of cleaved peptides may be achieved by several methods depending on 
factors such as cost, scale and purity required. The majority of published methods for the 
purification of expressed peptides utilise reversed phase, affinity or ion-exchange 
chromatography, either in single or sequential steps.274, 306, 311, 312, 317, 341-343 This is due to 
the high level of purity attained with these methods as well as technique simplicity and 
adaptability for varied peptides. While these methods are effective at the laboratory scale 
for early peptide characterisation, chromatography-based approaches add significant cost 
to overall peptide production and are impractical for large-scale processes.344, 345 An 
alternative approach is to utilise chromatography-free methodologies, which use selective 
precipitation steps induced by changes in solution pH, salt concentration or 
temperature.346-348 These methods utilise knowledge of the target peptide physicochemical 
properties to achieve separation from other cellular material. These techniques offer the 
potential for low-cost purification of expressed peptide and are easily scalable. However, 
the level of purity achieved in these methods may be lower than that achieved with 
conventional chromatography.345-348 While this may be acceptable for industrial 
applications, the production of therapeutic peptides necessitates the higher purity currently 
only achievable with chromatography. 
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The biological production of only a few self-assembling peptides has been reported to 
date. The majority of these have utilised a fusion protein approach and involved recovery 
via chromatography based methods as described above. For example, peptide 
amphiphiles PA2 and PA7 were expressed as SUMO fusion partners. Cleavage via SUMO 
protease gave monomeric peptides that self-assembled to form vesicles.274 Reed et al.341 
reported expression of a tetrameric RAD16-I construct as a cellulose-binding domain 
fusion protein. A glutamic acid residue was incorporated at the C-terminus of each peptide 
to enable endoproteinase GluC mediated cleavage that produced monomeric peptide that 
assembled similarly to synthetic RAD16-I.  
The expression of P11 peptides has been reported in several instances. Hartmann et al.312 
first reported the expression of tandem repeats of P11-2 separated by cysteine residues as 
KSI fusion proteins that were cleaved by CDAP. In this case the single peptide repeat 
gave the highest P11-2 recovery. However, the self-assembly of the expressed peptide was 
not reported. In another approach used by the Middelberg group, P11-2 was expressed as 
a thioredoxin fusion protein that was cleaved by TEV protease. Chromatography-free 
processes gave recovery of expressed peptide that self-assembled similarly to synthetic 
P11-2.347 P11-4 has also been expressed by the Aggeli group as either tandem- or single-
repeat KSI fusion proteins with methionine residues inserted for cleavage with CNBr.311, 348 
Recovery of the single-repeat fusion protein was achieved using chromatography-free 
methods.348 Of the recovered peptides, only P11-4 produced by the single-repeat fusion 
protein assembled similarly to synthetically produced P11-4. This was due to the C-terminal 
homoserine lactone formed during cleavage that altered the net peptide charge and 
modified the assembly of peptides produced as tandem repeats.311 
Self-assembling α-helical peptides have also been biologically produced. For example, 
studies of the coiled-coil fibril forming peptide α3 used peptide expressed as an adenylate 
kinase fusion protein that was cleaved by CNBr.342 The biological production of the α-
helical peptide surfactants Lac21 and AM1 has also been investigated. Lac21 was 
expressed as a KSI fusion protein that had terminal cysteine residues incorporated for 
cleavage with CDAP.306 Surfactant functionality of the product peptide was lower than that 
of synthetically produced peptide due to terminus modifications resulting from the chemical 
cleavage methods used. Kaar et al.343 reported expression of the surfactant peptide AM1 
as an MBP fusion protein with a glycine residue incorporated at the N-terminus (GAM1) to 
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enable cleavage by TEV protease. Recovered peptide showed similar interfacial properties 
to synthetically produced GAM1. However, a comparison to AM1 peptide was not 
reported. DAMP4 was then designed as a tetrameric coiled-coil concatemer of the AM1 
sequence separated by acid-cleavable linkers which was recovered using a 
chromatographic approach.317 More recent work by the same group has produced a 
chromatography-free process for recovery of “industrial grade” DAMP4.346 However, 
deamidation of asparagine residues occurred during cleavage of the expressed protein 
that affected the interfacial properties of the recovered peptide.349  
Several of these biologically produced peptides display altered self-assembly compared to 
synthetically produced equivalents.306, 311, 349 These examples illustrate the potential for 
sequence modifications to affect peptide properties. Given the limited range of cleavage 
methods available, it seems likely that compatibility of peptide sequences with these 
methods will be a limiting factor in determining sequences that are amenable to 
bioproduction. Future design of bioproduction processes may be able to overcome some 
of these issues by redesign of target sequences to be more compatible with expression 
and cleavage, or investigation of alternate cleavage methods. 
The examples outlined here represent a variety of approaches to peptide bioproduction 
and demonstrate the ability to design expression systems for self-assembling peptides. 
However as mentioned above, peptide recovered from bioproduction processes is 
potentially not equivalent to synthetically produced material due to modifications 
introduced during expression and cleavage. While this is currently a limitation to the field, 
the bioproduction of compatible sequences potentially enables the renewable production 
of these peptides at large scale and lower cost. Chromatography-free methods in 
particular may simplify the scale-up of bioproduction methods and increase the potential 
for large-scale production.346-348 The approaches detailed here focus on the adaptation of 
existing self-assembling peptides to biological production methodologies. An alternate 
strategy is to incorporate features for biological production during the de novo design of 
self-assembling peptides. In this way it may be possible to reconcile end-use properties 
with expressibility and provide a framework for the design of application-targeted 
expressible peptides. 
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1.5 Research aims and thesis overview 
The work reported in this thesis focused on the design, characterisation and bioproduction 
of self-assembling α-helical peptides. It was particularly focused on peptides that act as 
switchable surfactants or self-assemble to form fibrils and hydrogels. These peptides show 
potential utility in several applications such as emulsion and foam stabilisation, tissue 
engineering and drug delivery, as discussed in Section 1.3.  
As discussed in Section 1.4, one of the barriers to the large-scale adoption of these self-
assembling peptides for materials applications, such as foam and emulsion stabilisation, is 
the high cost of solid-phase synthesis. Bioproduction methodologies may offer a low-cost 
route for production of such peptides. The recombinant expression of designer peptides is 
a currently emerging field of research, making this an appealing research focus. As 
described in Section 1.4.2, one particularly promising approach for biological production of 
peptides is as designed protein concatemers. By combining design considerations for 
stable concatemer folding and expression with peptide end-use properties, this work 
aimed to produce an overall design framework for application targeted designer peptides 
which are amenable to bioproduction. This aimed to both expand the availability of 
designer peptides for large-scale applications such as emulsion and foam stabilisation, 
while also increasing the understanding of factors effecting concatemer folding and design. 
This is then summarized as research hypothesis 1; that by utilising peptide design 
methods that consider factors for both expression and end-use properties, a low-cost 
method for producing peptides for large-scale applications may be achieved. 
As discussed in Section 1.2, peptides that form α-helices and discrete coiled coils have 
been the subject of extensive studies. This now provides a solid background for future 
design of α-helix and coiled-coil forming peptides. However, in comparison to the 
established fields of fibril forming PAs and β-sheet forming peptides, the study of α-helical 
based fibrils and hydrogels is less well developed. At present, the majority of reported α-
helix based fibrils form insoluble materials (Section 1.2.3). This has limited the 
investigation of these materials in biomedical applications (Section 1.3). The investigation 
of peptides that form α-helical based fibrils and hydrogels with utility as cellular scaffolds 
and therapeutic delivery vehicles therefore represents an opportunity to expand the 
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knowledge base of the disciple and formed a secondary aim of the work reported in this 
thesis. 
This is then summarized as research hypothesis 2; that by characterising the self-
assembly and resulting physical properties of α-helical peptide hydrogels, as well as 
successive redesign of peptide sequences, a better understanding of these materials may 
Table 1-2. Research aims of each chapter within this thesis 
Chapter Research Aims 
2 
1) To design and assess expression of de novo peptide 
concatemers intended as bioproduction constructs for 
surfactant peptides. 
2) To develop a low-cost recovery and purification method 
for expressed concatemers, consistent with the aim to 
develop a production method for peptides for large-
scale applications 
3 
3) To cleave the expressed peptide concatemer from 
Chapter 2 to release constituent surfactant peptides. 
4) To characterise the pathways involved in heat and 
acid-mediated cleavage of the concatemer. 
5) To assess the thermodynamic and interfacial properties 
of the cleaved products. 
4 
6) To characterise the self-assembly of a novel hydrogel 
forming α-helical peptide. 
7) To devise a model for the fibril and hydrogel formation 
of the peptide based on biophysical characterisation of 
self-assembly. 
8) To utilise the proposed model of peptide self-assembly 
to design related peptides with desired properties. 
5 
9) To characterise the mechanical properties of hydrogels 
produced by peptides designed in Chapter 4. 
10) To investigate the peptide hydrogels as both 2D and 
3D cell scaffold materials. 
11) To assess the ability of hydrogel forming peptides 
designed in Chapters 4 and 5 to bind and release 
therapeutics. 
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be achieved which will allow for design of α-helical hydrogels with utility as cellular 
scaffolds and therapeutic delivery vehicles. 
The research focus of this project was therefore twofold. It initially aimed to design peptide 
sequences amenable to biological production while also possessing functionality. The goal 
of this work was to increase the availability of designer peptides by lowering production 
costs. The second focus of the project was to design and characterise novel self-
assembling peptides to expand the understanding of this field of biophysical chemistry. 
This project ultimately encompassed each step of the pathway from biological production 
through to the use of self-assembling peptides in novel applications.  
Table 1-2 shows the research aims of each chapter within this thesis and the outcomes of 
each chapter are described below. 
Chapter 2 describes the successful bioproduction of an anionic helical surfactant peptide 
EDP-11 as part of a charge-paired heteroconcatemer with the cationic partner RDP-4. The 
design of the constituent peptides and overall bioproduction process considered both the 
end-use properties of individual peptides and the ability of the concatemer to generate a 
stably folded coiled-coil structure for expression. The polypeptide sequence was further 
optimised for net charge, hydropathy and predicted protease resistance. The designed 
heteroconcatemer expressed at high levels in E. coli and was extremely stable to heat and 
proteases, allowing isolation of the concatemer by simple heat and pH precipitation steps.  
Following expression using this concatemer approach, cleavage was required to produce 
monomeric α-helical peptides. The design of acid-cleavable aspartate-proline sites within 
the concatemer sequence allowed for simple heat and acid cleavage to give constituent 
peptides, as detailed in Chapter 3. Quantification of intermediate species over time 
allowed modelling of the kinetic pathways involved, which showed previously unobserved 
preferences in cleavage sites. Both intact and cleaved heteroconcatemer were 
demonstrated to possess surfactant functionality, with the rate of adsorption to the air-
water interface controlled by the assembled state in solution. 
In Chapter 4 the peptide AFD19 is reported as part of ongoing work on the design of α-
helical surfactant peptides. This peptide unexpectedly self-assembled to form coiled-coil 
fibrils and underwent gelation as a function of solution pH. This chapter describes 
characterisation of the assembly of AFD19 and proposal of a model for self-assembly. 
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Based on this model, AFD19 was redesigned to give the peptide AFD36, which forms 
hydrogels at physiological pH and salt, giving potential utility in the biomaterial field. Both 
AFD19 and AFD36 possess high thermodynamic stability and results from transmission 
electron microscopy and small-angle X-ray scattering are consistent with the peptides self-
assembling to form unbundled higher-order coiled-coil fibrils. 
Chapter 5 describes the investigation of α-helical peptide hydrogels as potential cellular 
scaffolds and therapeutic delivery vehicles. Rheological characterisation of AFD36 
hydrogels showed weak viscoelastic properties potentially suitable for soft tissue 
engineering. Redesign of AFD36 gave peptide AFD49, and both supported the growth of 
NIH/3T3 fibroblasts at levels similar to those of TCPS controls. AFD49 hydrogels 
supported the proliferation of encapsulated NIH/3T3 fibroblasts over several weeks. 
Culture of induced pluripotent stem cells on AFD49 hydrogels indicated non-functionalized 
AFD49 hydrogels to be unsuitable as substrates for induced pluripotent stem cells. AFD49 
hydrogels were also investigated as therapeutic delivery vehicles for the hydrophobic drug 
all-trans-retinoic acid. 
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2 Bioproduction of Highly Charged Designer Peptide 
Surfactants: Expression and Chromatography-Free 
Purification of a Coiled-Coil Heteroconcatemer 
2.1 Introduction 
Designed self-assembling peptides show potential utility in several fields as described in 
Chapter 1. One particularly promising area of research involves the use of designed self-
assembling peptides as low-toxicity and highly biodegradable responsive surfactants.1-3 
Work within the candidate’s research group has shown that amphipathic helical peptides 
with a high content of carboxylate-containing amino acid residues confer emulsion stability 
in high salt. This is due to the stabilising role of strong headgroup hydration and is 
particularly true for peptides with carboxylate sidechains designed to align close the 
interface (unpublished data). Peptides of this kind are desirable for use in applications 
such as intravenous delivery of hydrophobic drugs as well as formulation of industrial 
drilling and cutting fluids, where exposure to salt may destabilise emulsions formed by 
conventional surfactants.4 
Adoption of peptides for material applications is only viable if they can be produced at low 
cost. As described in Chapter 1, the biological expression of designed peptides, 
particularly as concatemers, offers an attractive alternative to expensive chemical 
synthesis methods. Bioproduction methods should be able to be optimised to achieve 
renewable and economically viable processes at large scale.5 However, the strong 
negative charge present on peptides with a high carboxylate content is unfavourable for 
expression as tandem repeats, due to electrostatic repulsion preventing stable folding. 
One way to overcome this destabilisation is to reduce net charge by expressing the 
charged peptide with an oppositely charged partner.6, 7  
This chapter describes a bioproduction process for a highly anionic surfactant peptide. 
This process was designed to use low-cost approaches, and therefore avoided the use of 
fusion partners or enzymatic cleavage and targeted minimal reagent requirements. The 
process was also designed to be easily scalable to provide commercially relevant 
quantities of peptide. To this end the use of chromatographic purification was avoided and 
selective precipitation steps were used in downstream processing.  
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Maquette-type artificial proteins were designed in which the highly anionic surfactant 
peptide EDP-11 is paired with a cationic expression partner RDP-4 to form a coiled-coil 
heteroconcatemer for expression. The polypeptide sequences were optimised for net 
charge, hydropathy and predicted protease resistance (via the Guruprasad instability 
index).8 Constructs with differing ratios (2:1 2:2 and 3:2) of anionic to cationic partner were 
tested to investigate the effects of net charge and hydrophobic core packing on 
concatemer expression.  
The 2:2 construct, designated Het2-6, expressed as a soluble concatemer that 
accumulated to high levels in E. coli. The concatemer showed extreme stability to heat and 
proteolysis, allowing chromatography-free isolation by simple heat and pH precipitation 
steps. Chemical denaturation studies showed the concatemer to have extremely high 
thermodynamic stability. Finally, the bioinformatic parameters of the designed 
heteroconcatemer were then compared to all open reading frames of four reference 
microbes. This showed that this design lies in the extreme hydrophobic range for soluble 
proteins while also possessing an unusually low instability index. 
2.2 Experimental 
2.2.1 Materials 
Reagents and chemicals were of analytical grade unless otherwise indicated. Water was 
obtained from an Elga Purelab Classic system (Veolia, Saint Maurice, France) and had a 
resistivity of >18.2 MΩ.cm. Guanidine hydrochloride (G.HCl) (≥99%), 
tris(hydroxymethyl)aminomethane (Tris) (≥99%) and 2-(N-morpholino)ethanesulfonic acid 
(MES) hydrate (Biotech, performance certified) were purchased from Sigma-Aldrich. 
Magnesium sulfate (≥98%) and citric acid (≥99%) were from Ajax Finechem. Protein 
concentrations were determined by quantitative amino acid analysis (Australian Proteome 
Analysis Facility, Sydney). 
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2.2.2 Peptide charge predictions 
The net charge on peptide sequences was calculated as previously described9 using 
equation 2-1: 
 
𝑍 =  �𝑁𝑖 10𝑝𝐾𝑎𝑖10𝑝𝐻 + 10𝑝𝐾𝑎𝑖 −�𝑁𝑗 10𝑝𝐻10𝑝𝐻 + 10𝑝𝐾𝑗  
𝑗
 
𝑖
 (2-1) 
where Ni is the number of residues of a given cationic residue and pKai is the 
corresponding pKa value, while Nj and pKaj are the values for the anionic residues. The 
charge contributions from the N and C-termini were calculated similarly. Ionizing group pKa 
values were: arginine, 12.5; lysine, 10.8; N-terminus, 7.8; histidine, 6.1; glutamate, 4.5; 
aspartate, 4.1; C-terminus, 3.6. Ionizable sites were assumed to be non-interacting. 
2.2.3 Cloning and expression of concatemers 
DNA coding sequences were codon-optimised and synthesised by GENEART 
(Regensburg, Germany). Genes were cloned into pET-48b(+) (Novagen) using NdeI and 
BamHI restriction sites. Constructs were verified by DNA sequencing. For expression 
testing of Het2-5, Het2-6 and Het2-7, DNA constructs were transformed into E. coli 
BL21(DE3) and grown at 26 °C in 50 mL Luria broth (LB) containing 15 µg mL-1 
kanamycin. Following induction with 1 mM isopropyl-β-D-thiogalactoside (IPTG), samples 
were taken at 2 and 4 h and overnight. To test Het2-6 expression at larger scale, a single 
colony was used to inoculate 50 mL starter culture in LB containing 15 μg mL-1 kanamycin. 
This culture was then used to inoculate 2 × 500 mL shake flask cultures, which were 
grown at 32 °C in the same medium. The cultures were grown to OD600 = 0.6 and induced 
with 1 mM IPTG. Samples were taken at 0, 2, 5 and 8 h and analysed via SDS-PAGE. For 
larger-scale shake flask expression, a single colony was used to inoculate 100 mL starter 
culture in 2 × LB with 30 μg mL-1 kanomycin. This culture was used to inoculate 750 mL 
shake flask cultures in the same medium. The cultures were grown to OD660 = 1.0 at 37 °C 
and induced with 1 mM IPTG. The cultures were harvested at 4 h. 
2.2.4 Downstream processing 
Cell pellets were resuspended in 5 mL of H2O per gram of wet cell weight and lysed by 3 
passes through an Emulsiflex-C5 valve homogeniser (Avestin, Ottawa, Canada) at 19,000 
psi. The lysate was centrifuged at 20,000 g for 10 minutes at 20 °C. The clarified lysate 
was heated to 90 °C for 10 minutes then centrifuged again at 20,000 g for 10 minutes at 
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20 °C to remove heat-precipitated cellular proteins. The resulting supernatant was 
adjusted to pH 5.0 and centrifuged at 20,000 g for 10 minutes at 20 °C to harvest the 
desired protein. The pellet was taken up in water and the pH was adjusted to 9.0. 
Magnesium sulfate was added to 1 M and the solution was heated for 1 hour at 90 °C then 
centrifuged at 20,000 g for 10 minutes at 20 °C. The pellet containing nucleic acid and 
lipopolysaccharide was discarded and the supernatant was again adjusted to pH 5.0 and 
centrifuged at 20,000 g for 10 minutes at 20 °C to recover Het2-6. The pellet was taken up 
in water and the pH adjusted to 2.0. The final protein concentration was adjusted to ~10 
mg mL-1 based on electronic circular dichroism spectra. 
2.2.5 SDS-PAGE 
NuPAGE 4-12% Bis-Tris gels, lithium dodecyl sulfate (LDS) sample buffer, reducing agent, 
antioxidant and SeeBlue Plus2 Prestained Standard (Invitrogen, Grand Island, NY) were 
used following standard protocols for analysis of purification steps. Analysis of gel images 
used Image Lab software (Bio-Rad Laboratories, Hercules, CA, USA). 
2.2.6 Mass spectrometry 
Purified protein samples prepared at 2.5 mg mL-1 in water were diluted 3:20 with 5% 
acetonitrile (ACN) 0.1% (v/v) trifluoroacetic acid (TFA) and injected into an Agilent 
1100/1200 capillary LC system.  Samples were desalted on an Agilent 300SB-C8 trap 0.3 
× 5 mm (5 min) then eluted using a gradient of 0-60% buffer B at 10 µL min-1. Buffer A was 
0.1% formic acid (v/v) in 5% ACN (v/v) 95% water (v/v) and Buffer B was 0.1% formic acid 
in ACN. Eluted protein was analysed on-line on a QSTAR pulsar i over m/z 600-
2000. Data were reconstructed using Bayesian Protein Reconstruct Tool in BioTools 
(Bruker). 
2.2.7 Preparation of uninduced E. coli extract  
E. coli KC6 cells were grown in 1 L of defined medium10 in 2 L shake flasks at 37 °C, and 
harvested at OD600 5–6 (6,000 g, 30 min). The pellet was washed twice in cold S30 buffer 
(10 mM Tris acetate, 14 mM magnesium acetate, 60 mM potassium acetate, pH 8.2), then 
resuspended in 1 mL S30 buffer per gram of wet cells. The cells were lysed by a single 
pass through an Emulsiflex-C5 valve homogeniser at 17,500 psi. The lysate was cleared 
by centrifugation (30,000 g, 4 °C, 1 h). The extract (estimated protein concentration 60 mg 
mL-1)11 was aliquotted, flash frozen, and stored at -80 °C until use. On thawing, protease 
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inhibitor cocktail (Sigma P8465) was added to give final concentrations of 5.75 mM 4-(2-
aminoethyl)benzenesulfonyl fluoride hydrochloride, 25 mM ethylenediaminetetraacetic 
acid, 0.5 mM bestatin, 0.075 mM pepstatin A and 0.075 mM E-64. The cellular extract was 
stable to proteolysis over 19 h as assessed by SDS-PAGE and electronic circular 
dichroism. 
2.2.8 Electronic circular dichroism 
Electronic circular dichroism spectra were recorded on a Jasco J-815 spectropolarimeter 
in 0.1-1 mm quartz cuvettes. The temperature was regulated using a Jasco CDF-426S/15 
controller attached to a Zalman Reserator XT cooling system. All measurements used a 
data integration time of 4 s and a band width of 1 nm. Spectral scans were recorded at a 
scan speed of 50 nm min-1 and data pitch of 0.1 nm over 190-260 nm and were averaged 
over 3 scans. Single wavelength measurements were recorded over 60 s with a 5 s data 
pitch.  
Spectra of purified Het2-6 were recorded at 20 °C using 100 µM protein in 10 mM Na+ 
citrate pH 3.0 or 10 mM Tris.HCl pH 8.0. To study chemical denaturation, 0.4 mg mL-1 
Het2-6 solutions in 1.0-7.5 G.HCl were prepared by mixing separate protein stocks 
prepared in 10 mM Tris.HCl pH 8.0 containing either 0 or 8.0 M G.HCl. Samples were 
allowed to equilibrate for 10 min at 20, 50 or 90 °C prior to single wavelength readings at 
222 nm. Reference samples of uninduced E. coli extract in 1.0-6.0 M G.HCl were prepared 
by mixing solutions of cellular extract (est. 1.2 mg mL-1 protein) prepared in 10 mM MES 
pH 7.0 containing either 0 or 7.0 M G.HCl. E. coli total protein samples were allowed to 
equilibrate for 10 min at 20 °C prior to single wavelength readings at 230 nm. 
For monitoring the effect of SDS-PAGE sample preparation on Het2-6 secondary 
structure, samples were prepared at ca. 1.25 mg mL-1 in loading buffer and heated to 80 
°C for 10 minutes. Spectra were recorded at 20 °C after heating and compared to spectra 
of Het2-6 prepared in the absence of loading buffer and without heating. 
Mean residue ellipticity ([θ]) for Het2-6 samples was calculated using: 
 [θ] = 100 ∙ 𝜃𝑜𝑏𝑠
𝑛𝑏 ∙ 𝑙 ∙ 𝑐
 (2-2) 
where θobs is the measured ellipticity in degrees, nb is the number of peptide bonds, l is the 
pathlength in cm and c is the protein concentration in M. For thermodynamic analysis, data 
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were subjected to least-squares fitting in Igor Pro 6.2.2.2 software (WaveMetrics, Oregon, 
USA). 
2.2.9 Bioinformatic analysis 
Whole organism open reading frame (ORF) sequence data for Escherichia coli (taxon 
identifier 469008), Thermus thermophilus (taxon identifier 300852) Pyrococcus furiosus 
(taxon identifier 186497) and Colwellia psychrerythraea (taxon identifier 167879) were 
taken from the Uniprot database.12 For reference data on random peptide compositions, 
random sequences were generated using scripts written in Python (Python Software 
Foundation) to yield the same distribution of polypeptide length and amino acid 
composition, and the same total number of sequences as found in all ORFs of Escherichia 
coli. Calculations of pI,13 instability index8 and grand average hydropathy (GRAVY)14 for 
polypeptide sequences also employed Python scripts.  
2.3 Results and Discussion 
2.3.1 De novo sequence design 
The goal of the work presented in this chapter was to generate a bioproduction process for 
a surfactant peptide with a high level of negative charge. The design approach involved 
pairing this anionic peptide with a cationic partner in a heteroconcatemer, where helical 
peptides were connected with unstructured linkers to generate a stable coiled-coil 
structure for expression. Acid-sensitive sites were incorporated in the designed 
heteroconcatemer to allow cleavage to monomeric peptides after downstream processing. 
It was expected that the target anionic peptide could be recovered from the expression 
partner by selective pH precipitation following cleavage. 
2.3.1.1 Anionic peptide 
The surfactant peptides reported in this chapter were designed using similar principles to 
those used to design the surfactant α-helical peptides discussed in Chapter 1.1, 15 The 
peptide sequences were built around a canonical α-helix structure, with 3.6 residues per 
turn resulting in an 18 position repeat (Figure 2-1A). Hydrophobic residues were placed at 
positions 1, 4, 8, 11, 15 and 18 to give a hydrophobic face (Figure 2-1A boxed). The 
remaining positions were populated with hydrophilic residues to give a facially amphiphilic 
helix compatible with association at interfaces. As discussed in Chapter 1, the 
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arrangement of hydrophobic and hydrophilic residues for such a facially amphiphilic 
structure is compatible with the heptad repeats of coiled-coil structures over lengths of 1-3 
heptads.16 This compatibility allows peptides designed to function at a planar interface to 
also be incorporated into a folded structure to enhance stability during bioproduction. 
The anionic peptide EDP-11 was designed with an emphasis on carboxylate content and 
helical structure. Work within the candidate’s research group has shown that incorporation 
of multiple carboxylate-containing residues in an α-helical surfactant peptide yields 
emulsifiers with high salt resistance. This is particularly true if helix-favouring glutamate 
residues are placed in positions aligned close to the interface, corresponding to positions 
3, 5, 7, 12, 14 and 16 of the 18-mer (unpublished data). The remaining positions can be 
filled with hydrophilic and hydrophobic residues consistent with the design of an 
amphipathic helix to give an 18-residue α-helical core sequence.  
In selecting specific amino acid residues for the 18-mer core sequence, emphasis was 
placed on residues with high helix propensity and chemical stability, to obtain robust 
products with a well-defined secondary structure.17, 18 Accordingly, proline and glycine 
were avoided due to their helix-breaking character, while cysteine was not chosen due to 
redox instability.19 Asparagine and glutamine were omitted due to sidechain amide lability 
under the acidic conditions required for concatemer cleavage.19, 20 The hydrophobic 
residues phenylalanine, tyrosine and tryptophan were not chosen on the expectation that 
their large size might interfere with packing of the hydrophobic core of the coiled coil. In 
addition, the sidechains of tyrosine, methionine and tryptophan are susceptible to 
oxidation, which could affect yields, processing conditions or the shelf life of products 
containing the peptides.  
These considerations left the amino acid residues valine, leucine or isoleucine to populate 
the hydrophobic positions of the core amphipathic helix. Of these, leucine was emphasised 
due to its high helix propensity, while a smaller proportion of isoleucine and valine were 
included to avoid overloading cellular pathways for leucine production. For non-glutamate 
hydrophilic positions, the residues remaining to select from were polar serine and 
threonine, cationic lysine and histidine, and the small aliphatic residue alanine. Based on 
considerations of charge, solubility and helix propensity, the remaining sites were 
populated with alanine and serine. 
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Expression of insoluble inclusion bodies is useful in some bioexpression systems, allowing 
ready separation of desired products from cellular proteins. However, inclusion bodies are 
generally solubilised using high concentrations of denaturing agents, which adds to the 
cost of downstream processing and was therefore undesirable. Sequences of high 
solubility were therefore targeted in this design process. Polypeptide solubility was 
predicted based on sequence hydrophobicity by calculating the grand average of 
hydropathy (GRAVY).14 Positive values of GRAVY indicate more hydrophobic sequences, 
and ongoing studies indicate that GRAVY values greater than 0.6 are associated with 
insolubility, even for charged peptides (unpublished data). Sequence composition was 
adjusted to obtain hydropathy values of less than 0.6 while maintaining the hydrophobic 
face required for coiled-coil formation and surfactant functionality.14  
In addition to optimisation of parameters for predicted solubility, designed sequences were 
optimised using the Guruprasad instability index8 with the aim of improving protease 
resistance. The instability index was developed from a statistical analysis of 44 proteins 
found to have either long (>16 h) or short (<5 h) in vivo half-lives.8 Analysis of the 
dipeptide composition of these protein sequences allowed the assignment of numerical 
values to apparently stabilising or destabilising amino acid pairs. For example, the residue 
pair methionine-histidine was found to be destabilising (pair value +58.28), while the 
glutamate-tryptophan pair was found to be stabilising (pair value -14.03). The instability 
index (II) for a given sequence can be calculated by averaging the pair values for each 
dipeptide combination within a sequence and applying a scaling factor: 
 
𝐼𝐼 =  �10
𝐿𝑃
��𝐷𝐼𝑊𝑉(𝑥𝑖𝑦𝑖+1)𝐿−1
𝑖=1
 (2-3) 
where LP is the sequence length, xiyi+1 is a dipeptide and DIWV is an associated dipeptide 
instability weight value.8 Reference instability index values were also derived that were 
proposed to predict polypeptide stability in vivo. A calculated instability index of greater 
than 40 is taken to predict polypeptide instability. The physicochemical basis for the 
instability index is not well understood, and few further reports have studied the correlation 
between this parameter and observed protein in vivo stability.21  
To the candidate’s knowledge the index has not been tested as an element of de novo 
peptide design. However, it has been adopted as a simple predictor for in vivo stability of 
polypeptide sequences,22-24 and has been incorporated into several polypeptide property 
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prediction packages.25, 26 In the design of peptide sequences reported in this thesis, the 
instability index values of test sequences were minimised by manually replacing 
“destabilising” dipeptide sequences with other residue pairs having similar 
physicochemical properties. For example, an initial anionic peptide design included the 
dipeptides glutamate-isoleucine and isoleucine-glutamate within the tripeptide glutamate-
isoleucine-glutamate. Both dipeptides are considered to be destabilising, with DIWVs of 
+20.26 and +44.94, respectively. An isoleucine to leucine replacement gave the dipeptides 
glutamate-leucine and leucine-glutamate, each with DIWV +1.0, meaning that this 
sequence element is considered to be neither significantly stabilising nor destabilising for 
protease resistance. 
An important element in this overall design was a strategy for concatemer cleavage to 
allow recovery of the product peptides. For cost reasons as well as avoiding the 
incorporation of long recognition sequences, it was desirable to avoid enzymatic cleavage 
in downstream processing.27, 28 Of the available chemical cleavage methods (Chapter 1; 
Section 1.4), acid cleavage at aspartate-proline sites20, 29 was chosen as it is inexpensive, 
simple and employs relatively non-toxic reagents. At acidic pH and moderate 
temperatures, cleavage between aspartic acid and proline is favoured due to the basicity 
of the proline secondary amine group, while non-aspartate bonds in the polypeptide 
backbone are essentially fully stable.29 Aspartate-proline dipeptides were incorporated at 
the termini of peptide sequences to facilitate peptide recovery. Also included in peptide 
design was a glycine at the N-terminus of each helix, adjacent to the cleavage dipeptide, 
to provide increased local flexibility that may favour cleavage.30 
Residue patterning for an amphiphilic helix as outlined above, followed by stepwise 
optimisation of the instability index, gave an 18-residue core sequence that was extended 
to 22 residues to obtain greater helix stability.31 Addition of end residues consistent with an 
aspartate-proline chemical cleavage strategy yielded peptide EDP-11 (PG IAELEAE 
LSAVEAE LEAILAE LD, MW 2596; Figure 2-1B). This sequence had a predicted 
molecular charge of -8.1 at pH 7, instability index of +13.9 and GRAVY value of 0.488, 
indicating a highly negatively charged peptide that should be stable and soluble in vivo. 
2.3.1.2 Cationic peptide 
The design of a complementary charged peptide for incorporation into a heteroconcatemer 
with EDP-11 used cationic arginine as the main charged residue. The choice of arginine 
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was driven by the highly solubilising properties of this residue14 and its higher oxidative 
stability relative to lysine. Using a patterning and optimisation process similar to that 
described above, the peptide sequence RDP-4 (PG IRALARA IRALARA VRALIRA VRD, 
MW 2826) was obtained (Figure 2-1B). RDP-4 was predicted to have a charge of +5.9 at 
pH 7, an instability index of 6.4 and GRAVY value of 0.412, indicating a highly positively 
charged peptide that is expected to be stable and soluble in vivo.  
2.3.1.3 Linker and heteroconcatemer 
The constituent peptides EDP-11 and RDP-4 were both expected to be highly charged 
under physiological conditions. For concatemer sequences, which constituted a 
combination of the highly charged peptide sequences, calculation of sequence pI13 and 
predicted molecular charge at pH 7 were used to predict isoelectric points and levels of 
charge under physiological conditions. By adjusting charged residue selection, isoelectric 
points close to pH 7 were avoided, while a net molecular charge of at least ± 1 per 
concatemer helix was targeted to provide solubility.  
Charge-compensated concatemers for expression were designed with alternating EDP-11 
(E) and RDP-4 (R) sequences connected by a flexible, charge-neutral peptide linker (L), 
PGRGMD to allow folding of the constituent helices into an anti-parallel coiled coil (Figure 
2-1C). Linker ends were constrained by the same criteria for mild acid cleavage at aspartic 
acid as outlined above. A further glycine was included for linker flexibility30 and length, 
while arginine was included to help balance the overall protein charge. The hydrophilic 
residues of the linker sequence were also expected to increase the solubility of the 
concatemer.  
A methionine-aspartate (M) dipeptide was included at the start of the polypeptide 
sequence for initiation of expression, while also allowing for subsequent removal of 
methionine by acid cleavage. As with the concatemer examples discussed in Chapter 1, 
the number of incorporated peptide repeats was expected to affect construct expression 
and require optimisation.7, 32 Three different heteroconcatemers were designed using 
differing peptide ratios aimed at maximising the yield of the desired product EDP-11. 
These were trimeric Het2-5 (M-E-L-R-L-E), tetrameric Het2-6 (M-E-L-R-L-E-L-R) and 
pentameric Het2-7 (M-E-L-R-L-E-L-R-L-E).  
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As an illustration of the expected structural fold, Figure 2-1D shows EDP-11 and RDP-4 in 
heptad-based helical wheel projections for a tetrameric coiled coil, Het2-6. It can be seen 
that charged glutamate and arginine residues lie in largely water-exposed positions, with 
hydrophobic residues buried in the core. The e, g and c positions of the RDP-4 peptide are 
predominantly populated by the non-polar residue alanine. While this residue does not 
possess a strong hydrophobic character, this expanded non-polar face may be expected 
to promote coiled-coil assembly. 
 
Figure 2-1. Heteroconcatemer design. A) Helical wheel diagram showing amino acid positioning in 
an 18-mer peptide designed to associate with a hydrophobic interface, where boxed positions 
indicate the hydrophobic face of the peptide, B) Helical wheel diagrams for EDP-11 and RDP-4 
amphipathic core sequences, C) Design of a tetrameric heteroconcatemer comprising EDP-11 
(white) and RDP-4 (grey) helices connected by unstructured linkers, D) Heptad-based projection of 
core helices corresponding to C), based on EDP-11 (top left and bottom right) and RDP-4 (top right 
and bottom left). 
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Table 2-1. Table of computed properties of designed concatemers 
Concatemer Het2-5 Het2-6 Het2-7 
pIa 4.3 4.9 4.5 
Chargeb -11.1 -5.1 -13.1 
Instability 
Indexc 9.5 8.2 8.7 
GRAVYe 0.183 0.153 0.146 
a Following Bjellqvist et al..13 b Charge per concatemer at pH 7, as described in experimental 
section. c Following Guruprasad et al..8 d Following Kyte & Doolittle.14    
Values for pI, predicted molecular charge at pH 7, instability index and GRAVY were 
computed for each heteroconcatemer design (Table 2-1). Values of instability index and 
GRAVY were similar across all three concatemers as expected based on the properties of 
the constituent peptides.  However, the molecular charge at neutral pH varied due to 
differing contributions from anionic and cationic helices, with Het2-6 showing the lowest 
charge while still maintaining a net charge per helix of at least one unit, which was 
believed necessary to maintain solubility in the folded protein. The values of pI, predicted 
molecular charge, instability index and GRAVY for all three heteroconcatemers predicted 
sequences that would be soluble under physiological conditions and be stable in vivo. 
2.3.2 Bacterial expression 
Expression of the three designed heteroconcatemers, Het2-5, Het 2-6 and Het2-7, was 
tested under IPTG induction in E. coli. Samples were taken pre-induction as well as after 4 
hours, 8 hours and overnight induction (Figure 2-2 and Figure 2-3). Constructs coding for 
trimeric Het2-5 and pentameric Het2-7, intended for excess EDP-11 production, showed 
no over-expression and were not investigated further. In contrast, strong expression of a 
protein at ca. 10 kDa was seen for the DNA construct coding for the charge-balanced 
tetramer Het2-6.  
The failed expression of Het2-5 and Het2-7 was surprising, given the successful over-
expression seen from a DNA construct coding for Het2-6 that was designed using the 
same process as the failed concatemers. In the absence of further characterisation it is not 
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possible to conclude the reason for this failed expression; however several proposals may 
be made. Failure of expression of Het2-5 and Het2-7 may be a result of poor packing of 
residues within the hydrophobic core in the trimeric and pentameric coiled coils compared 
to the tetrameric Het2-6 (as discussed in Chapter 1). Alternately, Het2-5 and Het2-7 both 
contain an excess of the anionic peptide EDP-11, which results in a higher level of net 
charge under physiological conditions compared to Het2-6. This increased level of charge 
may destabilise the heteroconcatemer folding due to electrostatic interactions. 
Destabilisation by either poor hydrophobic core packing or excess charge would result in a 
partially unfolded heteroconcatemer structure that may be more susceptible to degradation 
in the cell and result in no observable over-expression. This is a point which will be 
returned to in Section 2.3.6, where further analysis is incorporated. 
Following the successful demonstration of protein over-expression from the construct 
coding for heteroconcatemer Het2-6, expression was then assessed at larger scale. Figure 
2-4 shows samples taken at 0, 2, 5 and 8 hours following IPTG induction of E. coli 
transformed with a plasmid coding for Het2-6 and grown in a shake flask. Strong 
overexpression of a protein having a molecular weight close to 10 kDa was seen, which at 
8 h constitutes 22% of total cellular protein. Based on this observation, expression was 
further scaled up in shake flasks and the overexpressed protein was purified for further 
characterisation as discussed in Section 2.3.3. 
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Figure 2-2. Expression testing of DNA constructs coding for concatemers Het2-5 and Het2-6. M is 
molecular weight marker. T is total protein and S is soluble protein at each time point. Red box 
highlights over-expressed protein. 
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Figure 2-3. Expression testing of DNA construct coding for concatemer Het2-7. M is molecular 
weight marker. T is total protein and S is soluble protein at each time point. 
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Figure 2-4. Overexpression of Het2-6 in E. coli. SDS-PAGE gel showing Het2-6 expression in 
shake flasks. M is molecular weight marker. T is total protein and S is soluble protein at each 
time point. 
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2.3.3 Purification of Het2-6 heteroconcatemer 
It was desirable for the surfactant peptide bioproduction process to be low cost and easily 
scalable to provide commercially relevant quantities of peptide for material applications. 
The recovery process therefore avoided the use of buffers or protease inhibitors to 
minimise associated costs, while also avoiding chromatography steps to increase 
scalability. On workup of freeze-thawed cell pellets from shake flask expression, cellular 
protein bands in SDS-PAGE (Figure 2-5, Lanes 2 and 3) were less intense than in 
samples taken during culturing (Figure 2-4).This indicated a high degree of autolysis of 
cellular proteins, likely by proteases released from cellular compartments during freezing 
and thawing of the cells.  In contrast to cellular proteins, the over-expressed protein (at ca. 
7 kDa) appears resistant to degradation, comprising 60% of residual protein after 
 
Figure 2-5. SDS-PAGE analysis of Het2-6 fractions across purification steps. Lanes show: 
1), 10) molecular weight marker, 2) total lysate, 3) clarified lysate, 4) heat-treated lysate, 5) 
pH 5.0 supernatant, 6) pH 5.0 pellet, 7) MgSO4-treated supernatant, 8) second pH 5.0 
supernatant, 9) second pH 5.0 pellet. 
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homogenisation. This proteolysis provides an initial purification step to reduce levels of 
native proteins in the lysate. 
Initial attempts to titrate the lysate directly to acidic pH for concatemer cleavage showed 
poor solubility of the over-expressed protein at low pH. This was attributed to association 
and co-precipitation of the over-expressed protein with other cellular components, 
indicating further purification was required. During an attempt to selectively precipitate 
cellular contaminants, it was found that when the clarified lysate was heated to 90 °C, the 
remaining cellular protein aggregated and could be removed by centrifugation. In contrast, 
the over-expressed protein remained in the supernatant (Lane 4), indicating a high degree 
of thermal stability. This heat induced precipitation provided a simple purification step to 
further reduce levels of native proteins in the lysate. 
The heat-treated lysate was then adjusted to pH 5.0 in an attempt to selectively precipitate 
the over-expressed protein at the expected isoelectric point of the heteroconcatemer Het2-
6 (Table 2-1). This led to precipitation of the over-expressed protein (Lane 5) along with 
removal of some nucleic acid (Table 2-2; see below). The over-expressed protein could be 
redissolved at pH 9.0 (Lane 6) and had an estimated purity of >99% by Coomassie Blue 
staining.  
Mass spectrometry of the purified protein gave a molecular weight of 12879.5, matching 
the expected value for Het2-6 (12877.9). The lower apparent molecular weight of the 
protein on SDS-PAGE (7-10 kDa) appears to be an artefact of incomplete denaturation 
prior to electrophoresis. Electronic circular dichroism (ECD) showed that heating Het2-6 in 
loading buffer, as done for SDS-PAGE sample preparation, gives only a 6% loss of helical 
structure measured at 222 nm. Retention of a compact folded structure would provide a 
decreased hydrodynamic cross-section for separation through the polyacrylamide network. 
The anomalous electrophoretic behaviour of Het2-6 is similar to that previously seen for 
other highly stable proteins.33 
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Table 2-2. Quantification of Het2-6 purification 
Sample Het2-6 (mg)a Yield
b Nucleic acid (mg)c 
Clarified lysate 274 - 246 
Heat-treated lysate 182 100% 209 
Supernatant at pH 5.0 0 - 48 
Redissolved Het2-6 at pH 9.0 166 91% 153 
MgSO4-treated supernatant 147 81% 146 
Second supernatant at pH 5.0 7 - 138 
Redissolved protein at pH 2.0 133 73% 6 
All values given per gram of dry cell weight.  
a Het2-6 yield estimated from ellipticity at 222 nm 
b Yield relative to initial heat precipitation step 
c Nucleic acid concentration estimated by absorption at 260 nm 
While the initial purification steps yielded Het2-6 free of other cellular proteins, large 
amounts of nucleic acid were still present (Table 2-2). This represented an almost equal 
concentration on a weight basis and decreased Het2-6 solubility under the acidic 
conditions required for cleavage. It appeared the nucleic acids were binding to the arginine 
tracts of the heteroconcatemer, leading to co-precipitation at pH 5.0, and preventing 
separation by pH precipitation. Most of the remaining nucleic acid was able to be removed 
by heating Het2-6 with 1 M MgSO4 at 90 °C, followed by a second protein precipitation 
step at pH 5.0 (Table 2-2). This effective separation of Het2-6 from nucleic acid is likely 
due to complexation of magnesium ions by nucleic acid, thereby preventing these sites 
from being available for association with the heteroconcatemer.34 The final preparation 
contained nucleic acid at less than 5% weight ratio to protein and was soluble at 50 mg 
mL-1 protein at pH 2.0. Some loss of Het2-6 was observed during MgSO4 treatment, but 
the overall recovery of protein was still high.  
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As Het2-6 does not possess aromatic residues suitable for UV spectroscopic analysis, 
ECD was used to monitor yields during purification. The ellipticity at 222 nm for a pure 
protein is directly proportional to concentration, with a proportionality constant (mean 
residue ellipticity, [θ]222) that can be determined by quantitative amino acid analysis. 
Measurements of raw ellipticity in the initial lysate include contributions from other proteins 
with helical secondary structure, but after heat treatment Het2-6 is essentially the only 
protein present. Consistent estimates of protein concentration were obtained using either 
ellipticity at 222 nm, Coomassie staining of SDS-PAGE gels or quantitative amino acid 
analysis.  
Quantification of purified Het2-6 by amino acid analysis (Table 2-2) showed that 
approximately 73% of the expressed protein was recovered from the initial lysate. 133 mg 
of Het2-6 was obtained per gram of dry cell weight, equivalent to 150 mg per litre of culture 
in shake flasks. This is favourable as compared to charge-pairing constructs reported in 
the literature that were isolated using chromatography methods and yielded 60-107 mg of 
peptide per litre of culture.6, 7 Notably, this volumetric yield of Het2-6 was obtained using 
low cell-density culture in shake flasks. It is anticipated that much higher yields could be 
obtained in high cell-density fermenters, as would be utilized in large-scale production.35, 36 
This series of workup steps provides a simple, inexpensive and effective way to recover 
Het2-6 at high purity following expression. The lack of any buffers or protease inhibitors in 
this process, as well as the chromatography-free approach that was developed, lowers the 
costs associated with purification and increases this method’s viability for large-scale and 
commercial applications. 
2.3.4 Protein structure 
Het2-6 folds into a strongly helical structure as judged by ECD. Figure 2-6 shows ECD 
spectra for purified Het2-6 at pH 3.0 and 8.0. The double minimum at 208 and 222 nm and 
maximum at 192 nm are characteristic of an α-helix. The value of [θ]222 is -29,600 deg cm2 
dmol-1 at pH 3.0 and 20 °C, indicating Het2-6 to be predominantly helical under these 
conditions,37 in agreement with the overall design. At pH 8.0 the value of [θ]222 is slightly 
smaller at -26,600 deg cm2 dmol-1, suggesting a slight unfolding of the helical structure on 
ionization of the glutamate residues, potentially due to increased electrostatic repulsion.  
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2.3.5 Thermodynamic stability 
Handling of Het2-6 during purification showed the protein to be highly thermostable. It was 
able to retain structure and solubility on heating to 90 °C, under conditions where other 
cellular proteins denature and aggregate. Chemical denaturation was employed to 
characterise the thermodynamic stability of Het2-6 in more detail, with comparison to a 
reference extract comprising total E. coli soluble protein. Figure 2-7 shows the effects of 
guanidinium chloride (G.HCl) on the secondary structure of Het2-6 and E. coli total protein. 
The secondary structure of E. coli cellular proteins is already partly lost at 1 M G.HCl at 20 
°C, with denaturation complete by 6 M G.HCl. In contrast, Het2-6 does not unfold fully at 
either 20 or 50 °C in the presence of 8 M G.HCl; it was therefore necessary to carry out 
chemical denaturation studies of Het2-6 at 90 °C, where heat plays an additional role in 
protein unfolding. In the absence of G.HCl, the value of [θ]222 at 90 °C for Het2-6 is -20,600 
deg cm2 dmol-1, approximately 23% lower than when measured at 20 °C. While this 
 
Figure 2-6. ECD spectra of Het2-6 (100 µM) at pH 3.0 (solid line) and pH 8.0 (dashed). 
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suggests a degree of unfolding, addition of 1-4 M G.HCl does not further affect the helix 
content, but higher concentrations of G.HCl induce denaturation in a two-phase process. 
The G.HCl concentration required to achieve 50% unfolding was 7.0 M for Het2-6 and 1.7 
M for E. coli cellular extract. This highlights the extreme thermodynamic stability of Het2-6 
compared to native proteins in bacterial cells. This is accentuated by the fact that in the 
case of Het2-6 the 50% unfolding value is determined from denaturation at 90 °C. 
Quantitative determination of the thermodynamic stability of a protein by chemical 
denaturation commonly assumes a two-state model in which the stability of the folded 
state can be calculated by plotting the fraction of protein in a folded state (Ff) as a function 
of denaturant concentration.31, 38 Quantitative determination of the thermodynamic stability 
of proteins in E. coli cellular extracts from chemical denaturation data was not possible. 
  
Figure 2-7. ECD analysis of intact Het2-6 and E. coli soluble protein chemical denaturation at pH 
8.0. Het2-6 samples (●) were monitored at 90 °C and 222 nm, while E. coli KC6 soluble protein (○) 
was monitored at 20 °C and 230 nm. Fits show a three-state unfolding transition for Het2-6 and 
non-linear regression for E. coli protein. 
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Analysis was complicated by the ECD signal of these samples resulting from a mixture of 
secondary structures present in all proteins in the extracts. In the case of Het2-6, fitting of 
the denaturation curve to a two-state model was attempted, however a good fit was not 
attained. Chemical denaturation data were therefore analysed using a three-state 
unfolding model adapted from Morjana et al.,39 where unfolding is taken to proceed 
through an observable intermediate (I) between the native (N) and fully unfolded (U) 
states: 
 𝑁
𝐾𝑁→𝐼
⇌  𝐼 𝐾𝐼→𝑈⇌ 𝑈 (2-4) 
The mean residue ellipticity measured by circular dichroism ([θ]obs) at a given denaturant 
concentration ([D]) was fit using the equation: 
 [𝜃]𝑜𝑏𝑠 = [𝜃]𝑁 + [𝜃]𝐼 ∙ 𝑒−(Δ𝐺𝑁→𝐼−𝑚𝑁→𝐼[D])RT + [𝜃]𝑈 ∙ 𝑒−(Δ𝐺𝑁→𝐼−𝑚𝑁→𝐼[D])RT ∙ 𝑒−(Δ𝐺𝐼→𝑈−𝑚𝐼→𝑈[D])RT1 + 𝑒−(Δ𝐺𝑁→𝐼−𝑚𝑁→𝐼[D])RT + 𝑒−(Δ𝐺𝑁→𝐼−𝑚𝑁→𝐼[D])RT ∙ 𝑒−(Δ𝐺𝐼→𝑈−𝑚𝐼→𝑈[D])RT  (2-5) 
where [θ]N represents the mean residue ellipticity of the native state, [θ]I the mean residue 
ellipticity of the intermediate state and [θ]U that of the unfolded state. ΔGN→I and ΔGI→U are 
the free energies of the N→I and I→U transitions extrapolated to [D] = 0. The m value is 
an empirical constant corresponding to the slope of a plot of ΔG versus [D], which for a 
two-step process is divided into mN→I and mI→U, the m values for the N→I and I→U 
transitions respectively. Data were plotted as Ff, calculated as: 
 
𝐹𝑓 = [𝜃]𝑜𝑏𝑠 − [𝜃]𝑈[𝜃]𝑁 − [𝜃]𝑈  (2-6) 
Table 2-3 shows parameters obtained by fitting Het2-6 denaturation to the three-state 
model. The summed ΔGN→U of 38.9 kcal mol-1 or 9.7 kcal mol-1 helix-1 is high for a tetramer 
of 23-24 residue helices. Maquette tetramers based on 27-residue α-helices had a much 
lower ΔG of 6.4 kcal mol-1 helix-1,40 while Fairman et al.31 reported the Lac peptide 
tetramer coiled coils in which the stability per helix ranged from 3.9 kcal mol-1 (21 residues) 
to 7.6 kcal mol-1  (28 residues) to 12.9 kcal mol-1 (35 residues). Dimer coiled coils are 
typically less stable, with a reported free energy of unfolding per helix of 6.0 kcal mol-1 for 
35-residue helices and 4.1 kcal mol-1 for 28-residue helices.41 Of note is the fact that these 
reference stability values were determined at room temperature, which again shows the 
thermodynamic stability of Het2-6 at 90 °C to be very high compared to related coiled-coil 
structures. 
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Table 2-3. Fit parameters for Het2-6 denaturation with G.HCl 
ΔGN→I(H2O)a ΔGI→U(H2O)a mN→Ib mI→Ub [θ]Nc [θ]Ic [θ]Uc 
7.7 31.2 1.27 4.38 -20.6 -14.0 -3.6 
a kcal mol-1 per coiled coil 
b kcal mol-1 M-1 
c × 10-3 deg cm2 dmol-1 at 222 nm 
The m value has been employed by other workers to estimate changes in the accessible 
surface area (ASA) of proteins on unfolding.38, 42 These estimates are based on 
correlations between the surface area buried on folding (from crystallographic data) and 
measured m values for a range of proteins. The m value determined for Het2-6 is large 
(5.65 kcal mol-1 M-1 summed across two transitions) compared to similar sized proteins 
and peptide coiled coils.31, 42 Applying literature correlations to the large m value calculated 
for Het2-6 gives a value for the change in ASA that is not physically meaningful and would 
exceed the total calculated surface area of Het2-6.43 Correlations across different proteins 
are relatively scattered, particularly for denaturation using G.HCl rather than urea, where 
ionic strength plays an additional role in unfolding.42, 44 High m values, comparable to 
those obtained here, have been reported for mutants of staphylococcal nuclease (149 
residues)45 and T4 lysozyme (163 residues),46 although these m values are not 
accompanied by the same high thermodynamic stability found for Het2-6. In addition, m 
values used in ASA correlations are determined at room temperature, and extrapolation to 
90 °C relies on assumptions about the effects of temperature on protein-denaturant 
binding that may not be justifiable.47 The absolute values of change in ASA calculated from 
m values determined in the fitting of Het2-6 denaturation are therefore likely not-
meaningful. 
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At the same time, the relative values of m for the two unfolding steps may be used to infer 
information about the changes involved in each step. The N→I transition involves a 
smaller value of m (22% of the total across two steps), suggesting that the hydrophobic 
face of each helix may still be largely excluded from the aqueous environment in the 
intermediate state. This could occur by opening of the tetramer to dimeric coiled coils still 
having a largely helical structure (Figure 2-8), as also supported by the smaller change in 
ellipticity in the first stage of unfolding. The I→U transition would then involve complete 
exposure of hydrophobic residues to solvent. As with the m values, the free energy change 
involved in the N→I transition represents a small fraction of the total free energy of 
unfolding. This is consistent with the proposal that the structural changes in the first 
unfolding step are relatively small. The larger change in free energy in the I→U transition 
is consistent with coiled-coil stability being largely dependent on hydrophobic interactions 
between helices, which would be disrupted upon unfolding of the intermediate state. 
  
Figure 2-8. Schematic of proposed unfolding pathway of Het2-6. N fully folded Het2-6, I, 
unfolding intermediate with high helical content, U, fully unfolded Het2-6. Cylinders indicate 
helical structure. Constituent peptides coloured as white (EDP-11) or grey (RDP-4). 
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2.3.6 Bioinformatics 
As discussed above, key parameters used in the design of the sequence of Het2-6 were 
pI, GRAVY and the Guruprasad instability index. Prediction of isoelectric point values were 
utilised to avoid insolubility at physiological pH, GRAVY values of less than 0.6 were 
targeted to increase solubility at all pH values, and instability index values were minimised 
in an attempt to increase in vivo stability. Given the unusually high proteolytic and 
thermodynamic stability of Het2-6, it was of interest to understand the extent to which the 
physicochemical parameters for the heteroconcatemer differed from typical bacterial 
proteins.  
The pI, GRAVY and instability index values for all open reading frames (ORFs) of four 
reference organisms were compared to designed sequences, as well as a series of 
randomly-generated polypeptide sequences, to obtain a better understanding of the 
mechanistic basis for the high stability of Het2-6. Escherichia coli was chosen as a 
reference organism as it is the expression host and one of the most commonly used 
expression systems in industrial processes.48 The remaining three reference organisms 
were extremophiles selected to examine the effect of specialisation on key protein 
properties. Thermus thermophilus and Pyrococcus furiosus were selected as 
(hyper)thermophiles, while Colwellia psychrerythraea is a psychrophile.49-51 Similar profiles 
for pI, GRAVY and instability index were found across all four model organisms (Figure 
2-9). This indicates that the organisms native thermal environment does not strongly select 
for these parameters. The same parameters were also calculated for a series of random 
sequences with the same average amino acid composition as E. Coli, to examine the 
extent to which proteins within the proteome fall into different composition classes.  
The physicochemical properties of designed sequences deviate from those of the bacterial 
proteome in several regards. For the complete proteomes, calculated pI values fall in a 
bimodal distribution on either side of intracellular pH with modal values of pH 5.6 and 9.4 
(Figure 2-9A). A similar distribution is found for random sequences having the same 
average amino acid composition as the E. coli proteome (modal values of pH 5.5 and 9.3). 
This distribution appears to be a simple consequence of the pKa values of amino acid 
sidechains, which lie well above or below physiological pH, with the exception of histidine. 
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Virtually no bacterial open reading frames have predicted pI values below 4.0 or above 
12.0. The pI values of RDP-4 (12.4) and EDP-11 (3.3) lie at the extremes of the 
distribution seen for bacterial proteomes. This reflects the design process that included a 
high proportion of cationic residues in RDP-4 and anionic residues in EDP-11. The pI of 
Het2-6 is 4.90, which lies at the lower end of the distribution seen for bacterial proteomes, 
but to a lesser degree than the non-expressed constructs Het2-5 (pI 4.3) or Het2-7 (pI 
4.5). The low pI values of the designed concatemers reflect the design of sequences with 
 
Figure 2-9. Calculated bioinformatic parameters for selected organisms and random polypeptide 
sequences. A) pI, B) GRAVY and C) instability index values for ORFs of Escherichia coli, 
Thermus thermophilus, Pyrococcus furiosus and Colwellia psychrerythraea. Solid line shows 
calculated parameters for random protein sequences. Dashed vertical lines show the 
corresponding values for Het2-6. 
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pI values that are not near physiological pH, as well as the high carboxylate residue 
content of these sequences due to the incorporation of anionic surfactant peptide EDP-11. 
GRAVY values for the bacterial proteomes show a bimodal distribution (with modal values 
of -0.19 and 0.80 in E. coli), while random polypeptide sequences have a monomodal 
distribution with a modal value of -0.03 (Figure 2-9B). The bimodal distribution of GRAVY 
values in the bacterial proteomes represents the division between membrane-bound and 
soluble proteins that show dissimilar levels of hydrophobic amino acid incorporation. A 
value of 0.45 has previously been associated with the threshold between integral 
membrane and soluble proteins,52 and is consistent with the distribution seen here. This 
distinction is not reflected in random amino acid sequences, which have amino acid 
compositions that are an average of those in membrane-bound and soluble proteins. The 
GRAVY value of 0.153 for Het2-6 lies toward the hydrophobic end of the range for non-
integral membrane proteins. This is a result of the design process, which employed highly 
amphipathic α-helices to drive self-assembly, while still targeting net solubility of the 
polypeptide structure by inclusion of hydrophilic residues in the linker sequences. The non-
expressed constructs Het2-5 and Het2-7 have GRAVY values of 0.183 and 0.146 
respectively, which are comparable to the value for Het2-6 due to the similarity in design. 
The GRAVY values for EDP-11 and RDP-4, at 0.488 and 0.412 respectively, lie closer to 
the values for membrane-bound cellular proteins. This is due to the high content of 
hydrophobic amino acids used to provide an amphiphilic character and the lack of 
hydrophilic linker sequences that are present in the designed concatemers.  
For the Guruprasad instability index, the ORFs of E. coli show a monomodal distribution, 
with a mean of 37.8 ± 10.8, similar to the other three reference species, while random 
polypeptide sequences give values of 36.9 ± 8.8 (Figure 2-9C). These values all lie close 
to the threshold value of 40 proposed to provide a distinction between in vivo stability and 
instability. In the absence of further information it is difficult to conclude if this reflects 
selection by the organisms for proteins that are neither perpetually stable due to 
accumulation of defective proteins, nor completely unstable due to high metabolic costs. 
Alternatively, the similarity between random sequences and proteome distributions may 
indicate that protein instability as measured by the instability index is not selected for or 
against in these organisms. The instability index values for the designed sequences Het2-
6 (8.2), EDP-11 (13.9) and RDP-4 (6.4) all lie more than two standard deviations below the 
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mean of the bacterial proteomes. This would appear to predict high in vivo stability, as was 
indeed observed in practice for Het2-6. However, Het2-5 and Het2-7 also had similarly low 
instability index values (Het2-5, 9.5; Het2-7, 8.7) yet showed no expression, potentially 
due to poor concatemer folding and degradation in the cell. 
There have been several different algorithms developed to predict the stability of folded 
proteins.53 One such tool is FoldIndex, which predicts the level of disorder in a polypeptide 
based on the average hydrophobicity of its amino acids and the net charge,54 effectively 
comparing stabilisation due to hydrophobic interactions with the destabilising effects of 
high charge. The index was developed by statistical analysis of 275 natively folded 
proteins and 91 proteins known to be natively unfolded.55 It was found that the two classes 
of protein could be distinguished based on the net charge at pH 7.0 (|<R>|) and the mean 
hydrophobicity14 (<H>), rescaled to a range of 0-1. 
 𝐹𝑜𝑙𝑑𝐼𝑛𝑑𝑒𝑥 = 2.785 < 𝐻 >  − |< 𝑅 >| − 1.151 (2-7) 
For this index, positive values represent sequences likely to be folded, while negative 
values represent sequences likely to be disordered. Due to a high hydrophobic content, 
the index predicts Het2-6 to be folded, with a value of 0.248. The index also predicts 
folding for the constituent peptides EDP-11 and RDP-4, with values of 0.072 and 0.138 
respectively. However, trimeric Het2-5 (value 0.176) and pentameric Het2-7 (value 0.189) 
are also predicted to be stable, though expression failed in these two cases. 
It is likely that the observed stability of Het2-6 can be accounted for by a combination of 
different factors. The calculated values for pI and GRAVY lie within the normal range for 
bacterial ORFs, which predicts good solubility as observed in practice. However, the 
instability index lies at the lowest extreme observed in bacterial ORFs, consistent with a 
polypeptide that is not readily digested by endogenous proteases, as also observed in 
practice. At the same time, Het2-6 has been designed to fold into a well-ordered coiled-coil 
structure, a design that has been validated by circular dichroism spectroscopy. In addition, 
FoldIndex, which has a well-characterised physicochemical basis, predicts 
heteroconcatemer stability based on the high hydrophobic content of the polypeptide. 
From this it can be inferred that minimisation of the Guruprasad instability index, along with 
stabilisation by a well-ordered hydrophobic core, may contribute to the unusually high 
proteolytic and thermodynamic stability of Het2-6. At the same time, the lack of expression 
of the similarly designed Het2-5 and Het2-7 suggest that optimisation of these design 
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parameters alone is not necessarily sufficient to give highly expressed stable 
concatemers.  
It was initially postulated (Section 2.2.3) that high net charge and consequent poor folding 
may be responsible for the lack of expression of Het2-5 and Het2-7. However the 
prediction of stable folding by calculation of the FoldIndex suggests that that excess net 
molecular charge is likely not the key determining factor in lack of expression of Het2-5 
and Het2-7. Poor packing of residues within the hydrophobic core in the trimeric (Het2-5) 
and pentameric (Het2-7) coiled coils compared to the tetrameric Het2-6 (as discussed in 
Chapter 1) is one potential factor which may play a role in destabilising coiled-coil folding. 
This would likely result in a less stably folded construct within the cell which may be more 
susceptible to proteolytic degradation and consequently show no over-expression.  Further 
investigation will be required to determine the precise reason for the lack of expression of 
these concatemers; however factors such as specific hydrophobic packing within the core 
likely influence concatemer stability and expression.  
2.4 Conclusions 
This chapter reports the successful bioproduction of the designed heteroconcatemer Het2-
6, which comprises the strongly anionic surfactant peptide EDP-11 and cationic expression 
partner RDP-4. This indicates that charge pairing can offer a successful strategy for the 
expression of designer anionic peptides by providing stably folded structures for 
downstream processing.  
The design of polypeptide sequences combined consideration of both surfactant 
functionality and the formation of a stably folded structure for expression. In the design of 
the concatemer Het2-6, the polypeptide sequence was optimised using the parameters of 
pI, GRAVY and instability index to enhance function and expression. Het2-6 accumulated 
to high levels in E. coli and displayed extremely high thermodynamic stability and protease 
resistance. By making use of these usual properties, a chromatography-free downstream 
process was developed that yielded Het2-6 at >99% purity in the absence of protease 
inhibitors or buffers. The simplicity, minimal reagent requirements and lack of 
chromatographic methods make this process low-cost and readily scalable. 
The bioinformatic parameters of pI, GRAVY and instability index of Het2-6 were also 
compared with those of all ORFs of four reference microbes, as well as random 
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polypeptide sequences. This showed that Het2-6 lies in the high hydrophobic range for 
soluble proteins, while also possessing an unusually low instability index. This allowed 
inference that minimisation of sequence instability index values as well as stabilisation by 
the high hydrophobic content of the coiled-coil structure may contribute to the unusually 
high stability of Het2-6. Future design processes similar to that outlined here may make 
use of these calculated bioinformatic parameters of designed sequences and bacterial 
proteomes as reference points. By targeting desired values corresponding to in vivo 
stability, hydrophobicity and solubility, along with an understanding of factors stabilising 
particular secondary structures, it may possible to generate de novo designs with 
properties suitable for expression. At the same time, the lack of expression of the 
concatemers Het2-5 and Het2-7 suggest that optimisation of these design parameters 
alone is not necessarily sufficient to give highly expressed and stable concatemers, and 
that future studies will be required to further refine this design process. 
While this chapter details the design and expression of the heteroconcatemer Het2-6, 
further processing is required to recover the product peptides. Chapter 3 focuses on the 
heat- and acid-mediated cleavage of the expressed concatemer to give monomeric 
surfactant peptides, and also reports characterisation of their interfacial properties. 
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3 Bioproduction of Highly Charged Designer Peptide 
Surfactants: Chemical Cleavage of a Parent Heteroconcatemer 
and Analysis of Kinetic Pathways 
3.1 Introduction 
Chapter 2 details the expression of the highly anionic surfactant peptide EDP-11 as part of 
a charge-paired heteroconcatemer with the cationic partner RDP-4. The tetrameric coiled-
coil concatemer comprises alternating copies of each peptide connected by short linker 
sequences. Within the concatemer, each peptide is flanked by acid-sensitive cleavage 
sites to allow cleavage to monomeric peptides. This chapter details the acid and heat 
mediated cleavage of the expressed heteroconcatemer to give designed surfactant 
peptides. Liquid chromatography-mass spectrometry was used to identify and quantify 
products and intermediates during cleavage. Observation of intermediate species allowed 
the proposal of cleavage pathways as well as kinetic modelling to provide information 
about the relative rates of cleavage at each of the chemically similar cleavage sites. This 
showed a previously unobserved preference for cleavage at the C-termini of peptide 
helices. Chemical denaturation of the cleaved products showed the removal of linkers 
between helices decreased the coiled-coil stability, but the tetramer retained a remarkably 
high stability compared to designed coiled coils. Surface activity studies at the air-water 
interface showed both intact and cleaved Het2-6 to lower interfacial tension to a similar 
extent, with slightly more rapid adsorption for the cleaved peptides. Partial denaturation of 
either intact or cleaved Het2-6 by guanidinium chloride increased the rate of adsorption to 
levels similar to that of unstructured surfactant peptide AM1. The cleaved peptides were 
also used to prepare heat-stable emulsions with droplet sizes in the nanometre range.  
3.2 Experimental 
3.2.1 Materials 
Reagents and chemicals were of analytical grade unless otherwise indicated. Water was 
from an Elga Purelab Classic system (Veolia, Saint Maurice, France). Guanidine 
hydrochloride (G.HCl) (≥99%) and tris(hydroxymethyl)aminomethane (Tris) (≥99%) were 
purchased from Sigma-Aldrich. Citric acid (≥99%) was from Ajax Finechem. Peptides 
EDP-11 (trifluoroacetate salt, H2N-PG IAELEAE LSAVEAE LEAILAE LD-COOH, FW 
2596), RDP-4 (trifluoroacetate salt, H2N-PG IRALARA IRALARA VRALIRA VRD-COOH, 
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FW 2826) and AM1 (trifluoroacetate salt, Ac-MKQLADS LHQLARQ VSRLEHA-CONH2, 
FW 2473) were custom synthesised and reversed-phase high-performance liquid 
chromatography (RP-HPLC) purified by GenScript (Piscataway, NJ). Peptides EP-11 
(trifluoroacetate salt, H2N-PG IAELEAE LSAVEAE LEAILAE L-COOH, FW 2481) and RP-
4 (trifluoroacetate salt, H2N-PG IRALARA IRALARA VRALIRA VR-COOH, FW 2711) were 
custom synthesised and RP-HPLC purified by Peptide 2.0 (Chantilly, VA). The final purity 
was >95% in each case. Peptide concentrations were determined by quantitative amino 
acid analysis (Australian Proteome Analysis Facility, Sydney). Bovine serum albumin 
(premium grade) was from Ausgenex (Molendinar, Australia). Group II base oil (Jurong 
150) was from Mobil Oil Australia. Tetrameric heteroconcatemer Het2-6 was expressed in 
E. coli and recovered using chromatography-free methods as described in Chapter 2. 
3.2.2 Heteroconcatemer cleavage and kinetic modelling 
Cleavage was carried out by heating Het2-6 (10 mg mL-1, pH 2) to 70 °C for 1-24 h. 
Samples were frozen at -80 °C until analysis. Liquid chromatography-mass spectrometry 
(LCMS) used a Waters 2695 separations module with a Waters 2489 UV detector (Waters 
Corporation, Milford, MA). Samples at 1 mg mL-1 were applied to a Jupiter 5 µm C4 300 Å 
column (Phenomenex) at a flow rate of 0.2 mL min-1, using a linear gradient of 10-100% 
(v/v) buffer B over 45 min with absorbance of the eluate monitored at 214 nm. Buffer A 
was 0.01% (v/v) trifluoroacetic acid (TFA) and buffer B was 0.01% (v/v) TFA in ACN. 
Eluate was injected directly into a Quattro micro API tandem quadrupole system in positive 
ion mode. Peptide species were quantified by integration of UV peak areas using synthetic 
RDP-4 as a standard. In two cases where multiple species co-eluted (R and R-, E- and L-
R-L-E), quantification was by integration of specific ion counts using synthetic peptide 
equivalents as standards. 
Pathway modelling was based on step-wise cleavage of 18 polypeptide species observed 
during Het2-6 cleavage, using an initial basis set of 25 possible reactions. Individual steps 
were assumed to occur with first-order kinetics at a fixed pH and temperature. Numerical 
integration of concentrations was carried out with a step size of 0.1 h. Least-squares fitting 
was carried out using Microsoft Excel Solver. To assist in fitting of the overall kinetic model 
to minor species, differential weighting was applied for species present at low (M-E-L-R-L-
E-L, M-E-L-R-L, L-R-L-E, L-E-L, M-E-; 100% weighting), intermediate (M-E-L-R-L-E, E-L-
R-L-E, L-R-L-E-L-R, M-E-L-R, L-E-L-R, E-L-R, M-E; 50% weighting) or high concentrations 
(Het2-6, L-R, R, R-, L-E, E, E-; 10% weighting). 
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3.2.3 Peptide charge predictions 
The net charge on the peptide was calculated as described in Chapter 2. 
3.2.4 Electronic circular dichroism  
ECD measurements were collected and mean residue ellipticity calculated as described in 
Chapter 2. 
ECD spectra for cleaved Het2-6 (1.3 mg mL-1) were recorded at 20 °C in 10 mM Na+ 
citrate pH 3 or 10 mM Tris.HCl pH 8. For chemical denaturation studies, ellipticity at 222 
nm was recorded for cleaved Het2-6 (0.4 mg mL-1) in 1.0-7.5 M guanidinium chloride 
(G.HCl) in 10 mM Tris.HCl pH 8, made by mixing separate stocks prepared in 0 or 8 M 
G.HCl. Samples were allowed to equilibrated for 10 minutes at the selected temperature 
prior to single wavelength measurements. 
For thermodynamic analysis, data were subjected to least-squares fitting using Microsoft 
Excel Solver.  
3.2.5 SDS-PAGE 
NuPAGE 4-12% Bis-Tris gels, LDS sample buffer, reducing agent, antioxidant and 
SeeBlue Plus2 Prestained Standards were used as per manufacturer’s instructions 
(Invitrogen, Grand Island, NY). For Coomassie blue and lanthanum chloride staining, 
samples were loaded at ca. 2 µg per lane. Following SDS-PAGE, peptides were detected 
by first soaking gels for 10 min in 50 mM LaCl3 and visualising under white light epi-
illumination. Gels were then stained using 0.1% (w/v) Coomassie blue R-250 (Bio-Rad) in 
40% (v/v) methanol, 10% (v/v) acetic acid for 30 min followed by destaining in 40% (v/v) 
methanol, 10% (v/v) acetic acid. Silver staining samples were loaded at ca. 0.5 µg per lane 
and stained following SDS-PAGE using a Bio-Rad Silver Stain Plus kit (Bio-Rad 
Laboratories, Hercules, CA). Partial destaining of silver stained gels was achieved by 
soaking gels in 2 g L-1 Na2S2O3, 2 g L-1 K3[Fe(CN)6]. Analysis of gel images used Image 
Lab software (Bio-Rad Laboratories, Hercules, CA). 
3.2.6 Interfacial tension 
Interfacial tension (IFT) data were collected on a Dataphysics OCA20 contact angle 
system (Dataphysics, Filderstadt, Germany). Drops (ca. 25 µL) of cleaved or intact Het2-6, 
bovine serum albumin or AM1 (1 mg mL-1 in 10 mM Tris.HCl pH 8) were formed in air 
using a straight dosing needle in an 8 mL quartz cuvette.  Measurements of buffer alone 
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gave IFT 70.2 ± 0.3 mN m-1, while 4 M G.HCl in buffer gave a slightly higher value of 71.4 
± 0.4 mN m-1, as expected for a chaotropic salt.1 IFT measurements were collected at 5 
sec intervals over 10 min, averaged over 3 measurements. Equilibrium surface pressure 
values were determined from the y-intercept of a plot of surface pressure vs. (time)-1/2.2 
3.2.7 Emulsion preparation and characterisation 
Cleaved Het2-6 (2.5 mg mL-1) in 10 mM triethanolamine.HCl pH 9 was pre-mixed with 5% 
(v/v) Jurong 150 base oil for 1 min at 24, 000 rpm using an IKA T25 digital Ultra-Turrax 
mixer fitted with a 24 mm dispersing tool. The resulting coarse emulsion was processed 
through an Avestin Emulsiflex C5 homogeniser for 3 passes at 16, 000 psi. Droplet sizing 
was carried out using dynamic light scattering (Zetasizer Nano ZS, Malvern Instruments, 
Worcestershire). The sample was heated for 3 h at 90 °C in a heating block and size 
measurements were repeated after this time. 
3.3 Results and Discussion 
3.3.1 Acid hydrolysis of Het2-6 
Chapter 2 described the design, expression and purification of heteroconcatemer Het2-6, 
a tetramer comprising alternating copies of peptides EDP-11 and RDP-4 connected by 
short unstructured linkers. Within Het2-6, each peptide is flanked by aspartate-proline 
dipeptides susceptible to cleavage at acid pH with mild heating.3, 4 The heteroconcatemer 
sequence can be represented as M-E-L-R-L-E-L-R, where M is the initial MD dipeptide, E 
is EDP-11, R is RDP-4 and L is the linker. Complete cleavage of all seven DP sites in 
Het2-6 will produce two copies each of EDP-11 and RDP-4, one MD dipeptide and three 
copies of the linker. During the design of Het2-6, an emphasis was placed on amino acid 
residues that display a high degree of chemical stability to prevent modification of amino 
acid sidechains under the cleavage conditions (Chapter 2).  
Several different reaction conditions for the cleavage of aspartate-proline bonds have 
previously been reported. Common to these reaction conditions are pH values below the 
pKa of the aspartate sidechain and temperatures of 60 °C or higher.3-6 Cleavage of Het2-6 
was carried out at 70 °C and pH 2, where the solubility of the concatemer exceeds 50 mg 
mL-1. At lower cleavage temperatures, similar product compositions were observed but 
with a slower overall rate of reaction (not shown).  
107 
 
 
Figure 3-1. Liquid chromatography elution profiles showing products of Het2-6 cleavage after 
0, 6 and 24 h at 70 °C. Peak positions for authentic standard peptides are indicated. 
108 
 
Samples of Het2-6 cleavage were collected over 24 hours. Cleavage samples were 
analysed by liquid chromatography-mass spectrometry (LCMS; Figure 3-1). Quantification 
of eluting species was by comparison to synthetically produced peptide standards. 
Identification of species used comparison of observed mass-to-charge ratios to those 
expected from all potential products of cleavage at aspartate-proline sites within Het2-6 
(Table 3-1). Of the observed species, only M-E-L-R-L-E and E-L-R-L-E were unable to be 
separately quantified. These two species co-eluted and the low concentrations involved 
and lack of synthetically produced equivalents of these longer polypeptides for comparison 
prevented individual quantification. 
A total of 18 different oligopeptide species were identified and quantified including intact 
Het2-6, monomeric peptides and partly-cleaved intermediates. Importantly, several 
species that would be expected to arise if cleavage occurred equally at all DP positions 
were either not present, or present in only trace amounts. This greatly simplified the 
proposal of a cleavage pathway and kinetic analysis as discussed below. 
Prior to heating, trace amounts of several early cleavage products were observed in 
purified Het2-6 solutions (Figure 3-1, 0 hours; minor peaks eluting at 35-40 min).The 
method employed for purification of Het2-6 from E. coli yielded the protein in solution at pH 
2 (Chapter 2). This means that the concatemer is exposed to the cleavage pH during 
handling at lower temperature prior to deliberate initiation of cleavage by heating, resulting 
in low levels of cleavage and the formation of early cleavage products.  
On heating a solution of Het2-6 at pH 2 to 70 °C, dimer and trimer combinations of EDP-11 
and RDP-4 were observed in the first several hours. From 4 h, these species decreased in 
concentration, in parallel with the emergence of monomer helix species with or without 
linkers. Intact Het2-6 was no longer detected after 10 h, and at 24 h cleavage was largely 
complete, with 93% of species present at this time point corresponding to monomeric 
peptides with or without linker attached.  
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Table 3-1. Species observed by LCMS and their potential and assigned identities. 
Elution time Observed molecular weight Potential species Assigned species 
24.8 
2626.4 R- R- 
2711.3 R R 
26.4 3440.1 R-L, L-R L-R 
30.5 3823.2 L-E-L L-E-L 
30.9 3209.5 E-L, L-E L-E 
31.7 2595.8 E E 
32.4 2842.1 M-E M-E 
33.5 
2480.7 E- E- 
6631.6 L-R-L-E, R-L-E-L,  L-E-L-R, E-L-R-L L-R-L-E 
34.1 2726.4 M-E- M-E- 
34.8 6631.6 L-R-L-E, R-L-E-L,  L-E-L-R, E-L-R-L L-E-L-R 
35.3 6877.9 M-E-L-R-L M-E-L-R-L 
35.8 6017.9 E-L-R, R-L-E E-L-R 
36.5 6264.2 M-E-L-R M-E-L-R 
37.6 10053.7 L-R-L-E-L-R,  R-L-E-L-R-L L-R-L-E-L-R 
40.8 10069.5 M-E-L-R-L-E-L M-E-L-R-L-E-L 
42.2 
9455.8 M-E-L-R-L-E M-E-L-R-L-E 
9209.5 E-L-R-L-E E-L-R-L-E 
43.0 12877.9 Het2-6 Het2-6 
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In addition to EDP-11 and RDP-4, monomer products in which the C-terminal aspartate 
had been lost were observed at longer incubation times. The resulting products were 
designated as EP-11 (E-) and RP-4 (R-). EP-11 and RP-4 appear to be formed via a 
second cleavage event N-terminal to aspartate, following initial cleavage between 
aspartate and proline. Cleavage of the bond C-terminal to aspartate is preferred under 
acidic conditions, with cleavage at aspartate-proline further preferred due to the basicity of 
proline (Figure 3-2A). However, cleavage N-terminal to aspartate is also possible, and this 
can account for loss of the final aspartate of EDP-11 and RDP-4 (Figure 3-2B).5, 6  
Initial cleavage of the Het2-6 backbone appeared to occur C-terminal to aspartate. All 
species observed at early time points were able to be assigned to products of cleavage 
between aspartate and proline. Furthermore, no species were observed that corresponded 
to a C-terminal fragment of Het2-6 with an N-terminal aspartate residue, which would be 
expected to arise if initial cleavage occurred N-terminal to aspartate. Furthermore, C-
terminally truncated species were observed only late in the cleavage process, consistent 
with cleavage N-terminal to aspartate occurring less readily than the expected C-terminal 
cleavage. Incubation of synthetic EDP-11 and RDP-4 at pH 2 and 70 °C also gives a rate 
of aspartate loss similar to that seen during Het2-6 cleavage (not shown). The loss of C-
terminal aspartate is undesirable, as a 1:1 mixture of the truncated peptides have lower 
solubility than the parent EDP-11 and RDP-4 species (Section 3.3.2).  
Examination of the intermediates observed at early time points during cleavage showed 
that not all aspartate-proline sites are equally susceptible to cleavage. In intact Het2-6 
there are seven chemically comparable cleavage sites. Early intermediates were identified 
corresponding to cleavage at three major sites, giving product pairs M-E/L-R-L-E-L-R, M-
E-L-R/L-E-L-R and M-E-L-R-L-E/L-R. In each case, cleavage occurred at the C-terminus 
of an α-helix, leaving a linker group attached to the N-terminus of the following helix. 
Smaller amounts (<1% of total species) of intermediates corresponding to cleavage at M-
E-L-R-L/E-L-R and M-E-L-R-L-E-L/R were also observed, but primary cleavage at the two 
remaining aspartate-proline sites was not detected. 
These initial observations yielded important clues as to cleavage selectivity in Het2-6, and 
also aided in identifying several intermediates. MS alone was unable to distinguish 
between the four different species comprising EDP-11 and RDP-4 with two linkers 
attached (E-L-R-L, L-R-L-E, R-L-E-L and L-E-L-R, MW 6632) that could arise by cleavage 
of Het2-6. However, it is possible to exclude two of these species (E-L-R-L and R-L-E-L) 
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from the model due to the absence of obligate precursors. Neither R-L-E-L-R nor L-R-L-E-
L (required to give R-L-E-L) was observed, and M-E-L-R-L (required to give E-L-R-L) was 
present only in trace amounts. Two separate species with mass-to-charge ratios 
corresponding to MW 6632 were observed using LCMS. Of these, one arose rapidly in the 
first hours of cleavage, while formation of the second species showed an initial lag period. 
The first species was assigned as L-E-L-R, as it can be generated by a single cleavage 
event (M-E-L-R/L-E-L-R), while the second species was assigned as L-R-L-E, which 
requires two cleavage events to be formed (M-E/L-R-L-E/L-R). In both cases, cleavage 
occurs at the C-terminus of an α-helix.  
The absence of several other species is also revealing. Among potential late intermediates 
in the cleavage pathway, neither M-E-L nor L-R-L was detected, which require a cleavage 
event at the N-terminus of an α-helix. Based on these observations, in further cases where 
it was not possible to distinguish between isomeric pairs (R-L-E / E-L-R, L-E / E-L and L-R 
/ R-L), the polypeptide was assigned as the product that would arise from cleavage at the 
C-terminus of an α-helix. At the same time, the preference for C-terminal cleavage was not 
absolute. Formation of L-E-L was observed at low concentrations, requiring cleavage at M-
E-L-R/L-E-L and/or L-E-L/R. In addition, while M-E-L-R-L-E and E-L-R-L-E were not able 
to be separately quantified, loss of the methionine-aspartate dipeptide by cleavage at the 
N-terminus of an E α-helix is a necessary element in overall cleavage and this step has 
accordingly been modelled into an overall kinetic analysis of cleavage. 
  
 
Figure 3-2. Sequential acid hydrolysis pathways A) C-terminal to aspartate at a DP site and B) N-
terminal to aspartate, leading to loss of the C-terminal aspartate residue. 
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Based on the observed and non-observed intermediates, a minimal scheme for cleavage 
of Het2-6 to products was proposed (Figure 3-3). This scheme was used to model the 
concentrations of cleavage intermediates with time and obtain values for individual rate 
constants, assuming sequential first-order reactions. Data for experimentally determined 
and model concentrations are given in Figure 3-4. Least-squares fitting of this model to 
experimental data also enabled refinement of the proposed pathways by removal of 
potential cleavage events that did not enhance the fit. Limitations in the data, in particular 
difficulties in obtaining integrated concentrations for several low-concentration 
intermediates, mean that there is uncertainty in the values of individual rate constants. 
Nevertheless, the overall fit provides interpretable results. Initial cleavage occurs primarily 
at the C-termini of peptide helices (M-E/L-R-L-E-L-R, M-E-L-R/L-E-L-R and M-E-L-R-L-
E/L-R), a preference which may be a result of helix dipole effects. Cleavage rates are 
similar at these three sites despite differences in the amino acid N-terminal to aspartate, 
with first-order rate constants of 0.100-0.120 h-1. Some cleavage occurs by reaction at two 
additional sites (M-E-L-R-L/E-L-R and M-E-L-R-L-E-L/R), with lower rate constants of 
0.050 and 0.016 h-1 respectively. 
Second-round cleavage can also partly be accounted for by cleavage at helix C-termini, as 
seen from reactions at M-E-L-R/L (0.498 h-1), M-E-L-R/L-E-L (0.142 h-1), L-R/L-E-L-R 
(0.171 h-1) and L-R-L-E/L-R (0.090 h-1). However, it becomes necessary to account for 
cleavage at L-E-L/R (0.154 h-1), as well as the loss of N-terminal MD at M/E-L-R-L-E 
(0.324 h-1) and M/E-L-R (0.103 h-1). Subsequent steps give rise to lower molecular weight 
intermediates, including monomer helices with short groups attached at the helix N-
terminus (L-R, L-E and M-E). For L-E and L-R, it is possible to model loss of the linker 
group at 0.144 h-1 and 0.058 h-1 respectively, with a subsequent slower loss of C-terminal 
aspartate. For M-E, it is necessary to model an additional pathway by which the C-terminal 
aspartate is lost first (forming M-E-), followed by loss of MD to give E- (0.136 h-1). The loss 
of C-terminal aspartate from M-E, E and R occurs at similar rates for all three species 
(0.01-0.04 h-1), suggesting the local sequence has little effect on terminal aspartate loss. 
Furthermore, the slower rate of these secondary cleavage events compared to initial 
cleavage C-terminal to aspartate, is consistent with the expected preferential cleavage at 
the aspartate-proline peptide bond. 
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To the author’s knowledge, this work represents the first attempt to quantitatively analyse 
the acid cleavage of a pure protein containing distinct aspartate sites. Although the local 
sequence at each site is similar, it was found that particular sites were preferentially 
cleaved, apparently due to secondary structure effects. This was particularly striking for 
initial cleavage of intact Het2-6, where similar cleavage rates were observed at each of 
three sites located at the C-terminus of an α-helix, while cleavage at the four sites N-
terminal to an α-helix was either slower or undetected. It appears that this is a result of 
helix dipole effects, possibly mediated by an effect on the pKa of the aspartate residues. At 
the same time, after initial cleavage, it is probable that at least some cleavage reactions 
occur in peptides liberated from the coiled coil, where local unfolding of α-helices and/or 
 
Figure 3-3. Proposed minimal cleavage pathway for Het2-6. M represents the N-terminal MD 
dipeptide, E is EDP-11, L is linker and R is RDP-4, while E- represents EP-11 and R- represents RP-
4. Line thicknesses are approximately proportional to the magnitude of first-order rate constants 
derived from modelling. 
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the effects of local chemical context begin to be important. For example, linker cleavage 
from L-E (0.144 h-1) was found to occur faster than for L-R (0.058 h-1), implying an effect of 
local charge.  The most rapid cleavage was found to occur for intermediates generated by 
a prior N-terminal cleavage (E-L-R/L-E, 1.93 h-1; E/L-R-L-E, 2.08 h-1; L-E/L, 1.13 h-1). No 
reason for this difference is apparent, but it is possible that local unravelling of uncapped 
helix ends may play a role. 
  
 
Figure 3-4. Time course of Het2-6 cleavage. Separate panels show species present at A) high, B) 
intermediate and C) low concentrations. Symbols indicate species concentrations determined by 
LCMS, while solid lines indicate data from the model fit. (M)-E-L-R-L-E represents a combination 
of the species M-E-L-R-L-E and E-L-R-L-E due to the inability to separately quantify these species 
(as discussed in text). 
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3.3.2 Product characterisation 
The initial design of this concatemer expression system was focused on the production of 
the anionic peptide EDP-11. EDP-11 was to be separated from the cationic partner RDP-4 
by pH precipitation following cleavage; however, it was found that EDP-11 and RDP-4 
formed a stable heteromeric complex. Following cleavage, or when using an equal mixture 
of synthetically produced EDP-11 and RDP-4, the peptides exhibited co-precipitation at the 
pI predicted for a heteromeric complex in which the peptides were incorporated at a 1:1 
ratio, similar to intact Het2-6. The co-precipitation of EDP-11 and RDP-4 made separation 
by pH precipitation impossible. LCMS analysis showed that reversed-phase 
chromatography was able to isolate the product peptides (Section 3.3.1). However, the 
bioproduction method described in this and the preceding chapter was centred on easily 
scalable methods and therefore precluded utilising chromatography to separate the 
product peptides. Given that RDP-4 was based on an amphiphilic helical design similar to 
 
Figure 3-5. Effect of aspartate loss on molecular charge. Predicted molecular charge for 2:2 
complexes of EDP-11/RDP-4 (solid line) and EP-11/RP-4 (dashed) 
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EDP-11, the decision was made to continue characterisation as a mixture of the two 
peptides with the hope that this would still possess surfactant functionality. 
Het2-6 cleavage products showed high solubility at acidic pH at all cleavage times 
assessed. To determine the solubility of cleavage products at higher pH, samples were 
taken at varied cleavage times and titrated to alkaline pH. Cleaved products showed 
decreased solubility at alkaline pH when cleavage was allowed to proceed for longer than 
9 h at 70 °C. This was undesirable for many potential surfactant applications where 
exposure to near neutral or alkaline pH may be required.7 This decreased alkaline 
solubility correlated with the accumulation of end-truncated EP-11 and RP-4 peptides 
(Figure 3-4A). The possibility that lower solubility was a result of lower molecular charge 
under alkaline conditions was investigated. Figure 3-5 shows the effect of terminal 
aspartate loss on predicted molecular charge for coiled coils comprising a 2:2 ratio of 
either EDP-11 and RDP-4 or EP-11 and RP-4. The predicted charge per helix for a 2:2 
complex of EDP-11 and RDP-4 is -1.94 at pH 9, whereas the charge for a 2:2 complex of 
EP-11 and RP-4 is -0.94, which is lower but is still close to the charge of ±1 per helix 
expected to be required for solubility (Chapter 2). However, the GRAVY value for EP-
11/RP-4 is 0.610, while for EDP-11/RDP-4 the value is 0.449, at the threshold of values 
considered to define integral membrane proteins.8, 9 It appears that the hydrophobicity of 
the peptide complex causes insolubility when the terminal aspartate is lost. At the 9 h 
timepoint, cleavage of Het2-6 is 95% complete, with 58% of material present as single 
peptides with or without linkers attached as determined by LCMS (Section 3.3.1). Cleaved 
products at 9 h were expected to possess desirable surfactant properties. When carrying 
out preparative cleavage of Het2-6 at 70 °C to give material for further characterisation, 
heating was terminated at 9 h to minimise accumulation of over-cleaved products. 
3.3.3 Secondary structure  
ECD was used to assess the secondary structure of cleaved Het2-6 at acid and alkaline 
pH (Figure 3-6) and compare it to intact Het2-6 (Chapter 2). The spectrum for both intact 
and cleaved Het2-6 shows a double minimum at 208 and 222 nm and maximum at 192 
nm, which is characteristic of an α-helical fold. At pH 3, the mean residue ellipticity at 222 
nm was -28,200 deg cm2 dmol-1 for cleaved Het2-6 and -29,600 deg cm2 dmol-1 for intact 
Het2-6. At pH 8, ellipticity values were -24,500 and -26,600 deg cm2 dmol-1 for cleaved 
and intact Het2-6, respectively. This shows both intact and cleaved Het2-6 to have a 
predominantly α-helical secondary structure, with cleaved Het2-6 having a slightly lower 
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helical content.10 Part of the decrease in helical structure following cleavage may be due to 
end-fraying of  unlinked helices and suggests cleavage of Het2-6 may partially destabilise 
coiled-coil assembly.11 
3.3.4 Thermodynamic stability 
Given the unusually high thermodynamic stability of intact Het2-6 (Chapter 2) it was of 
interest to investigate the stability of cleaved Het2-6 in more detail. Characterisation of 
intact Het2-6 showed that a temperature of 90 °C in the presence of G.HCl was required to 
effect complete unfolding. Denaturation of cleaved Het2-6 was conducted under the same 
conditions as denaturation of intact Het2-6 to enable comparison with the intact protein. 
Figure 3-7 shows the G.HCl induced denaturation of secondary structure of both intact 
(reproduced from Chapter 2 for comparison) and cleaved Het2-6 at 90 °C and pH 8. 
Cleaved Het2-6 precipitated at 90 °C in the absence of G.HCl; however addition of 1 M 
G.HCl restored solubility. Unfolding of cleaved Het2-6 (at 0.4 mg mL-1) occurs 
 
Figure 3-6. Electronic circular dichroism spectra of cleaved Het2-6 at pH 3 (solid) and pH 8 
(dashed). 
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progressively above 2 M G.HCl, with 50% unfolding achieved at 4.7 M G.HCl, while 
unfolding of the intact protein does not commence until the G.HCl concentration reaches 
5.0 M, and is only 50% complete at 7.0 M G.HCl. The precipitation of cleaved Het2-6 at 90 
°C in the absence of denaturant suggests the cleaved products are able to rearrange and 
aggregate, unlike intact Het2-6 (Chapter 2). This suggests that at least part of the unusual 
stability to high temperature observed during purification of Het2-6 is due to the linkers 
constraining rearrangement of the coiled coil and preventing aggregation. 
Analysis of the stability of cleaved Het2-6 from ECD data utilised a model originally 
developed by Fairman et al.,12 assuming in the first instance that the cleaved protein 
retains a tetramer configuration. The fitting equation is given as: 
 [𝜃]𝑜𝑏𝑠 = [𝜃]𝑚𝑜𝑛 × [𝑚𝑜𝑛][𝑃]𝑡𝑜𝑡 + [𝜃]𝑡𝑒𝑡 × 4 × [𝑚𝑜𝑛]4
𝑒
�
∆𝐺(𝐻2𝑂)
−𝑅𝑇 � × 𝑒�−𝑚[𝐷]−𝑅𝑇 �  1[𝑃]𝑡𝑜𝑡 (3-1) 
where [θ]obs is the observed mean residue ellipticity at 222 nm, [θ]mon is the mean residue 
ellipticity of the monomer state, [θ]tet is the mean residue ellipticity of the tetramer state, 
[mon] is the concentration of free monomer as either EDP-11 or RDP-4, [P]tot is the total 
concentration of peptide, ΔG(H2O) is the unfolding free energy in the absence of denaturant 
and m is an empirical constant accounting for the dependence of folding free energy on 
the G.HCl concentration. Values for [θ]mon and [θ]tet were chosen based on observed 
ellipticity values at high and low G.HCl concentration respectively. Data were plotted as 
fraction folded (Ff): 
 
𝐹𝑓 = [𝜃]𝑜𝑏𝑠 − [𝜃]𝑚𝑜𝑛[𝜃]𝑡𝑒𝑡 − [𝜃]𝑚𝑜𝑛  (3-2) 
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Least-squares fitting was carried out to obtain values for ΔG(H2O) and m given estimated 
values of [θ]mon and [θ]tet. A free energy of unfolding of 32.8 kcal mol-1 was determined for 
cleaved Het2-6, taking a value of -20,300 deg cm2 dmol-1  for [θ]tet and -4,600 deg cm2 
dmol-1 for [θ]mon at 90 °C and pH 8. The estimated value of [θ]tet at 90 °C is approximately 
18% lower than the experimentally determined value of [θ]222 for cleaved Het2-6 at 20 °C 
(Section 3.3.3). This is similar to the decrease in helicity seen on heating intact Het2-6 in 
the absence of G.HCl (Chapter 2). While this suggests a degree of unfolding, addition of 
more than 2 M G.HCl is required to induce further denaturation. The free energy of 
unfolding obtained in this fit is lower than the 38.9 kcal mol-1 determined for intact Het2-6 
under the same conditions (Chapter 2), but still represents a remarkable degree of stability 
for a designed coiled-coil system.12-14 In addition, the relatively small change afforded by 
the cleavage of linker regions suggests that Het2-6 thermodynamic stability derives more 
 
Figure 3-7. G.HCl-dependent denaturation of intact and cleaved Het2-6. Denaturation of intact (●) 
and cleaved Het2-6 (○) was carried out at 90 °C and pH 8. The fits are to a three-state unfolding 
transition for intact Het2-6 (reproduced from Chapter 2) and disassembly of a tetrameric coiled coil 
for cleaved Het2-6. 
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from the hydrophobic association of amphipathic helices, than the fact that the helices 
have been constrained into a single polypeptide chain. 
Fitting also obtained an m value of 2.44 kcal mol-1 M-1 for cleaved Het2-6, comparable to 
values obtained for native proteins of similar size,15 but much lower than the m value of 
5.65 kcal mol-1 M-1 for intact Het2-6.  As discussed in Chapter 2, it is not possible to obtain 
good estimates of the surface area exposed on unfolding from m values obtained at 90 
°C.16, 17 However, the smaller value of m for unfolding of cleaved Het2-6 compared to 
intact Het2-6 suggests that there is a smaller change in exposed surface area on unfolding 
of the cleaved concatemer. This suggests that the structure of cleaved Het2-6 is more 
open than that of the intact concatemer, likely due to the removal of helix end-capping by 
the linker regions. 
3.3.5 Gel electrophoresis 
Gel electrophoresis was used an alternate method to study Het2-6 cleavage. Analysis of 
Het2-6 cleavage by gel electrophoresis revealed unusual staining patterns for the 
cleavage products (Figure 3-8). Conventional Coomassie blue and silver staining tests for 
intact and cleaved Het2-6, as well as synthetic EDP-11 and RDP-4, are shown in Figure 
3-8;A-B. Intact Het2-6 appears as a band with an apparent molecular weight of 8 kDa 
(Lane 2), lower than expected due to incomplete denaturation under standard sample 
preparation conditions (Chapter 2). Samples of cleaved Het2-6 (Lane 3), showed several 
bands that migrated similarly to Het2-6, along with a reverse-stacked band near 6 kDa that 
matched the mobility of authentic RDP-4 (Lane 5). The additional bands at ca. 8 kDa are 
likely intermediate cleavage species, several of which have molecular weights of between 
6 and 10 kDa (Section 3.3.1). No band is observed for EDP-11 (Lane 4).  
The unusual mobility of RDP-4 (Lane 5, actual MW 2826) may be due either to the high 
isoelectric point of the peptide, or to co-assembly with sodium dodecyl sulfate into a folded 
structure under the conditions of electrophoresis. RDP-4 band intensity is weak under 
silver staining, relative to Coomassie blue staining, which may be attributed both to high 
affinity of the Coomassie dye for basic residues,18 and a relative lack of chemistries 
supporting silver reduction in RDP-4.19-21 The lack of staining of EDP-11 by Coomasie blue 
is likely due to this peptide possessing no basic residues to promote staining,18 while the 
absence of visualisation by silver staining is likely due to a lack of interactions between 
stain molecules and the anionic peptide.22 
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EDP-11 was also unable to be visualized using zinc-imidazole staining23 (not shown). 
While exploring alternate methods for protein staining in SDS-PAGE gels using transition 
metals,23, 24 a novel staining method was developed based on peptide precipitation in the 
presence of lanthanum chloride. Soaking of SDS-PAGE gels in a lanthanum chloride 
solution gave a semi-opaque background. Synthetic EDP-11 was visualised as a white 
band in these gels due to local precipitation of a peptide-La3+ complex due to the high 
carboxylate content of this peptide (Figure 3-8C, Lane 4). EDP-11 is visible at 
approximately 2.5 kDa, in agreement with the actual molecular weight of 2596 Da. A 
similar faint band can be observed for cleaved Het2-6 (Lane 3), suggesting that cleaved 
Het2-6 is dissociated to EDP-11 and RDP-4 monomers. This is in contrast to intact Het2-6, 
which shows anomalous electrophoretic mobility, proposed to be due to incomplete 
concatemer unfolding by heating in sample loading buffer (Chapter 2). The observation of 
monomeric peptides following cleavage suggests that removal of concatemer linkers 
destabilises coiled-coil assembly sufficiently for dissociation of monomers under the 
conditions used for SDS-PAGE sample preparation.  
In gels soaked in a lanthanum chloride solution, RDP-4, Het2-6 and acid-cleavage 
products apart from EDP-11, are visualised as negatively stained bands due to a lack of 
 
Figure 3-8. Gel electrophoresis of Het2-6 and cleavage products. A) Coomassie blue R-250 stain; 
B) silver stained gel after partial destaining and C) lanthanum chloride stain. Lanes are: 1, MW 
standard; 2, intact Het2-6; 3, cleaved Het2-6; 4, EDP-11 and 5, RDP-4. 
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precipitation of these species in the presence of La3+. Additionally, RDP-4, Het2-6 and 
acid-cleavage products apart from EDP-11 could be weakly visualised in unstained gels, 
apparently as a result of complexation with sample dye components. Post-staining of 
lanthanum chloride stained gels with Coomassie blue dye was also possible and gave 
similar results to when gels were stained using this method immediately. 
3.3.6 Surfactant function 
Peptide EDP-11 was designed as a renewable surfactant for practical applications. While 
RDP-4 was initially intended only as an expression partner, it was based on a similar 
amphiphilic helical design to EDP-11 and was also expected to possess surfactant 
properties. It was thus of importance to investigate the surface activity of the peptides at 
fluid interfaces. Air-water interfacial tension measurements were carried out on cleaved 
and intact Het2-6. Results were compared to those of the previously characterised α-
helical surfactant peptide AM125 as an example of a designed peptide surfactant. The 
globular protein bovine serum albumin (BSA), similar to several other native proteins, has 
previously been shown to be surface active and was included in this study as a reference 
point for a native protein with no design for surfactancy.26 
Figure 3-9 shows the changes in IFT over time at the air-water interface for solutions of 
intact and cleaved Het2-6, AM1 and BSA. BSA is slow to adsorb, reaching an equilibrium 
surface pressure of only 16 mN m-1 and requiring 290 sec to achieve 50% of this value. 
Intact and cleaved Het2-6 adsorb more readily, with both showing equilibrium surface 
pressures of 29 mN m-1. Cleaved Het2-6 was faster to adsorb to the interface, taking only 
15 sec to achieve 50% of equilibrium surface pressure, while intact Het2-6 took 30 sec to 
achieve the same proportionate change in IFT. This suggests cleavage of Het2-6 and the 
resulting lower coiled-coil stability (Section 3.3.4) may enhance the rate of adsorption at 
the interface. The lowering of IFT by intact and cleaved Het2-6 is consistent with the 
design of peptide sequences with surfactant properties. Reference peptide AM1, which is 
largely unstructured in solution at the concentrations used here,27 gave an equilibrium 
surface pressure of 25.2 mN m-1, with most of the change occurring before the first 
measurement point. This is consistent with the unstructured state of AM1 enabling rapid 
adsorption to the interface, while the thermodynamically stable assembled state of intact 
and cleaved Het2-6 (Section 3.3.4) may retard adsorption due to the requirement for 
disassembly.  
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To investigate the effects of peptide coiled-coil assembly on interfacial adsorption, 
interfacial tension studies were carried out on partly-denatured peptides. Addition of 4 M 
G.HCl to intact and cleaved Het2-6 slightly lowered equilibrium surface pressure (intact 
Het2-6, 24.8 mN m-1; cleaved Het2-6, 25.7 mN m-1; not shown), presumably by solubilising 
hydrophobic portions of the peptide structure in aqueous solution. At the same time, 
addition of G.HCl brought the time required to achieve 50% of these equilibrium surface 
pressures below the dead time of the apparatus. These results are similar to those 
obtained for AM1, supporting the argument that it is the liberation of surface-active 
monomers from stable complexes that limits the rate of association with the air-water 
interface.28 This suggests that the high thermodynamic stability (Section 3.3.4) of the EDP-
11/RDP-4 coiled coil acts to retard the rate of interfacial adsorption of these peptides. 
As a final test of peptide surfactant functionality, an oil-in-water emulsion was prepared 
using cleaved Het2-6 (2.5 mg mL-1). Emulsion preparation used a two-step process with 
initial preparation of a coarse emulsion followed by passage through a high-pressure 
 
Figure 3-9. Interfacial activity of Het2-6 (red line), cleaved Het2-6 (black line), BSA (green line) 
and AM1 (blue line). 
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homogeniser. A droplet size of 200 nm and polydispersity index of 0.27 was determined 
for the emulsion as initially prepared, containing 5% (v/v) of an industrial lubricating oil. 
When heated to 90 °C for 3 h, the emulsion showed only a slight increase in droplet size to 
210 nm, while the polydispersity index increased to 0.35. The resulting emulsion is a 
candidate for a renewable, low-toxicity industrial coolant or lubricant that could be 
separated into oil and water phases once spent,29 allowing potential reuse of the oil phase. 
3.4 Conclusions 
This chapter described the acid-catalysed cleavage of the designed heteroconcatemer 
Het2-6 to monomer surfactant peptides. By identifying and quantifying the intermediate 
species present over time it was possible to carry out kinetic analysis of the cleavage 
pathway. Notably, this showed previously unobserved preferences in cleavage across 
chemically similar sequences. Specifically, cleavage occurred preferentially at the helix C-
termini, potentially due to effects of peptide secondary structure. Also observed during 
analysis of Het2-6 cleavage were monomeric peptides which had lost C-terminal aspartate 
residues. This appeared to occur in a secondary cleavage event and resulted in decreased 
solubility of product peptides at alkaline pH. 
Cleaved peptides assembled into a remarkably thermodynamically stable coiled coil, with 
stabilities exceeding those seen in most designer coiled-coil systems. While the initial 
design of this expression system included the separation of target anionic peptide from 
cationic expression partner, the high heteromeric coiled-coil stability prevented separation 
of these species by selective precipitation. A solution of intact or cleaved Het2-6 lowered 
interfacial tension at the air-water interface. However, the high stability of the coiled-coil 
structure retarded interfacial adsorption, with more rapid association at the interface 
achieved by partial chemical denaturation of peptide assembly. Even in the absence of 
denaturant, it was possible to use cleaved Het2-6 to prepare a thermostable oil-in-water 
emulsion with droplet sizes in the nanometre range, demonstrating the functionality of 
these bio-produced self-assembling peptides. 
Chapters 2 and 3 report the design and implementation of a bioproduction method for a 
strongly anionic peptide surfactant through incorporation into a charge-compensated 
coiled-coil heteroconcatemer. This heteroconcatemer expressed at high levels in E. coli 
and showed extreme thermodynamic stability, facilitating purification using 
chromatography-free pH and heat precipitation steps. Heat- and acid- mediated cleavage 
of the concatemer was used to produce monomeric peptides, however isolation of the 
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anionic surfactant peptide using pH precipitation was not possible. Intact and cleaved 
concatemer was demonstrated to possess surfactant functionality. Recovery and 
processing of the expressed concatemer utilised inexpensive and scalable methods to 
increase the potential for future large-scale peptide production. These methods may be 
adaptable to future bioproduction approaches, especially those targeting highly charged 
sequences. Furthermore, while these results demonstrate a step towards the 
bioproduction of designer peptides, there are several future studies that may be able to 
improve upon this initial bioproduction process. 
3.5 Future directions 
3.5.1 Design parameters 
The design of peptide and concatemer sequences in Chapter 2 makes use of several 
parameters for predicting sequence properties. These were predicted molecular charge as 
a function of pH, GRAVY and instability index. To the candidates knowledge there have 
been no systematic investigations into the use of these parameters in peptide sequence 
design. While the sequences reported in this thesis provide some reference values for 
these parameters, a comprehensive investigation of the relationships between these 
parameters and polypeptide properties was not the target of this research. A beneficial 
objective for future research may therefore be more detailed studies of the effects of 
variations of molecular charge, GRAVY and instability index on sequence properties, to 
better define target values for future designs. Any such study would require careful design 
of new polypeptide sequences to minimise changes to other physicochemical properties 
such as residue helix propensity and patterning, to allow isolation of the effects of varying 
each parameter. 
Of particular interest for future study may be the relationship between the calculated 
instability index for designed sequences and in vivo stability. While minimization of the 
instability index was used in the design of sequences in Chapter 2, the physicochemical 
basis for the index is not well understood. Furthermore, in the absence of further studies, it 
is not possible to determine whether minimisation of the instability index alone was 
instrumental in producing the high proteolytic stability observed for Het2-6. Future studies 
may involve the investigation of a series of sequences in which the instability index is 
intentionally varied, by substitution of dipeptides with residue pairs having similar 
physicochemical properties, but either higher or lower associated DIWV values. Such 
studies would involve monitoring the rates of proteolysis of polypeptides with varied 
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instability indices. If calculated instability index values were observed to predict proteolytic 
stability of designed sequences, this would further validate the use of the index in future 
design processes.  
In designing sequences for such a study, maintaining other factors such as sequence 
GRAVY and net charge, as well as residue patterning and helix propensity will also be key 
considerations. For example, if such a study were conducted on sequences derived from 
EDP-11 or Het2-6, appropriate sequence modifications may involve replacement of 
leucine with isoleucine in the tripeptides glutamate-leucine-glutamate. While this 
substitution maintains similar residue hydropathy and helix propensity,9, 30, 31 the 
isoleucine-glutamate and glutamate-isoleucine dipeptides both have high DIWVs.32 The 
incorporation of one, or multiple such substitutions would allow a series of sequences with 
varied instability indices to be produced, while maintaining other sequence parameters. 
3.5.2 Bioproduction 
The failed expression of concatemers Het2-5 and Het2-7 indicate that the design strategy 
described in Chapter 2 is not in itself sufficient to give highly-expressed sequences. The 
successful expression of Het2-6 and failure of other concatemers may be due to a variety 
of factors such as hydrophobic packing in the coiled-coil concatemers or net molecular 
charge. While predictions of stable folding based on the FoldIndex (Chapter 2) suggested 
that excess molecular charge was not the key factor in poor expression of Het2-5 and 
Het2-7, it is not possible to deduce the exact reasons for expression failure from the data 
in hand. Future experiments may further probe several of the potential factors involved. 
Studies of the effects of net molecular charge on concatemer expression will be beneficial 
for the design of future bioproduction constructs, especially for those targeting expression 
of highly charged peptides. Modification of the sequence of Het2-6 to vary net molecular 
charge while maintaining other design considerations would allow investigation of the 
effects of this parameter on a design already demonstrated to express at high levels. By 
observing the levels of expression of sequences with varied net charge, it may be possible 
to determine an optimal target level of charge for future designs. Such studies may involve 
the replacement of the serine of EDP-11 with glutamate, or the replacement of one or 
more of the arginine residues of RDP-4 with alanine residues. However, such substitutions 
will also affect other design considerations such as GRAVY values and residue helix 
propensity that may complicate results. 
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Additionally, the increased molecular charge of Het2-5 and Het2-7 compared to the 
charge-compensated Het2-6 is due to the incorporation of a higher proportion of anionic 
peptide EDP-11. It may therefore be of interest to investigate the expression of a 
hexameric charge-compensated heteroconcatemer, composed of three copies of each 
EDP-11 and RDP-4. Such a heteroconcatemer would possess a level of charge closer to 
Het2-6 than the highly-charged Het2-5 and Het2-7, and provide more information about 
whether the lack of expression of Het2-5 and Het2-7 resulted from poor hydrophobic 
packing, or excess anionic charge. More detailed information about the effects of net 
molecular charge and concatemer coiled-coil assembly on expression will aid in future 
design of bioproduction constructs. 
It may also be possible in future studies to determine a crystal structure for Het2-6. 
Computer modelling of the folding of the Het2-6 coiled coil may also be possible. A better 
understanding of the folded structure of Het2-6 may provide insights into the packing of 
residues within the hydrophobic core, as well as allow conclusions to be drawn about the 
origins of the concatemers extremely high thermodynamic stability. 
3.5.3 Het2-6 redesign 
Chapters 2 and 3 describe the design and implementation of a successful bioproduction 
method for the highly anionic surfactant peptide EDP-11. However, several unfavourable 
properties of expressed peptides were observed which may be accounted for in future 
designs. This future design process will likely be a recursive procedure, in which 
observations from successfully expressed sequences are used to influence design 
considerations. 
For example, the loss of terminal aspartate residues from EDP-11 and RDP-4 lowered 
resulting complex solubility and required cleavage to be halted prior to completion (Section 
3.3.2). However, if these secondary cleavage events are accounted for during the design 
process it may be possible to produce sequences which maintain solubility following the 
loss of terminal aspartate residues. This would then allow for cleavage to be continued to 
completion to give homogenous surfactant peptide products. 
The decreased solubility of the EP-11/RP-4 complex compared to the EDP-11/RDP-4 
complex was attributed to increased hydrophobicity following loss of terminal aspartate as 
reflected by a higher calculated GRAVY value (Section 3.3.2). A potential redesign 
approach to overcome this would be to replace one or more non-polar alanine residues 
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with the more polar serine.9 The placement of serine residues would need to consider 
factors such as residue patterning and avoiding dipeptide combinations with high DIWVs, 
however several potential positions consistent with these considerations are possible 
(Table 3-2). Of the potential substitutions, those in the anionic peptide may be more 
beneficial in future designs, as these would increase the solubility of the target surfactant 
peptide even if it is isolated from the cationic expression partner. The solubility of such 
redesigned sequences could be assessed using synthetically produced peptides prior to 
attempting bioproduction. 
Table 3-2. Potential redesign of EDP-11 and RDP-4 
Peptide Sequence 
EDP-11 PG IAELEAE LSAVEAE LEAILAE LD 
RDP-4 PG IRALARA IRALARA VRALIRA VRD 
Potential sequence redesign of Het2-6 constituent peptides EDP-11 and RDP-4. Bold indicates 
potential residues for replacement with serine to increase solubility following loss of terminal 
aspartate residues. Underline indicates potential residues for replacement with aspartate for internal 
cleavage sites. 
Both the lack of ability to separate EDP-11 and RDP-4 via pH precipitation (Section 3.3.2) 
and results from interfacial tension studies (Section 3.3.6) indicate that the highly stable 
coiled-coil assembly, which is beneficial during expression and chromatography-free 
purification, is detrimental to the functionality of this surfactant peptide system following 
cleavage. It may therefore be beneficial in future designs to include elements that promote 
disassembly of the peptide coiled coil to allow selective precipitation and more rapid 
interfacial adsorption.  
The ability of the concatemer to fold into a stable coiled coil is required for expression and 
during downstream processing. Destabilising elements would therefore be required to only 
influence assembly following expression and recovery. This may be accomplished by 
including an aspartate residue within the cationic peptide to give an internal cleavage site, 
thereby destabilising the heteromeric coiled coil following cleavage by decreasing cationic 
peptide length.12, 13 Similar to the redesign approaches discussed above, any such 
redesign would need to consider factors such as residue patterning and avoiding 
dipeptides with high DIWVs. Several alanine residues close to the centre of RDP-4 may be 
appropriate for insertion of such an internal cleavage site (Table 3-2).  
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Due to the shorter length of fragments of the cleaved cationic peptide, heteromeric coiled-
coil formation would likely be disfavoured. The anionic peptide may therefore be 
selectively precipitated at acidic pH, providing a simple method to isolate the desired 
anionic peptide surfactant. Even if selective precipitation is found to be impractical or 
undesirable, internal cleavage of the cationic peptide will result in destabilised heteromeric 
coiled-coil assembly which will result in more rapid interfacial adsorption of the surfactant 
peptides. The properties of such redesigned peptides may be assessed using synthetically 
produced peptides prior to attempting bioproduction. The additional anionic residue in 
each cationic helix will also increase the net charge on the heteroconcatemer. The effect 
this has on expression will also need to be assessed.  
130 
 
3.6 References 
1. Breslow, R.; Guo, T. Surface-Tension Measurements Show That Chaotropic 
Salting-in Denaturants Are Not Just Water-Structure Breakers. Proc. Natl. Acad. Sci. U. S. 
A. 1990, 87, 167-169. 
2. Dexter, A. F. Interfacial and Emulsifying Properties of Designed Beta-Strand 
Peptides. Langmuir 2010, 26, 17997-18007. 
3. Dimitrijev-Dwyer, M.; He, L.; James, M.; Nelson, A.; Wang, L.; Middelberg, A. P. J. 
The Effects of Acid Hydrolysis on Protein Biosurfactant Molecular, Interfacial, and Foam 
Properties: Ph Responsive Protein Hydrolysates. Soft Matter 2012, 8, 5131-5139. 
4. Inglis, A. S. Cleavage at Aspartic-Acid. Methods Enzymol. 1983, 91, 324-332. 
5. Li, A. Q.; Sowder, R. C.; Henderson, L. E.; Moore, S. P.; Garfinkel, D. J.; Fisher, R. 
J. Chemical Cleavage at Aspartyl Residues for Protein Identification. Anal. Chem. 2001, 
73, 5395-5402. 
6. Zhang, S. F.; Basile, F. Site-Specific Pyrolysis-Induced Cleavage at Aspartic Acid 
Residue in Peptides and Proteins. J. Proteome Res. 2007, 6, 1700-1704. 
7. Banat, I. M.; Makkar, R. S.; Cameotra, S. S. Potential Commercial Applications of 
Microbial Surfactants. Appl. Microbiol. Biotechnol. 2000, 53, 495-508. 
8. Lobry, J. R. Influence of Genomic G+C Content on Average Amino-Acid 
Composition of Proteins from 59 Bacterial Species. Gene 1997, 205, 309-316. 
9. Kyte, J.; Doolittle, R. F. A Simple Method for Displaying the Hydropathic Character 
of a Protein. J. Mol. Biol. 1982, 157, 105-132. 
10. Chen, Y. H.; Yang, J. T.; Chau, K. H. Determination of Helix and Beta-Form of 
Proteins in Aqueous-Solution by Circular-Dichroism. Biochemistry 1974, 13, 3350-3359. 
11. Zhou, N. E.; Kay, C. M.; Hodges, R. S. Synthetic Model Proteins - Positional Effects 
of Interchain Hydrophobic Interactions on Stability of 2-Stranded Alpha-Helical Coiled-
Coils. J. Biol. Chem. 1992, 267, 2664-2670. 
12. Fairman, R.; Chao, H. G.; Mueller, L.; Lavoie, T. B.; Shen, L. Y.; Novotny, J.; 
Matsueda, G. R. Characterization of a New Four-Chain Coiled-Coil: Influence of Chain 
Length on Stability. Protein Sci. 1995, 4, 1457-1469. 
13. Litowski, J. R.; Hodges, R. S. Designing Heterodimeric Two-Stranded Alpha-Helical 
Coiled-Coils: The Effect of Chain Length on Protein Folding, Stability and Specificity. J. 
Pept. Res. 2001, 58, 477-492. 
14. Gibney, B. R.; Johansson, J. S.; Rabanal, F.; Skalicky, J. J.; Wand, A. J.; Dutton, P. 
L. Global Topology & Stability and Local Structure & Dynamics in a Synthetic Spin-Labeled 
Four-Helix Bundle Protein. Biochemistry 1997, 36, 2798-2806. 
15. Myers, J. K.; Pace, C. N.; Scholtz, J. M. Denaturant M-Values and Heat-Capacity 
Changes - Relation to Changes in Accessible Surface-Areas of Protein Unfolding. Protein 
Sci. 1995, 4, 2138-2148. 
16. Zweifel, M. E.; Barrick, D. Relationships between the Temperature Dependence of 
Solvent Denaturation and the Denaturant Dependence of Protein Stability Curves. 
Biophys. Chem. 2002, 101, 221-237. 
17. Scholtz, J. M.; Grimsley, G. R.; Pace, C. N., Solvent Denaturation of Proteins and 
Interpretations of the M Value. In Methods in Enzymology: Biothermodynamics, Pt B, 
Johnson, M. L.; Holt, J. M.; Ackers, G. K., Eds. Elsevier Academic Press Inc: San Diego, 
2009; Vol. 466, pp 549-565. 
18. Congdon, R. W.; Muth, G. W.; Splittgerber, A. G. The Binding Interaction of 
Coomassie Blue with Proteins. Anal. Biochem. 1993, 213, 407-413. 
19. Syrovy, I.; Hodny, Z. Staining and Quantification of Proteins Separated by 
Polyacrylamide-Gel Electrophoresis. J. Chromatogr.-Biomed. Appl. 1991, 569, 175-196. 
20. Williams, L. R. Staining Nucleic Acids and Proteins in Electrophoresis Gels. 
Biotech. Histochem. 2001, 76, 127-132. 
131 
 
21. Merril, C. R.; Pratt, M. E. A Silver Stain for the Rapid Quantitative Detection of 
Proteins or Nucleic-Acids on Membranes or Thin-Layer Plates. Anal. Biochem. 1986, 156, 
96-110. 
22. Goldberg, H. A.; Warner, K. J. The Staining of Acidic Proteins on Polyacrylamide 
Gels: Enhanced Sensitivity and Stability of ''Stains-All'' Staining in Combination with Silver 
Nitrate. Anal. Biochem. 1997, 251, 227-233. 
23. Hardy, E.; Castellanos-Serra, L. R. "Reverse-Staining" of Biomolecules in 
Electrophoresis Gels: Analytical and Micropreparative Applications. Anal. Biochem. 2004, 
328, 1-13. 
24. Lee, C.; Levin, A.; Branton, D. Copper Staining - a 5-Minute Protein Stain for 
Sodium Dodecyl-Sulfate Polyacrylamide Gels. Anal. Biochem. 1987, 166, 308-312. 
25. Dexter, A. F.; Malcolm, A. S.; Middelberg, A. P. J. Reversible Active Switching of 
the Mechanical Properties of a Peptide Film at a Fluid-Fluid Interface. Nat. Mater. 2006, 5, 
502-506. 
26. Pereira, L. G. C.; Theodoly, O.; Blanch, H. W.; Radke, C. J. Dilatational Rheology of 
Bsa Conformers at the Air/Water Interface. Langmuir 2003, 19, 2349-2356. 
27. Dexter, A. F.; Middelberg, A. P. J. Switchable Peptide Surfactants with Designed 
Metal Binding Capacity. J. Phys. Chem. C 2007, 111, 10484-10492. 
28. Middelberg, A. P. J.; Radke, C. J.; Blanch, H. W. Peptide Interfacial Adsorption Is 
Kinetically Limited by the Thermodynamic Stability of Self Association. Proc. Natl. Acad. 
Sci. U. S. A. 2000, 97, 5054-5059. 
29. Dexter, A. F. Controlling Coalescence and/or Phase Separation of an Emulsion 
Stabilized by an Ionic Surfactant Comprises Adding to the Emulsion a Chaotropic 
Counterion. WO2011116412-A1. 
30. O'Neil, K. T.; Degrado, W. F. A Thermodynamic Scale for the Helix-Forming 
Tendencies of the Commonly Occurring Amino Acids. Science 1990, 250, 646-651. 
31. Blaber, M.; Zhang, X. J.; Matthews, B. W. Structural Basis of Amino-Acid Alpha-
Helix Propensity. Science 1993, 260, 1637-1640. 
32. Guruprasad, K.; Reddy, B. V. B.; Pandit, M. W. Correlation between Stability of a 
Protein and Its Dipeptide Composition - a Novel Approach for Predicting in Vivo Stability of 
a Protein from Its Primary Sequence. Protein Eng. 1990, 4, 155-161. 
 
 
132 
 
4 Characterisation of a pH-responsive coiled-coil peptide 
hydrogel 
4.1 Introduction 
This chapter details the characterisation of the 21-residue α-helical peptide AFD19, which 
was designed as part of ongoing work on peptide surfactants. This peptide was designed 
using similar methods to those reported in Chapter 2 for the design of amphiphilic peptides 
EDP-11 and RDP-4. This process targeted residues of high helix propensity, as well as 
predicted sequence solubility and protease resistance. Characterisation of AFD19 
unexpectedly showed the peptide to form self-healing hydrogels at low weight fractions as 
a function of pH. 
As discussed in Chapter 1, hydrogels are promising materials for use in the biomedical 
area where they show utility in applications such as tissue engineering,1, 2 drug delivery2, 3 
and wound healing.4, 5 Hydrogels formed by self-assembling peptides are of particular 
interest.6, 7 However, to date the majority of reported peptide hydrogels have been based 
on β-sheet structures,8-12 for which there remain concerns about clinical application.13 One 
alternative to these β-sheet systems are α-helical peptide-based hydrogels, however thus 
far few have been reported.14-16 The investigation of AFD19 self-assembly therefore 
represented an opportunity to further develop the field and characterise a system that 
avoids these undesirable β-sheet elements. 
Hydrogel formation by AFD19 was pH-dependent, whereby low pH gave free flowing 
solutions, gelation occurred as the pH approached 6 and the peptide precipitated at pH 7. 
Characterisation via electronic circular dichroism indicated AFD19 coiled-coil assembly to 
occur with a degree of cooperativity of ~ 6, while electron microscopy showed an 
entangled network of thin fibrils, with diameters consistent with a higher-order coiled-coil 
as the cross-sectional unit. Characterisation of AFD19 self-assembly and comparison of 
peptide sequence with previously reported fibril-forming α-helical peptides allowed the 
proposal of a model for AFD19 fibril and hydrogel formation. In this model, the self-similar 
heptad repeats of the peptide allow permissive helix offsetting. These offset helices 
provide end-to-end overlaps resulting in staggered coiled-coil fibril formation. Physical 
cross-link formation between fibrils and consequent gelation is controlled by the level of 
molecular charge on the peptide whereby highly-charged peptide states gave free-flowing 
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solutions, gelation occurred at a peptide charge of ±1, and the peptide precipitated as the 
charge approached zero. 
While AFD19 formed hydrogels at pH 6 and precipitated at physiological pH, targeted 
modification of this peptide based on the proposed model of self-assembly gave peptide 
AFD36, which formed hydrogels under conditions of physiological pH and salt. Results 
from small-angle X-ray scattering showed assembly of AFD36 to give fibrils similar to 
those observed for AFD19 by electron microscopy. Hydrogels formed by both AFD19 and 
AFD36 were extremely thermostable and the constituent coiled coils showed high 
thermodynamic stability. The use of bicarbonate as a transient buffer enabled the 
preparation of homogenous materials from this single-peptide gelling system. The ability to 
form hydrogels under physiological conditions gives these materials potential for use in 
biomedical applications 
4.2 Experimental 
4.2.1 Materials 
All reagents used were of the highest grade available. Water was purified using an Elga 
Purelab Classic system (Veolia Water, Saint Maurice, France) and had a resistivity of 
>18.2 MΩ.cm. Guanidine hydrochloride (G.HCl) (≥99%), 2-(N-morpholino)ethanesulfonate 
hydrate (MES; ≥99.5%) and sodium bicarbonate (≥99.5%) were purchased from Sigma-
Aldrich. Glassware was acid-cleaned as previously described.17  
Peptide AFD19 (trifluoroacetate salt, Ac-LKELAKV LHELAKL VSEALHA-CONH2, FW 
2354) was custom synthesised and RP-HPLC purified by Genscript (Piscataway, New 
Jersey). Peptide AFD36 (trifluoroacetate salt, Ac-LKELAKV LHELAKL VKEALHA-CONH2, 
FW 2395) was custom synthesised and RP-HPLC purified by Genscript (Piscataway, New 
Jersey) or Peptide 2.0 (Chantilly, VA). The final purity was >95% in each case. The 
peptide content of the solid was determined by quantitative amino acid analysis (Australian 
Proteome Analysis Facility, Sydney, Australia). 
Similar to the Het2-6 concentration determination described in Chapter 2, the 
concentration of AFD36 was in some cases estimated by measurement of ellipticity at 222 
nm using a mean residue ellipticity of -27,500 deg cm2 dmol-1 at a peptide concentration of 
close to 1 mM in 10 mM MES buffer, pH 6.0.  
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4.2.2 Electronic circular dichroism 
ECD measurements were collected and mean residue ellipticity calculated as described in 
Chapter 2. 
AFD19 solutions for studies on the effect of peptide concentration or solution temperature 
on self-assembly were prepared directly in 10 mN or 1 mN HCl or buffered in 10 mM Na+ 
acetate (pKa = 4.76) at pH 4.0 or 5.0 or 10 mM Na+ 2-(N-morpholino)ethanesulfonate 
(MES; pKa = 6.27) pH 6.0. NaCl was added to adjust the final ionic strength to 0.01. 
Samples for studying the effect of peptide concentration on self-assembly were prepared 
by serial dilution in the appropriate buffer from a concentrated peptide solution. 
All studies of the effect of temperature on peptide self-assembly were carried out in the 
temperature range of 20-90 °C at a heating rate of 1.5 °C min-1. AFD19 samples were 
prepared at 200 μM peptide in buffers as above. AFD36 samples were prepared at 0.84 
mM peptide in 10 mM MES pH 7.0. 
Peptide solutions for chemical denaturation studies were prepared at 250 µM peptide in 10 
mM Na+ acetate pH 5.0 (AFD19) or 10 mM MES pH 6.0 (AFD36) containing 0-8 M G.HCl, 
and were equilibrated at 20 or 50 °C before recording ellipticity at 222 nm.  
For thermodynamic analysis, data were subjected to least-squares fitting using Microsoft 
Excel Solver.  
4.2.3 Peptide charge predictions 
The net charge on the peptide was calculated as described in Chapter 2. 
4.2.4 AFD19 gel formation 
AFD19 samples for photographing at varied pH values and determination of hydrogel 
melting temperature were prepared by titrating unbuffered solutions of 1.2 mM (0.3 % 
(w/v)) peptide with strong acid or base. Hydrogels at pH 6.0 and 10.7 were prepared by 
titrating peptide solutions from pH 3.0 and 11.0 respectively. Aggregated peptide at pH 7.5 
was prepared by neutralisation of an acidic solution. 
4.2.5 Electron microscopy 
For negative staining transmission electron microscopy (TEM), self-buffered AFD19 
solutions (0.2 mg mL-1) were prepared at integral pH values from 3.0 to 7.0. A drop of 
peptide solution was placed on a formvar-coated 100 mesh copper TEM support grid 
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(ProSciTech, Thuringowa, Australia) and allowed to stand for 1 minute before blotting. 
Each sample was stained for 1 minute by addition of 2% (w/v) ammonium molybdate 
solution, previously adjusted to the same pH as the initial peptide solution using 1 N HCl or 
NH4OH. Samples were viewed on a Jeol-1010 instrument (JEOL, Tokyo, Japan) under an 
accelerating voltage of 80 kV and imaged using a Veleta CCD camera (Olympus Soft 
Imaging Solutions). Image processing used iTEM software (Olympus). 
For cryo-TEM, peptide samples at 1 mg mL-1 were plunge frozen on C-flat holey carbon 
grids (EMS, Hatfield, PA, USA) into liquid ethane using an FEI Vitrobot Mark 3 (FEI, 
Hillsboro, OR, USA). Optimal blot time was 6 s. Frozen/vitrified samples were viewed on a 
Technai F30 TEM (FEI) fitted with a Direct Electron LC-1100 4k camera (San Diego, CA, 
USA) using the low-dose mode of the SerialEM image acquisition software.18 Images were 
captured unbinned with an electron dose of 20 Å-2 at magnification 39,000×, 50 Å-2 at 
78,000× and 44 Å-2 at 93,000×. 
For the measurement of fibril diameters, images were analysed using imageJ software 
(National Institutes of Health, USA), with twenty measurements averaged for each pH 
value. 
4.2.6 Plate reader assays 
Spectrophotometric determination of pH used an Infinite M200 plate reader (Tecan, 
Männedorf, Switzerland) with 48-well plates and sample volumes of 200 μL. The acidity 
constant of phenol red in Dulbecco’s modified Eagle’s medium (DMEM) was determined 
by titration, with absorbance monitored at 433 nm. Reference A433 readings for fully 
protonated and fully deprotonated phenol red were obtained by addition of 10 mN HCl and 
10 mN NaOH, respectively. A pKa of 7.70 was obtained as the y-intercept of a plot of pH 
vs. log((Aacid – A433)/(A433 – Abase)). 
For gelling tests, 100 μL of an AFD36 stock solution (8.4 mM, pH ~ 3) was mixed in a 48-
well plate with 100 μL of an NaHCO3 solution containing 120 μM phenol red. UV-visible 
spectra (700-350 nm) were recorded at 3 min intervals over 60 min and single wavelength 
readings were extracted for analysis. Spectra showing an isosbestic point at 477 nm were 
used for pH calculations, while samples showing light scattering were excluded. For 
greater sensitivity, the pH of gelling samples was determined at 558 nm, with pH 
calculated as 7.70 + (A558 – Aacid)/(Abase – A558).  
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4.2.7 Small-angle X-ray scattering 
Small-angle X-ray scattering (SAXS) data were collected using an Anton Paar SAXSess 
instrument using a monochromated Cu sealed tube operating at 40 kV and 50 mA as a 
source, a line focus (Kratky) geometry and a CCD detector at a fixed sample-to-detector 
distance.  Peptide samples were prepared at 5 mg mL-1 in 10 mM Na+ acetate (pH 4.0 or 
5.0) or MES (pH 6.0 or 7.0) with addition of NaCl to maintain an ionic strength of 0.01. 
Samples were housed in a silica capillary maintained at 20 °C during the measurements. 
SAXS data were measured over a range of q = 0.007 to 0.2 Å-1 (where q is the momentum 
transfer vector) and the data were reduced by standard procedures to remove the dark 
current and background measured from the buffer, accounting for the relative transmission 
of the sample and background. The data were placed on an absolute intensity scale using 
the known cross section of water as a primary standard.19 The data presented represent 
the average of 1800 exposures collected for 10 sec each to ensure that there were no 
changes occurring during exposure to the X-ray beam.  
Analysis of the X-ray data was carried out using the NCNR analysis macros in Igor Pro. 
For the data obtained here, a flexible cylinder model was used to determine both the mean 
radius and persistence length of the fibrils as a function of pH.  In these models the 
electron density for the buffer was calculated to be 9.45 × 10-6 Å-2, while that for AFD36 
was estimated to be 1.22 × 10-5 Å-2 based on chemical composition. 
4.2.8 AFD36 gel melting 
A ball drop test was conducted using a stainless steel ball (6 mm diameter; 1.0 g) placed 
on the surface of an AFD36 gel heated in a water bath. The gel was prepared at 4.2 mM 
AFD36 in 10 mM MES and 22.5 mM NaHCO3 (final concentrations), and was allowed to 
stand overnight before the heating test to allow loss of CO2 and complete setting. The gel 
was heated from 30 to 80 °C in 10 °C steps, and was observed and photographed after 
being held for 15 min at each temperature. A separate test was conducted on an AFD36 
gel prepared in phosphate-buffered saline (140 mM NaCl, 5 mM KCl, 1.5 mM Na+ 
phosphate, 22.5 mM NaHCO3, final concentrations) at the same peptide concentration with 
heating from 30 to 90 °C. Gel melting was recorded at the temperature where the ball 
dropped completely through the gel. 
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4.3 Results and Discussion 
4.3.1 Peptide Design 
The peptide AFD19 was designed as part of ongoing work on α-helical surfactant 
peptides.20-22 The design of this peptide used similar principles to the design of surfactant 
peptides EDP-11 and RDP-4 of Chapter 2, as well as the designs of previously reported α-
helical surfactants AM1 and AFD4 discussed in Chapter 1. This approach utilises a 
canonical α-helix structure, with 3.6 residues per turn resulting in an 18 position repeat. In 
previous designs, hydrophobic residues were selectively placed at positions 1, 4, 8, 11, 15 
and 18, with the remaining positions populated by hydrophilic residues to give an 
amphiphilic helical structure (Figure 4-1A). In the design of AFD19, the hydrophobic 
component was expanded to include positions 5, 7, 12 and 14 with the aim of increasing 
the affinity of the surfactant peptide for the interface. 
Residue selection was based on considerations of high helix propensity,23, 24 similar to the 
peptide design process described in Chapter 2. For hydrophobic positions, residues 
alanine and leucine were favoured due to their high helix propensity, with a smaller 
component of valine residues. Similarly for hydrophilic positions, glutamate was selected 
over aspartate as an anionic residue due to its high helix propensity. Cationic lysine 
residues were used to balance the charge contributions from glutamate residues to avoid a 
sequence with high net charge. The inclusion of two histidine residues (pKa ~ 6.1) at 
positions 8 and 20 was driven by a desire to possess control over molecular charge and 
  
Figure 4-1. Helical wheel representations of; A) canonical 18 position helical wheel representation 
of a facially amphiphilic α-helix associated with a hydrophobic interface (boxed); B) the peptide 
AFD19 originally designed as a peptide surfactant with expanded hydrophobic face (boxed). 
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potentially surfactant functionality near physiological pH, as well as the potential for 
intermolecular cross-link formation similar to peptide AFD4.21 Serine was preferred over 
glutamine or asparagine as a neutral polar residue due to side-chain chemical stability 
considerations.25 Similar to the design of EDP-11, RDP-4 and heteroconcatemer 
sequences in Chapter 2, minimisation of the instability index was used to optimise 
proteolytic stability,26 while GRAVY27  values of less than 0.6 were targeted to provide 
solubility. This resulted in a final sequence for AFD19 of (Ac-LKELAKV LHELAKL 
VSEALHA-CONH2, FW 2354) that displays an amphiphilic character (Figure 4-1B), had a 
predicted molecular charge of +0.23 at pH 7, a pI of 8.3, an instability index of 6.57 and a 
GRAVY value of 0.429. This predicted AFD19 to be soluble at high and low pH values, 
and stable to proteolysis. 
4.3.2 Peptide characterisation 
The solution properties of synthetically produced AFD19 in water were initially assessed 
as a function of pH. As-received peptide dissolved in water to give a free-flowing solution 
with a pH close to 3.0 due to residual trifluoroacetic acid (TFA) from the chromatography 
step utilised in purification. Unexpectedly, AFD19 formed optically clear gels at 0.1-0.5% 
(w/v) as the pH approached 6.0 on addition of NaOH. Gel strength and rate of formation 
strongly depended on peptide concentration. Mechanical disruption of the hydrogel by 
pipetting or vigorous stirring gave a liquid state that re-gelled on a similar time scale to the 
original gelation, consistent with the formation of physical cross-links between 
components. Samples lyophilized from pH 6.0 did not re-gel on hydration, consistent with 
the formation of physically cross-linked hydrogels that do not form by swelling. Solutions of 
AD19 at pH 5.0 thickened but did not gel, while above pH 7.0, peptide precipitated from 
solution. Reacidification of gelled samples caused rapid gel dissolution, as did the addition 
of excess NaOH to give pH ~ 12. Precipitate obtained at pH 7.0 redissolved on the 
addition of excess HCl or NaOH. Given the few α-helical peptide hydrogels reported to 
date (Chapter 1), the serendipitous observation of gel formation by AFD19 prompted 
further investigation of the self-assembly of this peptide. 
4.3.3 AFD19 secondary structure 
Titration of an acidic 1.75 mM (0.41% (w/v)) AFD19 solution to pH 5.9 resulted in gelation 
within 1 minute. ECD was used to probe the peptide secondary structure under the initial 
solution (pH 3.4) and final gelled (pH 5.9) conditions (Figure 4-2). Both gelled and ungelled 
AFD19 samples showed characteristic α-helical spectra with double minima at 208 and 
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222 nm and a maximum at 192 nm with very little change between the two conditions. The 
mean residue ellipticities at 222 nm for gelled and ungelled samples were -27,800 and -
30,500 deg cm2 dmol-1 respectively. These values indicate AFD19 to be in a predominantly 
helical structure in both states,28 consistent with the design of an α-helical peptide. The 
similarity in helical content between these states indicated that hydrogel formation was not 
solely dependent on folding of the peptide into α-helices.  
As discussed in Chapter 1, the folding of an amphiphilic peptide such as AFD19 to give a 
soluble α-helical product, as opposed to adsorption of the peptide at an interface or being 
unfolded in solution, was expected to involve the formation of a coiled-coil structure. In 
such an arrangement, the hydrophobic faces of the peptides associate, resulting in the 
helices wrapping around one another in a left-handed coil. The positioning of residues in 
such a supercoil involves a smaller periodicity of 3.5 residues per helix turn compared to 
the 18-position repeat used to design AFD19 (Section 4.3.1) and is represented using a 
classical heptad-based helical wheel with positions a, b, c, d, e, f and g (Figure 4-3). 
 
Figure 4-2. ECD spectra of self-buffered AFD19 (1.75 mM) at 20 °C in gelled (solid line, pH 
5.9) and ungelled (dashed, pH 3.4) states. 
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As discussed in Chapter 1, in the design of coiled coil forming peptides, positions a and d 
are generally reserved for hydrophobic residues while the remaining positions are 
populated with hydrophilic residues.29 Specifically, positions e and g are often populated 
with charged residues that are involved in electrostatic helix-helix interactions.29-31 In the 
design of AFD19, the hydrophobic component of the peptide was increased to include 
positions 5, 7, 12 and 14 of the original design (Section 4.3.1) in an effort to enhance 
peptide adsorption at the interface. One consequence of this is that when arranged in a 
coiled coil, positions e and g of AFD19 are populated with the non-polar amino acids 
leucine, valine and alanine. As discussed in Chapter 1, such an expansion of the 
hydrophobic face of helical peptides has been associated with an increased coiled-coil 
oligomerization state.32-34  
The helical structure of AFD19 and gel formation at low weight percentages suggested 
that this peptide most likely assembled into fibrillar coiled coils rather than globular 
structures as the basis of the gel. Furthermore, minimal change in the relative mean 
residue ellipticities at 222 and 208 nm was seen upon gelation. This is in contrast to 
 
Figure 4-3. Heptad-based helical wheel projection of peptide AFD19. Positions a, d, e and g are 
occupied by non-polar residues. Positions b, c and f are occupied by hydrophilic residues with 
self-similar heptad repeats. 
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observations of thickened α-helical fibrils where lateral association of helices often results 
in large changes to this ratio, likely due to light scattering.14, 35, 36 The absence of this 
spectral change and the optical transparency of the hydrogels supported the formation of 
unbundled coiled-coil fibrils. The self-assembly of AFD19 was further investigated to better 
characterise the assembled state of AFD19 and the mode of hydrogel formation. 
4.3.4 Characterisation of coiled-coil assembly 
To further investigate the self-assembly of AFD19, ECD data were collected across a 
range of peptide concentrations at the non-gelling pH values of 2.0, 3.0, 4.0 and 5.0 at a 
buffer ionic strength of 0.01 (Figure 4-4). Mean residue ellipticity at 222 nm ([θ]222) was 
used as a measure of helical secondary structure, with smaller magnitude values 
indicating less helical structure.  
 
Figure 4-4. Electronic circular dichroism spectroscopy study of the self-assembly of AFD19 into 
α-helical structures as a function of peptide concentration at pH values of 2.0 (○), 3.0 (▲), 4.0 
(□) and 5.0 (▼). Lines are a fitted two-state dissociation model described in text.  
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At acidic pH and low peptide concentration, AFD19 is fairly unstructured in solution as 
indicated by [θ]222 values close to zero. As the peptide concentration is increased, the 
value of [θ]222 decreases sharply, reflecting peptide assembly into coiled coils. As the pH is 
increased from 2.0 to 5.0 the midpoints of the folding curve shift to lower concentrations. 
This indicates the peptide-peptide affinity is increased as gelling pH is approached. Also 
notable from these results at higher pH, is the increasing magnitude of minimum [θ]222 
values seen at low peptide concentrations. This indicates that as the gelling pH is 
approached, the monomeric peptide is able to adopt a partly helical arrangement, likely 
due to changes in the charged state of the peptide and potentially the pH dependent helix 
propensity of ionisable residues.37 The [θ]222 values at higher peptide concentrations are 
also seen to vary with pH, possibly indicating  subtle structural differences in assembled 
coiled coils. In particular, at pH 2, assembled AFD19 has a much smaller magnitude [θ]222 
than at higher pH values, indicating that as glutamate residues become protonated at 
acidic pH, electrostatic repulsion may partially destabilise coiled-coil assembly due to the 
high level of positive charge on the peptide. 
The cooperativity of AFD19 self-assembly was assessed with the aim of determining the 
oligomerization state of the coiled coil. ECD data was analysed using a two-state model 
based on an approach by Fairman et al.,38 adapted for a coiled coil of unknown 
oligomerization state (n-mer). In this model, n peptide monomers (mon) with a low helix 
content assemble into helical n-mers in an equilibrium governed by a dissociation constant 
Kd: 
 𝐾𝑑 =  [𝑚𝑜𝑛]𝑛[𝑛−𝑚𝑒𝑟]  (4-1) 
For each pH, fraction folded (Ff) was calculated at each concentration from observed 
values of [θ]222; [θ]obs: 
 𝐹𝑓 = [𝜃]𝑜𝑏𝑠−[𝜃]𝑚𝑖𝑛[𝜃]𝑚𝑎𝑥 − [𝜃]𝑚𝑖𝑛  (4-2) 
Where [θ]min and [θ]max are the mean residue ellipticity values for the unstructured and fully 
folded peptide states respectively, and were chosen using an iterative approach to achieve 
the best fit to the collected data. 
Using the self-assembly model, the fraction folded can also be expressed as: 
 𝐹𝑓 =  𝑛 [𝑛−𝑚𝑒𝑟][𝑚𝑜𝑛]+ 𝑛 [𝑛−𝑚𝑒𝑟]  (4-3) 
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The degree and strength of self-association may be determined from the concentration of 
monomer and n-mer in solution: 
 log[𝑛 −𝑚𝑒𝑟] = 𝑛 log[𝑚𝑜𝑛] −  log[𝐾𝑑] (4-4) 
   
or equivalently: 
 log𝑛[𝑛 −𝑚𝑒𝑟] = 𝑛 log[𝑚𝑜𝑛] −  log𝐾𝑑 + log 𝑛 (4-5) 
Equation 4-5 is in terms of n[n-mer], which corresponds to the concentration of peptide in 
the assembled state and allows determination of the values of n and Kd from a linear least-
squares fit to data points at peptide concentrations in the assembly transition region 
(Figure 4-5). The values obtained by this approach are given in Table 4-1. These results 
indicate AFD19 assembly under non-gelling conditions to proceed with a cooperativity of n 
~ 6, suggesting a hexameric coiled-coil structure. 
 
Figure 4-5. Linear least-squares fits of AFD19 assembly using Equation 4-5 at pH values of 2.0 
(○), 3.0 (▲), 4.0 (□) and 5.0 (▼). 
144 
 
From the determined values of n and Kd it is possible to calculate the thermodynamic 
stability of the peptide coiled coil. The stability of AFD19 complexes increases with pH, 
varying from 4.5 kcal mol-1 per monomer at pH 2.0, to 5.9 kcal mol-1 per monomer at pH 
5.0. The AFD19 samples for this concentration dependence study were prepared as 
dilution series and the use of a similar method for gelling peptide solutions was not 
feasible. This thereby precluded the study of AFD19 self-assembly at gelling pH by the 
same methods. However, based on the observed trend of increasing stability, it may be 
expected that gelling conditions would give even higher stability.  
Table 4-1. Parameters used to fit ECD data for AFD19 self-assembly under non-gelling conditions 
pH n Kd ΔGmona [θ]minb [θ]maxb 
2.0 6.0 1.3 × 10-20 -4.5 -3.5 -20.8 
3.0 6.0 2.5 × 10-21 -4.7 -6.2 -26.9 
4.0 6.1 2.6 × 10-25 -5.5 -12.9 -25.5 
5.0 5.8 3.0 × 10-26 -5.9 -15.7 -24.3 
a binding energy per monomer in kcal mol-1 
b 103 deg cm2 dmol-1 at 222 nm 
As discussed in Chapter 1 and in Section 4.3.3, the expansion of the hydrophobic face of 
amphiphilic α-helices is associated with the formation of higher-order coiled coils such as 
pentamers,16, 39 hexamers34 and heptamers.33, 40 Given the hydrophobic face of AFD19 
was expanded to include positions e and g of the heptad, the hexameric structure 
proposed here is therefore reasonable. However, the data analysis procedure used here to 
examine the self-assembly of AFD19 may be too insensitive to changes in oligomerization 
state of higher-order coiled coils to unequivocally determine the assembled state. For 
example, in the case of AFD19, values of n of ~ 5-7 were obtained with a similar goodness 
of fit by varying the chosen values for [θ]max.  
The results of characterising coiled-coil assembly were therefore consistent with AFD19 
forming a higher-order coiled coil of approximately a hexamer, consistent with the known 
effects of expanding the peptide hydrophobic face. However, more detailed studies are 
required to confirm the oligomeric state of AFD19 and better understand the mode of self-
assembly as a function of pH. This may involve the use of techniques such as 
sedimentation equilibrium ultracentrifugation in the future. 
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4.3.5 AFD19 gelling as a function of charge 
The dependence of peptide gel formation on solution pH indicated the important role 
molecular charge plays in gelation. At acidic pH, AFD19 solutions have low viscosity that 
then increases upon titration to pH 5 where a thickened solution is observed. Upon titration 
of AFD19 solutions to pH 6, gelation occurs in a concentration-dependent manner. While 
no detailed study of charge dependence of gelation appears to have been made in α-
helical peptides, there have been several studies of the effects of charge and solubility for 
β-sheet peptide hydrogelators, as discussed in Chapter 1. 
The formation of physical hydrogels involves a balance between component solubility and 
self-association. For example, Aggeli et al.41 have shown that gelation of β-sheet peptides 
proceeds as a function of solvent quality in both aqueous and organic solvents for a series 
of peptides of varying hydrophilicity. The same group also reported that one unit of positive 
or negative charge per 11-residue P11 peptide permitted fibril and hydrogel formation in 
unbuffered solutions, while higher charged states were required in higher ionic strength 
cell culture media.11, 42  This charge dependence allows pH control of gelation. Separate 
work has also shown pH-dependent gelation of a number of β-sheet peptides under 
conditions of moderate ionic strength.43, 44 Several charged peptides have also been 
shown to undergo gelation in response to solution ionic strength,45-47 while other related 
sequences display gel formation as peptide net charge is lowered to near zero.45, 48, 49 The 
precise charge dependence of gel formation varies across these β-sheet peptide systems 
depending on peptide sequence and solution conditions. However, the balancing of 
solubility due to molecular charge with the strength of self-association is a common theme 
throughout these reports. 
The pH-dependent gelation of AFD19 indicated molecular charge to play a role in 
determining peptide self-assembly. To further investigate this, the predicted molecular 
charge for AFD19 was calculated across the pH range 2-12, based on an assumption of 
independent, non-interacting ionisable sites (Figure 4-6). Figure 4-6 also shows images of 
AFD19 solutions prepared at pH values 3.0, 6.0, 7.5, 10.7 and 11.5 to illustrate 
macroscopic properties as a function of molecular charge. At low pH, where solutions are 
free flowing, the predicted charge on AFD19 is very positive (+4.9 at pH 3.0). As the pH is 
raised this charge decreases to approximately +1 at pH 6 where gelation occurs. If the pH 
is raised further to pH 7.5, where the predicted charge is approaching 0, a precipitate 
forms that can be redissolved at either high or low pH. 
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To investigate whether the level rather than type of charge was dominant in controlling 
gelation, a free-flowing AFD19 pH 11.5 solution with a predicted per-peptide charge of -2.5 
was titrated with HCl until gelation occurred over several minutes at pH 10.7 where the 
predicted charge approaches -1. These results indicate that AFD19 gelation occurs at a 
charge of ±1 and is inhibited when the peptide is highly charged in either basic or acidic 
conditions, most likely due to charge-charge repulsion of peptide assemblies preventing 
association. 
4.3.6 Fibril formation 
Formation of low weight percentage peptide hydrogels is generally contingent on the 
formation of fibrillar structures for both β-sheet43, 50 and α-helical based14, 15 systems. 
Negative staining transmission electron microscopy (TEM) was therefore employed as a 
means to visualise the assembled state of AFD19. TEM of dried peptide samples utilised 
pH adjusted ammonium molybdate staining solutions and images are presented in Figure 
4-7;A-E. The low peptide concentration of 0.2 mg mL-1 was utilised to enable sample 
 
Figure 4-6. Predicted per peptide molecular charge of AFD19 and observed phase changes in 
self-buffered AFD19 (1.2 mM; 0.3% (w/v)) solutions as a function of pH.  
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preparation without gel formation and enable visualisation of assembly at pH 7.0 where 
AFD19 is only sparingly soluble. 
Under acidic conditions AFD19 formed thin fibrils of only limited length (Figure 4-7;A-B). 
Measured fibril diameters at pH 3.0 and 4.0 were 2.9 ± 0.8 nm and 3.7 ± 0.8 nm 
respectively. As the pH is raised to 5.0, longer fibrils are observed, with concomitant 
formation of a bundled structure (Figure 4-7C). This resulted in average fibril diameters of 
6.7 ± 2.4 nm, however individual thinner fibrils are still visible. Bundling is further increased 
at pH 6.0 and 7.0 (Figure 4-7;D-E) with average fibril diameters of approximately 20 nm.  
The fibril diameters observed at acidic pH are comparable to the previously reported 
diameters of higher-order coiled coils.33, 40, 51 The fragmented structure observed by 
negative staining TEM at acidic pH may be due to peptide assembly being less stable at 
higher molecular charge (Section 4.3.5). The bundling of fibrils as the pH approaches 
neutrality likely results from a reduction in molecular charge coupled with the drying 
process used to prepare samples. Given the ECD spectrum of gelled AFD19 does not 
 
Figure 4-7. A-E) Negative staining TEM images of 0.2 mg mL-1 AFD19 at pH 3.0, 4.0, 5.0, 6.0 
and 7.0 respectively (scale bars 100 nm); F) Cryo-TEM image of 1.0 mg mL-1 AFD19 gel at pH 
6 (scale bar 50 nm). 
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display changes associated with fibril bundling (Figure 4-2), it seems likely that this 
bundled state does not exist in solution but rather forms during sample preparation.  
Cryo-TEM was utilised as an alternate method to visualise self-assembled structures 
formed by AFD19. This method allows visualisation of plunge-frozen hydrated samples 
and thus avoids drying and staining steps that are potential sources of artefacts. In a 
gelled sample at 0.1% (w/v) peptide and pH 6, an entangled network of hydrated fibrils 
with an unbundled morphology can be seen (Figure 4-7F). Measurement of fibril diameters 
gives 7.1 ± 1.1 nm, which while much smaller than the bundled fibrils seen using 
conventional TEM at equivalent pH, is still larger than may be expected for a hexameric 
coiled coil. Measurement inaccuracies may be due to the low contrast present in these 
organic molecules limiting resolution. Most notable from this cryo-TEM experiment is the 
observation of an entangled but unbundled fibrillar structure, which is in agreement with 
ECD predictions of unbundled fibrils. 
4.3.7 Thermal stability 
To better understand the mechanism of AFD19 assembly and gel formation, the helical 
secondary structure of AFD19 was monitored as a function of temperature at different pH 
values (Figure 4-8). While hydrophobic interactions are strengthened at elevated 
temperatures,52, 53 hydrogen bonding tends to be weakened,54, 55 which allows inferences 
to be drawn about the stabilising interactions of peptide hydrogel systems in which self-
assembly is promoted by either chilling14, 56 or heating.14, 43 
Heat destabilised AFD19 helical structure most effectively at acidic pH, with temperature of 
50% denaturation (Tm) values of ~ 45 °C at pH 2.0 and ~ 59 °C at pH 3.0. At pH values of 
4.0 and above, α-helix thermostability was greatly increased, with Tm values in excess of 
100 °C. Indeed, at pH 4-6 more than 65% of initial secondary structure was preserved at 
90 °C, consistent with thermostable hydrophobic interactions stabilising coiled-coil 
assembly. Cooling of peptide samples gave recovery of almost all helical structure, 
demonstrating the denaturation to be reversible. The pH dependence of stability is likely 
due to the high molecular charge at acidic pH partially destabilising coiled-coil assembly. 
This destabilising effect is then lessened as the pH is increased and peptide molecular 
charge is partially neutralised (Section 4.3.5). 
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Compared to helical secondary structure, the macroscopic gel structure was less stable. A 
hydrogel prepared at 1.2 mM AFD19 and pH 6.0 showed a gel-sol conversion on heating 
to 90 °C, which is well below the temperature required to denature the constituent helices. 
These results together reinforce the distinction between coiled-coil self-assembly and 
hydrogel formation. While the former is likely to be predominantly stabilised by 
hydrophobic interactions, gel melting suggests that hydrogen bonding may play a role in 
cross-linking between peptide fibrils. 
4.3.8 Mechanism of gelation 
By considering the data collected on AFD19 self-assembly, it becomes possible to 
propose a mechanism for fibril assembly and hydrogel formation. Figure 4-9 illustrates a 
 
Figure 4-8. Secondary structure of AFD19 as assessed at 222 nm using ECD as a function of 
temperature during heating (solid line) and cooling (dashed) at different pH values. The 
concentration of peptide was 200 µM and the buffer ionic strength was maintained at 0.01. 
Solution pH as indicated by colour. 
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two stage process for the assembly of AFD19 to form low weight percentage hydrogels as 
a function of pH. 
Monomeric AFD19 adopts an increasing level of helical secondary structure as pH is 
raised towards gelling conditions and molecular charge decreases (Section 4.3.4). Stage a 
involves the self-assembly of these monomeric peptides into staggered coiled-coil fibrils, 
involving association of helices through the expanded hydrophobic face. The concentration 
dependence of self-assembly suggests a cooperativity of assembly of ~ 6 (Section 4.3.4). 
The formation of extended fibrils (as observed in Section 4.3.6) would involve the 
assembly of many orders of magnitude more peptide monomers than this determined n 
value. It was therefore thought that the concentration dependence study is predominantly 
probing an initial coiled-coil nucleation event that involves ~ 6 peptide monomers. This 
suggests the formation of an approximately hexameric coiled coil with staggered helices, 
which is consistent with the increase in oligomerization state previously associated with 
expansion of the hydrophobic core from positions a and d to include positions e and g of 
the heptad repeat.32-34 Fibril diameters observed via electron microscopy are consistent 
with the formation of a higher-order coiled coil, while an oligomerization state larger than a 
heptamer is thought to be unlikely as to the candidates knowledge, these have not been 
observed in self-assembling peptide systems.32 These results therefore suggest an 
 
Figure 4-9. Proposed scheme for AFD19 self-assembly into fibrils that form physically cross-
linked hydrogels. Stage a involves the assembly of monomeric peptides into staggered coiled-coil 
fibrils. Stage b then involves the formation of a three-dimensional network of fibrils where 
association is controlled by peptide charge as a function of pH. Horizontal lines within each 
peptide mark the ends of heptads. 
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oligomerization state of between a pentamer and a heptamer, however confirmation of 
oligomerization state will require more detailed structural studies such as sedimentation 
equilibrium ultracentrifugation due to limitations inherent in the self-assembly modelling 
and TEM studies. 
The helix orientation within AFD19 coiled coils has not been determined; however 
pentamer,39 hexamer34 and heptamer33 structures with expanded hydrophobic cores have 
been reported to form parallel coiled coils. Furthermore, α-helices in which e and g sites 
are populated by oppositely-charged residues are generally expected to form parallel 
coiled coils due to charge-charge repulsion in the antiparallel arrangement.29 While the e 
and g sites in AFD19 are occupied by non-polar residues, similar interactions may occur 
between the b and c flanking positions, making it likely that these peptides assume a 
parallel arrangement.57 
The coiled-coil structure of AFD19 is shown to be extremely stable to thermal 
denaturation, most likely as a consequence of the hydrophobic interactions driving 
assembly (Section 4.3.7). The α-helical form of AFD19 is quite stable as judged by the 
energetics of self-assembly (ΔG = -4.5 to -5.9 kcal mol-1, Section 4.3.4). However the 
measured thermodynamic parameters cannot be assigned to the formation of a discrete 
coiled coil, as TEM studies showed fibril formation under conditions similar to those 
employed for ECD data collection (Section 4.3.6). The fitted values of ΔG may therefore 
correspond to the formation of staggered coiled-coil fibrils rather than discrete coiled coils, 
as illustrated in Stage a, a point that will be returned to later. 
Several approaches to specify the formation of coiled-coil fibrils through the introduction of 
forced helix offsets have been reported by the Woolfson,14, 36, 56, 58-63 Conticello64-66 and 
Fairman67, 68 groups (Chapter 1). The peptide AFD19 lacks these design elements, but 
possesses some similarities with the peptides reported by Kojima et al.,69 Takei et al.,70 
Potekhin et al.,16 Melnik et al.71 and Dong et al.15 to form coiled-coil fibrils in the absence of 
any design for forced helix offsets. As described in Chapter 1, these peptides all possess 
self-similar heptad repeats. While AFD19 has a lower degree of self-similarity than many 
of these peptides, it possesses all non-polar residues at positions a, d, e and g, anionic 
glutamate residues at position c and predominantly cationic residues at positions b and f. 
This gives it a comparable degree of self-similarity to a peptide reported by Dong et al.15 to 
form fibrils and transparent gels. Based on the similarities between these sequences, it 
appears likely that fibril formation occurs by permissive, rather than specified, offsetting of 
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facially amphiphilic helices. One consequence of these self-similar heptad repeats is that 
helices offset by a full heptad would have similar net intermolecular interactions to an in-
register arrangement. Similarly to the specified offset helices of the Woolfson,14, 36, 56, 58-63 
Conticello64-66 and Fairman67, 68 groups’ designs, these out-of-register helices could then 
provide end-to-end overlaps leading to staggered coiled-coil fibril formation (Figure 4-9). 
Furthermore, crystal structures of parallel coiled coils formed by GCN4 peptide variants 
have shown that non-polar residue placement at peptide e and g positions (as in AFD19) 
can result in helix offsetting due to non-classical packing of residues within the 
hydrophobic core.32 For example, peptide GCN4-pVe has valine residues at all e positions 
and formed tetrameric coiled coils with three-residue offsets between adjacent helices.72 
Additionally, peptide GCN4-pAA has alanine residues at both e and g positions and 
formed a heptameric coiled coil with single-residue offsets between adjacent helices.33 If 
such an effect were involved in AFD19 assembly, then this offsetting may assist in driving 
fibril formation by providing “sticky ends” for end-to-end helix overlaps. The prediction of 
such interactions in the hydrophobic core of coiled coils are not straightforward and further 
experiments are required to determine the packing of residues within the core of AFD19 
fibrils.32 
More detailed studies are required to determine the exact structure of AFD19 coiled-coil 
fibrils in terms of oligomerization state and helix offsetting. This is a non-trivial process as 
such fibril forming peptides are difficult to characterise using conventional techniques such 
as X-ray crystallography or solution nuclear magnetic resonance spectroscopy. However, 
in the future, further analysis by techniques such as higher resolution electron microscopy, 
X-ray fibre diffraction or sedimentation equilibrium ultracentrifugation may be able to better 
characterise peptide assembly.34, 40, 73 Given the data in hand it appears likely that fibril 
formation occurs by the permissive offsetting of helices due to self-similar heptad repeats, 
potentially assisted by preferential packing of hydrophobic residues at positions a, d, e and 
g. 
The similar intermolecular interactions predicted for offset and in-register helices with self-
similar heptad repeats have implications for analysis of peptide self-assembly. The 
determined thermodynamic parameters (Section 4.3.4) will correspond primarily to the 
formation of a coiled coil of offset helices and be comparable to values determined for an 
in-register coiled coil. This is supported by the determined cooperativity of assembly (n ~ 
6), and is consistent with the proposal (above) that the concentration dependence study is 
153 
 
predominantly probing an initial nucleation event, as further assembly to coiled-coil fibrils 
will not involve changes in peptide-peptide intermolecular interactions. This also suggests 
that extended fibril formation is not readily observed by ECD.  
Despite the absence of a strong driving force for helix offsetting, it appears that the 
majority of peptide in solution is involved in extended fibril formation even at moderate 
concentrations, as indicated by electron microscopy and the formation of hydrogels at low 
peptide concentrations. Head-to-tail association of α-helices has been observed in several 
crystal structures,74, 75 stabilised by hydrogen bonding and possibly also by interactions 
between helix dipoles. The proposed parallel arrangement of helices within AFD19 coiled-
coil fibrils would yield summed α-helix dipoles that may stabilise the head-to-tail 
association of helices, thereby increasing the strength of fibril assembly. 
Given the non-specified nature of helix offsetting, there are several potential combinations 
of offset helices that would result in staggered coiled-coil fibril formation. Adjacent helices 
may be offset by either one or two heptads, of which Figure 4-9 illustrates one possible 
combination. However, many other possibilities may be envisaged and it appears unlikely 
that a single configuration would be present across all fibrils. If the packing of hydrophobic 
residues within the core is involved in specifying the formation of offset helices, a more 
ordered arrangement of helix offsetting may be present. However, in the absence of 
further experimental data this cannot be confirmed. Fibril-forming peptides based on self-
similar heptad repeats avoid the thermodynamically destabilising63, 76 placement of polar 
residues in the coiled-coil core. This facilitates development of gels composed of short 
single peptides, as opposed to paired peptides or longer sequences that may be 
expensive to synthesise. As exact repeats are not required for fibril assembly, this also 
allows the incorporation of specific residues to control molecular charge (as is described in 
Section 4.3.9). It also allows for diversity of residue composition, which may be useful in 
the contexts of peptide bioproduction or functionalization for enhanced cellular 
interactions. 
Stage b of hydrogel formation is physical cross-link formation between coiled-coil fibrils to 
create a three-dimensional network that can immobilise large volumes of water. 
Visualisation of hydrated fibrils in a gelled AFD19 sample using cryo-TEM (Section 4.3.6) 
indicated that individual fibrils are able to associate laterally and may wrap around each 
other for distances of up to 50-100 nm. The formation of physical cross-links between 
these fibrils results in network formation and gelation. It is likely fibril-fibril interactions are 
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inhibited by electrostatic repulsion at higher molecular charge, thereby generating the 
observed pH dependence of gel formation. These fibrillar networks were observed in 
increasing amounts as the pH was adjusted from 4.0 to 6.0, reflecting the decreasing 
peptide charge (Section 4.3.5). This is then followed by precipitation as the charge is 
neutralised to a point too low to provide solubility, illustrating the fine balance of molecular 
charge effects on fibril solubility and fibril-fibril association. Observations of AFD19 
hydrogel formation as a function of pH indicate that a charge of ±1 per 21-residue peptide 
is required for fibril-fibril interactions to overcome electrostatic repulsion without 
precipitation (Section 4.3.5). The character of fibril-fibril interactions for AFD19 fibrils has 
not been explicitly determined; however they are likely to be a combination of hydrophobic 
interactions and hydrogen bonding. This is consistent with the gel melting temperature of ~ 
90°C, which while indicating high thermostability of fibril-fibril interactions, is still a lower 
temperature than that required for helix unfolding (Section 4.3.7). This indicates that fibril-
fibril interactions are less stable to elevated temperature than the hydrophobic interactions 
within the coiled coil. 
This proposed model of AFD19 coiled-coil fibril formation is consistent with observations of 
fibril formation via electron microscopy, hydrogel formation as a function of solution pH, as 
well as the characterisation of peptide self-assembly via ECD. Furthermore, the role of 
molecular charge in determining gelling conditions allows directed modification of peptide 
sequence to obtain desired gelling properties as is discussed in Section 4.3.9. 
4.3.9 Peptide re-design for physiological gelling 
As the peptide AFD19 forms hydrogels at pH 6.0 and precipitates at pH 7.0, it is not usable 
in applications where exposure to physiological conditions will occur. However, with the 
model of assembly proposed in Section 4.3.8 in hand, it was possible to redesign this 
peptide sequence with the aim of generating a peptide that gels under physiological 
conditions. 
Changes to the sequence of AFD19 were minimised in an attempt to preserve peptide 
self-assembly. Given the dependence of hydrogel formation on peptide charge proposed 
in Section 4.3.5, the serine at position 16 was replaced with a lysine to increase the 
predicted peptide charge to +1 at physiological pH. This generated the new sequence 
AFD36 (Ac-LKELAKV LHELAKL VKEALHA-CONH2, FW 2395, Figure 4-10). This 
substitution is consistent with the placement of residues for formation of an amphiphilic 
helix, as well as the self-similar heptad repeats proposed to be required for fibril formation 
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(Section 4.3.8). The sequence of AFD36 possessed a calculated GRAVY value of 0.281, 
predicting higher solubility than AFD19. The instability index of AFD36 is -3.98, which 
predicts a sequence more stable to proteolysis than AFD19 and much lower than the value 
of 40 proposed to divide proteolytically stable and unstable sequences.26 The predicted 
charge per peptide of AFD36 is shown in comparison to AFD19 in Figure 4-11. AFD19 is 
predicted to possess +1 charge at pH 6.0, where gel formation is observed, followed by 
zero charge at pH 7.0, which is in line with the observed precipitation at this pH. In 
comparison, the predicted charge on AFD36 only approaches +1 as the pH is raised 
above pH 7.0 and does not decrease to zero until pH 10.3. It was therefore expected for 
AFD36 to be compatible with gel formation at physiological pH. 
4.3.10 Self-assembly and gel formation 
Similarly to AFD19, as-received AFD36 peptide dissolved in water to give an acidic 
solution. However, upon titration of a 0.1-0.5% (w/v) peptide solution with NaOH, AFD36 
gave a free-flowing solution at pH 6.0 with gelation occurring at pH 7.0, where the 
molecular charge is predicted to approach +1, and precipitation not observed until pH 
10.3. Similarly to AFD19, if a highly alkaline solution of AFD36 is taken and the pH 
adjusted down, gelation was seen to occur where the molecular charge approaches -1, 
 
Figure 4-10. Comparison of heptad based helical wheel projections of peptides AFD19 and 
AFD36 with the serine-lysine substitution highlighted in red. 
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which for AFD36 is close to pH 11. As found with AFD19, mechanical disruption of AFD36 
hydrogels gave a liquid state that then re-gelled on a similar time scale to the original 
gelation.  
As expected, AFD36 adopted a helical conformation as judged by ECD, with a double 
minimum at 208 and 222 nm and a maximum at 192 nm characteristic of α-helix formation 
observed for both ungelled (pH 3.1) and gelled (pH 7.0) states (Figure 4-12). In the gelled 
state the mean residue ellipticity at 222 nm is -30,100 deg cm2 dmol-1, indicating AFD36 to 
be predominantly helical under these conditions.28 This is similar to the level of helicity of 
AFD19 in gelled and ungelled states (Figure 4-1). In the ungelled state, the mean residue 
ellipticity at 222 nm is -25,700 deg cm2 dmol-1, indicating marginally lower α-helical 
content. This possibly reflects destabilisation of the coiled-coil structure by electrostatic 
repulsion due to the higher charge of +6 present on AFD36 at pH 3.1 compared to the +5 
for AFD19 at pH 3.0. These spectra also show no change in [θ]222/[θ]208 ratio upon gel 
formation, supporting the formation of unbundled fibrils as discussed in Section 4.3.3. 
 
Figure 4-11. Predicted charge per peptide of AFD19 (dotted) and AFD36 (solid line) as a 
function of pH. 
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These results indicate successful redesign of the gelling peptide AFD19 to give a peptide 
that is capable of gelation at physiologically pH. Similarly to AFD19, gelation of AFD36 
occurs at a predicted charge of ±1, is reversible with pH, and demonstrates self-healing 
after mechanical disruption. The self-assembly and hydrogel formation of peptide AFD36 
at the predicted pH further supports the model proposed in Section 4.3.8 for the assembly 
of the α-helical peptides to form staggered coiled-coil fibrils which then form physical 
cross-links as a function of molecular charge. The tolerance of the self-assembling 
peptides for modifications such as that described here may allow future targeted sequence 
modifications as desired for individual applications. The gelation of AFD36 under 
physiological conditions makes this peptide a potential candidate for biomaterial 
applications, specifically ones where injection of a hydrogel under physiological conditions 
is required. 
 
Figure 4-12. ECD spectra of self-buffered AFD36 (1.6 mM) at 20 °C in gelled (solid line, pH 7.0) 
and non-gelled (dashed, pH 3.1) states. 
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4.3.11 Investigation of fibril structure 
Small-angle X-ray scattering (SAXS) was used to further investigate the fibril self-
assembly of AFD36. Samples were prepared at pH 4.0-6.0 (non-gelled) and 7.0 (gelled) in 
an effort to provide structural information for a range of assembled states. Figure 4-13 
shows X-ray scattering data for each pH with fits to a flexible-cylinder model. Fibril 
formation is observed at all pH values assessed, even though gelation is not seen below 
pH 7.0. This supports the proposal in Section 4.3.8 that monomeric peptides assemble to 
form staggered coiled-coil fibrils, with gelation controlled by fibril-fibril interactions as a 
function of molecular charge. 
Table 4-2. Diameters of AFD36 fibrils at different pH values obtained by SAXS fitted to a flexible 
cylinder model 
pH Fibril diametera 
Persistence 
lengtha 
4.0 3.91 ± 0.01 10.6 ± 1.4 
5.0 3.82 ± 0.02 10.7 ± 2.1 
6.0 3.79 ± 0.01 14.0 ± 0.3 
7.0 3.78 ± 0.01 12.4 ± 3.5 
a nm 
Fitting of X-ray scattering data allowed determination of fibril diameters and persistence 
lengths across the entire pH range (Table 4-2). Fibril diameter is similar across the pH 
range with values of 3.8-3.9 nm. This is comparable to the widths of short AFD19 fibrils 
observed at acidic pH using negative staining TEM, although much smaller than the 
bundled fibrils observed at increased pH (Section 4.3.6). This indicates the formation of 
unbundled AFD36 fibrils in the pH range 4.0 to 7.0. Assuming that assembly of AFD19 
follows a similar pathway to AFD36, this supports the idea that the thickened fibrils 
observed at pH 4.0-6.0 in negative staining TEM are an artefact of sample preparation and 
staining, with fibrils instead existing unbundled in solution as visualised in cryo-TEM 
(Figure 4-7). For comparison, the hSAF peptides reported by Banwell et al.14 that were 
designed to form coiled-coil fibrils with forced offsets showed bundled fibrils (as judged by 
electron microscopy and ECD; discussed in Chapter 1) as well as opaque gels. It appears 
that the molecular charge on AFD36 at the pH values tested here prevents fibril bundling 
through electrostatic repulsion. 
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The diameter of AFD36 fibrils may be compared with those of other higher-order coiled 
coils for which 3D structures are available from X-ray crystallography or nuclear magnetic 
resonance spectroscopy. The data give approximate diameters of 3.1 nm for the 
heptameric designed peptide GCN4-pAA (2HY6),33 3.3 nm for the hexameric designed 
peptide CC-Hex (3R48),34 3.0 nm for the pentameric M2 segment of the acetylcholine 
receptor (1EQ8)77 and 2.9 nm for the pentameric cartilage oligomeric matrix protein 
(COMP, 1VDF).51 Redesign of GCN4-pAA has recently yielded peptide 7HSAP1, which 
forms fibrils with a proposed heptamer structure and a diameter of 3.0 nm as measured by 
X-ray diffraction.40  
The modelled diameter of AFD36 fibrils, at 3.8-3.9 nm is larger than these reference 
systems. The diameter of an α-helix is not constant but instead dependent on residue 
composition. The larger observed fibril diameter may in part reflect the higher content of 
larger aliphatic residues leucine and valine in the AFD36 core than are present in the 
 
Figure 4-13. Small-angle X-ray scattering by AFD36 as a function of pH. Data were collected 
for 0.5% (w/v) peptide at pH 4.0 (○), 5.0 (□), 6.0 (◇) and 7.0 (△). Solid lines show fits to a 
flexible-cylinder model. Data sets above pH 4.0 are displaced vertically progressively by a factor 
of ten for clarity. 
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comparison systems. However, the diameter is still consistent with a fibril structure 
comprising unbundled higher-order coiled coils of at least a pentamer cross-section.  
Size exclusion chromatography (SEC) was attempted under acidic conditions in an effort 
to more precisely determine the minimum oligomer state of the peptide. At lower pH, high 
molecular charge was hoped to prevent fibril assembly. Due to instrument limitations the 
lowest pH able to be assessed was 4.0, and solutions of AFD36 were thickened at the 
concentrations required for SEC. This suggested the peptide to be in an assembled state, 
and when applied to the size exclusion column the peptide was seen to be retained on the 
column, preventing determination of AFD36 oligomerisation state. The inability to 
determine conditions that give coiled-coil assembly in the absence of fibril formation 
hinders the use of SEC in more accurately determining the oligomerization state of the 
peptide coiled coil. Future studies involving alternate techniques such as sedimentation 
equilibrium ultracentrifugation may be better suited for such studies, and allow 
experimentation under more acidic conditions. 
Comparison of the determined persistence lengths of AFD36 fibrils with other biomolecular 
systems shows them to be relatively flexible. In the pH range 4.0 (non-gelled) to 7.0 
(gelled), AFD36 fibrils show relatively constant persistence lengths of 10-14 nm, indicating 
that fibril flexibility varies little with the non-gelled to gelled transition. As comparison, the 
persistence length of double-stranded DNA, with a comparable hydrodynamic diameter of 
3 nm, is a much larger 50-100 nm,78 while fibrils of 1-6 nm diameter formed from the milk 
protein β-lactoglobulin have persistence lengths of 90 nm to 4 µm depending on β-sheet 
content.79 Additionally, the fibrils formed by the designer β-sheet peptide P11-2 have been 
reported to have persistence lengths of up to 70 µm at a diameter of 8 nm.80 When 
compared with these other fibril forming biomolecules it can be seen that AFD36 fibrils are 
relatively flexible even given their small diameter, which may relate to the non-specific 
character of hydrophobic interactions between subunits in the fibril. This is consistent with 
the entangled network of bending fibrils of AFD19 observed using electron microscopy in 
Section 4.3.6. 
One feature common to higher-order coiled coils is the presence of a hydrophobically lined 
central pore.33, 34, 39, 40 Fitting of SAXS data was also attempted to a hollow-cylinder model, 
however this was unsuccessful, possibly due to the data not being across a broad enough 
range of q to distinguish such a structure.40 This may be overcome in the future by 
conducting experiments over a larger scattering range as well as enhancing the X-ray 
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scattering contrast by loading hydrophobic molecules with a larger X-ray scattering cross 
section into the coiled-coil core. 
4.3.12 Bicarbonate controlled pH adjustment for gelation 
The pH-responsive gelling of the AFD peptides provides a simple and reversible method 
for gel formation; however it also poses the disadvantage of difficulties in producing a 
homogenous material. Poor mixing due to local gelation can be observed on the addition 
of acid or base to a peptide solution containing pH indicator dyes (Figure 4-14; inset). On 
NaOH addition to a stirred peptide solution containing phenol red, a basic gel forms locally 
(crimson) that is surrounded by acidic medium (yellow). Equilibration occurs only slowly, 
leading to a non-uniform structure and lower gel strength; in some cases, gel formation 
may fail completely.  
 
Figure 4-14. pH changes over time for AFD36 gels prepared on titration with different 
concentrations of bicarbonate. Solid line, 20.0 mM NaHCO3; dotted line, 22.5 mM NaHCO3; 
dashed line, 25 mM NaHCO3 (Final concentrations). Inset: local gelling and pH inhomogeneity on 
addition of NaOH to acidic solution of AFD36 containing phenol red. The peptide concentration in 
each case was 4.2 mM. 
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One method to overcome this problem involves slow pH adjustment based on transient 
buffering by carbon dioxide. This slower rate of gelling provides a handling window for 
gelation of concentrated peptide solutions, while also allowing uniform mixing to maximise 
gel homogeneity and strength. This is achieved by titration of an acidic peptide solution 
with the weak base sodium bicarbonate, leading to the formation of carbonic acid, which 
itself dissociates to give a slightly acidic solution pH. However, carbonic acid is in 
equilibrium with atmospheric carbon dioxide and is gradually lost from the gelling solution 
(Equation 4-6), leading to a slow pH rise that can be observed using an indicator dye. 
 𝐻𝐶𝑂3− +  𝐻+  𝑝𝐾𝑎
6.3��  𝐻2𝐶𝑂3  ⟷  𝐶𝑂2 + 𝐻2𝑂  (4-6) 
UV-visible spectrophotometry and phenol red were used to track pH changes in solutions 
of AFD36 titrated with different amounts of sodium bicarbonate (Figure 4-14). Samples 
were prepared in the wells of a 48-well plate as would be utilised for cell culture 
experimentation. As would occur on titration with a strong base, the final gel pH is 
dependent on the amount of base added. Following bicarbonate addition, pH change is 
seen to follow an initial step change (prior to measurements commencing) followed by a 
slow rise, with equilibrium in a 200 µL volume with an exposed surface area of ~ 1 cm2 
taking more than an hour. 
Clear gels are obtained at pH values up to 8.2, however at more alkaline pH light 
scattering is observed, consistent with fibril bundling as the peptide molecular charge 
approaches zero and solubility is lowered. Gel formation occurs before the pH change is 
complete, however the slow rate of pH change afforded with this method allows a handling 
window of several minutes for the peptide solutions prior to gelation. This property may be 
useful in a clinical setting where gelling solutions may initially be handled and applied in 
liquid form before assuming their soft-solid state. Overnight exposure of the gels to a 5% 
CO2 atmosphere in a mammalian cell incubator lowered the pH by approximately 0.4-0.5 
pH units (not shown), but appropriate concentrations of bicarbonate could be chosen to 
allow the preparation of gels at physiological pH after equilibration in an incubator. 
Additionally, gel preparation using 10 mM MES-bicarbonate buffer allowed sample 
characterisation (Section 4.3.13) in the absence of interference by salt. 
As discussed in Chapter 1, the majority of peptide hydrogels reported to date are formed 
on the addition of salt to a peptide solution to increase ionic strength and trigger assembly. 
This approach appears to result in sufficiently homogenous materials for characterisation 
and further experimentation. However, there are several examples of hydrogels formed on 
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adjusting the pH of peptide, most commonly Fmoc-dipeptide, solutions.81-86 As discussed 
here, the addition of inorganic acid or base to trigger gelation of these systems often gives 
inhomogeneous materials due to gelation occurring on a shorter timescale than pH 
equilibration across the solution. Ongoing research has led to the development of a 
number of approaches to overcome this, the majority of which involve the slow 
homogenous acidification of a peptide solution. For example, Adams et al.81 incorporated 
glucono-δ-lactone in the peptide solution which gradually hydrolysed to gluconic acid and 
lowered solution pH, thereby triggering homogenous gelation. Another approach by 
Raeburn et al.82 involved the incorporation of a photoacid generator, allowing gelation to 
be triggered by exposure to UV light and consequent acidification. More complex 
approaches to lower pH have also been developed which involve the use of enzymatic 
processes,83 as well as the binding of sugar to a boronic acid.84 The approach described in 
this thesis where bicarbonate is used to adjust pH is most similar to the approach of 
Adams et al., whereby a simple organic molecule, which alters pH over time, induces 
homogenous gelation. Importantly, while previously reported approaches are directed 
towards acidification of a solution, the approach used here induces a slow increase in pH 
which may be useful in many systems. 
4.3.13 Thermal denaturation of AFD36 
Thermal denaturation studies were conducted to determine the heat stability of self-
assembled AFD36 structures. This was done in terms of both primary (coiled coil) and 
secondary (gel) assembly as assessed via ECD and gel melting respectively. Figure 4-15 
shows the effects of temperature on AFD36 helical structure, as measured by ECD at 222 
nm. At 20 °C, the mean residue ellipticity at 222 nm is -30,100 deg cm2 dmol-1 for a gelled 
sample at pH 7.0. This decreases to -25,500 deg cm2 dmol-1 upon heating to 90 °C, 
indicating that similarly to AFD19 (Section 4.3.7), the Tm of AFD36 helical structure at 
gelling pH is well in excess of 100 °C. Upon cooling most, but not all, of the original helical 
content is recovered, giving a final mean residue ellipticity of -28,800 deg cm2 dmol-1. The 
extreme stability of helical structure to thermal denaturation shown for AFD19 and AFD36 
is similar to that seen for other higher-order peptide coiled coils, with the CC-Hex 
hexamer34 shown to also have a melting temperature > 100 °C and the GCN4-pAA 
heptamer33 reported to have a melting temperature of ~ 95 °C (although at lower 
concentrations than used here). These higher-order coiled-coil forming peptides possess 
expanded hydrophobic faces compared to lower-order coiled-coil forming peptides. This 
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increased level of thermostable hydrophobic interactions52 driving assembly is likely 
responsible for the observed trend in high stability to thermal denaturation. 
Compared to helical content, the macroscopic gel structure of AFD36 is less stable. A ball 
drop test showed a gel-sol transition temperature of ~ 80 °C for an AFD36 gel prepared in 
10 mM MES-bicarbonate buffer. This increased to ~ 90 °C for a gel prepared in 
phosphate-buffered saline at higher ionic strength, which is similar to the stability of AFD19 
hydrogels described previously (Section 4.3.7). The dependence of gel melting 
temperature on ionic strength may be due to both enhanced hydrophobic interactions and 
weakened repulsive electrostatic interactions at higher ionic strength. The disparity 
between ECD and gel-sol transition temperature is consistent with the idea that the gel-sol 
transition may occur by loss of the physical cross-links between fibrils, rather than 
denaturation of the helical structure. Alternatively, the slight decrease in helix content seen 
at elevated temperature may lead to shortening of the fibril segments and eventual loss of 
 
Figure 4-15. Thermal stability of secondary structure for gelled AFD36. Thick line, heating 
curve; thin line, cooling curve. Inset: Determination of gel melting temperature via a ball drop 
test with photos taken at 30 °C (upper left) and 80 °C (lower right). Arrow indicates melting 
temperature. The peptide concentration was 4.2 mM in the gel. 
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the overall network structure. In either case, the melting temperature for the AFD36 gel lies 
well above physiological temperatures, which is promising for biomedical applications. 
4.3.14 Guanidinium denaturation of AFD36 
G.HCl denaturation studies of AFD19 and AFD36 were used to quantify the stability of 
these two peptide systems. Both peptides were studied at concentrations slightly below 
gelling conditions and approximately 1 pH unit bellow gelling pH (AFD19 at pH 5.0 and 
AFD36 at pH 6.0). Under these conditions the peptides were expected to be assembled 
and possess similar levels of charge. Figure 4-16 shows the effect of added G.HCl on 
mean residue ellipticity for 250 µM AFD19 and AFD36 at 20 °C. Both peptides are seen to 
be highly resistant to chemical denaturation, with a G.HCl concentration of approximately 
5.3 M required for 50% denaturation of AFD36, while AFD19 required an even higher 
concentration of 6.0 M. To assess the effect of temperature, a similar G.HCl denaturation 
study of AFD36 was conducted at 50 °C. This showed a G.HCl concentration of 
approximately 5.8 M was required for 50% denaturation at this temperature. 
Thermodynamic analysis of peptide self-assembly in the presence of G.HCl utilised a 
similar method to that described in Chapter 3, and was based on an approach by Fairman 
et al.38 that was adapted for higher-order coiled-coil assembly. This allowed the fitting of 
ECD data to monomer-oligomer models as a function of G.HCl concentration and 
calculation of parameters ΔG(H2O) and m. 
Assembly of monomers to higher-order oligomers (n-mers) in the absence of denaturant 
was treated as a two-state system in which Kd is the equilibrium constant for disassembly 
of coiled-coil n-mers to n unstructured peptide monomers (mon): 
 𝐾𝑑 =  [𝑚𝑜𝑛]𝑛[𝑛−𝑚𝑒𝑟]  (4-7) 
and ΔG is the associated positive free energy change: 
 Δ𝐺 =  −𝑅𝑇𝑙𝑛𝐾𝑑 (4-8) 
The presence of G.HCl was taken to modify the free energy of peptide self-assembly in a 
linear fashion: 
 ∆𝐺 =  ∆𝐺(𝐻2𝑂) −𝑚[𝐺.𝐻𝐶𝑙]  (4-9) 
where m acts to decrease the free energy penalty of coiled coil disassembly, thereby 
promoting denaturation. A larger value of m represents a larger effect of G.HCl on peptide 
folding. 
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For electronic circular dichroism, the contribution of monomers and n-mers to the ellipticity 
at a single wavelength (in this case, 222 nm) is given by: 
 [𝜃]𝑜𝑏𝑠 = [𝜃]𝑚𝑜𝑛  ×  [𝑚𝑜𝑛][𝑃]𝑡𝑜𝑡 + [𝜃]𝑛−𝑚𝑒𝑟  ×  𝑛 × [𝑚𝑜𝑛]𝑛𝐾𝑑  × [P]𝑡𝑜𝑡 (4-10) 
where [P]tot is the total concentration of peptide in solution, [θ]mon is the mean residue 
ellipticity of the monomer and [θ]n-mer the corresponding value for the n-mer. Values for 
[θ]mon and [θ]n-mer were chosen based on observed ellipticity values at low and high G.HCl 
concentration respectively. For chemical denaturation studies with G.HCl, in which the free 
energy of self-assembly is different at each denaturant concentration, Equation 4-10 was 
modified to give: 
 [𝜃]𝑜𝑏𝑠 = [𝜃]𝑚𝑜𝑛  ×  [𝑚𝑜𝑛][𝑃]𝑡𝑜𝑡 + [𝜃]𝑛−𝑚𝑒𝑟  ×  𝑛 × [𝑚𝑜𝑛]𝑛𝑒(Δ𝐺(𝐻2𝑂)−𝑅𝑇 ) × 𝑒(−𝑚 [G.HCl]−𝑅𝑇 )  ×  1[𝑃]𝑡𝑜𝑡 (4-11) 
 
Figure 4-16. Guanidinium chloride denaturation of AFD19 (○) and AFD36 (▲) at 20 °C. Lines 
represent fits to the data obtained as described in text. 
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For test values of Kd and m for each value of n, values for the free monomer concentration 
[mon] are obtained by numerical fitting to the mass balance equation for the total peptide 
in solution, allowing assessment of the least-squares fit to the data: 
 [𝑃]𝑡𝑜𝑡 = [𝑚𝑜𝑛] +  𝑛 × [𝑚𝑜𝑛]𝑛
𝑒(Δ𝐺(𝐻2𝑂)−𝑅𝑇 ) × 𝑒(−𝑚 [G.HCl]−𝑅𝑇 ) (4-12) 
Table 4-3 gives the values of ΔG(H2O), m, [θ]mon and [θ]n-mer obtained for fitting of AFD19 
and AFD36 experimental data to this model. Fitting of AFD19 denaturation at 20 °C 
assumed a hexameric oligomerization state based on previous results (Section 4.3.4). 
Fitting of AFD36 data collected at 20 °C used pentamer, hexamer and heptamer models 
as the coiled-coil cross-section, as well as a dodecamer based on end-to-end association 
of two hexamers. This allowed the effect of assumed oligomerization state on determined 
values to be assessed. As similar results on a per monomer basis were seen for each 
model, fitting of AFD36 denaturation at 50 °C used only a hexamer model for comparison 
to data collected at 20 °C. 
Modelling of AFD19 denaturation using a hexamer model gave a ΔG(H2O) value of 9.5 kcal 
mol-1 per monomer. This is larger than the 5.9 kcal mol-1 per monomer previously 
determined in Section 4.3.4 via a dilution method. Notably, in the dilution study the 
monomeric peptide retained high helix content. In this experiment, G.HCl denatured the 
oligomeric AFD19 to an unstructured monomer, as indicated by the low helical content at 
high denaturant concentration. The difference of 3.6 kcal mol-1 likely represents at least in 
part the free energy of unfolding of a monomeric α-helix to a random coil, which has also 
been studied in model polyalanine systems.87 However, it is also possible that effects 
relating to ionic strength may interfere with modelling G.HCl denaturation and cause an 
overestimation of α-helix stability. Indeed, an increase in helicity at up to 2 M G.HCl is 
observed for both AFD19 and AFD36, with AFD36 samples showing induced gelation in 
the presence of 2-6 M G.HCl. This suggests an initial stabilisation effect of added salt, 
likely due to increased strength of hydrophobic interactions. Above 2 M G.HCl, 
denaturation of secondary structure occurs in both peptides.  
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Table 4-3. Fitting parameters for modelling G.HCl denaturation of AFD19 and AFD36 
Peptide pH Ta ΔG(H2O)b mc nd [θ]mone [θ]n-mere 
AFD19 5.0 20 9.5 0.88 6 0.4 -28.5 
AFD36 6.0 20 9.1 0.95 5 0.9 -28.0 
AFD36 6.0 20 9.3 0.95 6 0.9 -28.0 
AFD36 6.0 20 9.2 0.92 7 0.9 -28.0 
AFD36 6.0 20 9.5 0.90 12 0.9 -28.0 
AFD36 6.0 50 10.6 1.04 6 0.0 -27.0 
a °C 
b kcal mol-1 per monomer 
c kcal mol-1 (M G.HCl)-1 per monomer 
d oligomer state assumed in fitting 
e 103 deg cm2 dmol-1  at 222 nm 
The stability of AFD19 is high compared to values reported for peptide coiled coils also 
determined using G.HCl denaturation.38, 88 Values of 3.4-5.6 kcal mol-1 per monomer were 
reported for a series of dimeric coiled coils of three to four heptads in length.88 A tetrameric 
coiled coil of the same length as AFD19 was reported to have a stability of 3.9 kcal mol-1 
per monomer,38 while a related tetrameric coiled coil was reported to have a stability of 5.6 
kcal mol-1 per monomer as determined using thermal denaturation.89 The high stability of 
AFD19 assembly likely reflects both the selection of amino acids with high helix propensity 
during peptide design, as well as a strong hydrophobic driving force for coiled-coil 
assembly. The per-helix value of ΔG for AFD19 approaches the value determined for the 
extremely thermodynamically stable Het2-6 in Chapter 2, although in that case, 
denaturation was conducted at 90 °C. 
The stability of AFD36 was found to vary only slightly, from 9.1 to 9.5 kcal mol-1 per 
monomer when modelled using pentamer, hexamer, heptamer and dodecamer models, 
indicating that the per monomer stability values are relatively insensitive to assumed 
oligomerization state. This enabled comparison of determined stability values with AFD19 
and previously reported systems without explicitly determining the coiled-coil 
oligomerization state. As AFD19 was previously modelled as a hexamer, the hexamer 
model state was used to compare self-assembly across different conditions. AFD36 at pH 
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6.0 has a stability of approximately 9.3 kcal mol-1 per monomer when analysed using a 
hexamer model. This is slightly lower than AFD19 in a similar charge state at pH 5.0, but 
still high compared to previously reported coiled coils of similar peptide length.38, 88, 89 
The lower stability of AFD36 is surprising, given that the serine-to-lysine mutation should 
favour helix formation due to the higher helix propensity of lysine.23 However, the 
difference is small (0.2 kcal mol-1 per monomer) and may relate to stabilisation of the 
unfolded state by interactions involving lysine, or slight differences in the pKa values of 
amino acid sidechains between the two peptides, due to interactions between charged 
groups or changes in side chain burial,90 leading to differences in the actual molecular 
charge. Raising the temperature from 20 to 50 °C increased the stability of AFD36, with an 
increase in G.HCl concentration required for 50% denaturation of secondary structure from 
5.3 to 5.8 M. This corresponds to an increase in stability from 9.3 to 10.6 kcal mol-1 per 
monomer for AFD36 on increasing the temperature form 20 to 50 °C. This is consistent 
with the strengthening of hydrophobic association with temperature,52 and highlights the 
key role of hydrophobic interactions in stabilising the coiled coil. 
As well as the ΔG of unfolding, the m value, or the dependence of free energy of unfolding 
on denaturant concentration may be determined from the fitting of chemical denaturation 
data. Similar to the stability values, the per-monomer m value varies little with assumed 
oligomerization state, with values from 0.90-0.95 kcal mol-1 (M G.HCl)-1 per monomer. The 
m values reported here are larger than those previously reported for designed coiled coils 
of 0.68 kcal mol-1 (M G.HCl)-1 per monomer for a 28-residue tetramer coiled coil38 and 
between 0.56 and 0.81 kcal mol-1 (M G.HCl)-1 per monomer for a series of 21-residue 
dimer coiled coils.88 In fact the per monomer m value for the 21-residue AFD36 is closer to 
that reported for a 35-residue tetrameric coiled coil.38 The m values are also larger than 
reported for native proteins of similar molecular weight,91 and on a per helix basis 
approach the anomalously large value determined for Het2-6 in Chapter 2. As discussed in 
Chapters 2 and 3, these values are also used to analyse the change in ASA on 
unfolding.91 However, similar to Het2-6, applying literature correlations to the large 
calculated m values for AFD19 and AFD36 gives a value for the change in ASA wich is not 
physically meaningful. As discussed in Chapter 2, the correlations across different proteins 
are relatively scattered91 and outlier values for m have previously been observed.92, 93 
Moreover, the correlations between m values and change in ASA were determined from 
series of reference proteins, and how these values may translate to peptide systems has 
not as yet been reported. Modelling of AFD36 denaturation at 50 °C gives an even larger 
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m value than that already discussed. However as discussed in Chapter 2, the m values for 
reference proteins have been determined at room temperature and extrapolation of this 
relationship to elevated temperatures relies on assumptions about protein-denaturant 
interactions that may not be justifiable.94 
4.4 Conclusions 
This chapter describes characterisation of the self-assembly of α-helical peptide AFD19 
that, while designed as part of ongoing work on peptide surfactants, was serendipitously 
observed to form hydrogels as a function of solution pH. Peptide hydrogels formed at low 
weight percentages and were self-healing following mechanical disruption. Investigation of 
peptide self-assembly via ECD indicated AFD19 to form a higher-order coiled coil, and 
electron microscopy showed the formation of a network of unbundled fibrils with diameters 
consistent with this proposal. Self-assembly as a function of pH was consistent with coiled-
coil fibrils forming physical cross-links resulting in gel formation at a molecular charge of 
approximately ±1. Precipitation was observed at pH values where molecular charge 
approached zero, while solution pH values where the molecular charge was high gave 
free-flowing solutions. Comparison with reported fibril-forming peptides allowed proposal of 
a fibril-formation pathway involving permissive offsetting of helices due to self-similar 
heptad repeats, thereby forming end-to-end overlaps and staggered coiled-coil fibrils. 
While AFD19 displayed gel formation at non-physiological pH, targeted redesign of this 
peptide based on the proposed model of self-assembly gave peptide AFD36, which forms 
hydrogels under conditions of physiological pH and salt, making it potentially applicable in 
biomedical applications. Characterisation of AFD36 assembly using SAXS showed fibril 
formation similar to that shown for AFD19 using electron microscopy. Hydrogels formed by 
both peptides were extremely thermostable, and chemical denaturation experiments 
showed the constituent coiled coils to possess high thermodynamic stability. The use of 
bicarbonate as a transient buffer enabled the preparation of homogenous materials. These 
peptide hydrogels are materials of interest for applications such as tissue engineering and 
drug delivery, and are further investigated in Chapter 5.  
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5 α-Helical peptide hydrogels for mammalian cell growth and 
drug delivery 
5.1 Introduction 
Chapter 4 detailed characterisation of the self-assembly of peptide AFD19, which formed a 
hydrogel at weight fractions below 0.1%. Gelation occurred as a function of solution pH, 
with gel formation observed at a peptide charge of ±1 and precipitation occurring where 
charge approached zero. While AFD19 precipitated at physiological pH, redesign of this 
sequence gave the peptide AFD36, whsich was capable of gel formation under 
physiological conditions of pH and salt, giving this peptide hydrogel potential utility in 
tissue engineering and wound healing applications.1, 2 Only one α-helical peptide hydrogel 
has previously been characterised for its ability to support cell growth,3 and it was 
therefore of interest to assess AFD36 hydrogels as cellular scaffold materials. 
Characterisation of AFD19 and AFD36 showed the peptides to assemble into coiled-coil 
fibrils of approximately 5-7 helices in cross-section. As discussed in Chapter 1, higher-
order coiled coils such as these are predicted to possess a hollow internal channel; as 
observed in heptamer,4, 5 hexamer,6 pentamer7 and tetramer7, 8 structures. The 
hydrophobically lined channels of coiled coils may potentially be used for encapsulation 
and delivery of hydrophobic drugs.9 Loading of such molecules into the coiled-coil fibrils of 
a hydrogel may allow for slow release of therapeutics from the hydrogel material in 
applications such as wound healing and drug delivery. 
This chapter reports investigation of hydrogels formed by AFD36 and the subsequent 
peptide design AFD49 as cellular scaffolds and drug delivery vehicles. Rheological 
characterisation showed AFD36 hydrogels to possess soft-solid properties, similar in 
modulus to soft tissues of the body. Treatment of the peptide to remove chemical 
contaminants was required for peptide hydrogels to support the growth of mouse fibroblast 
NIH/3T3 cells. Fibroblasts proliferated on AFD36 hydrogels at levels similar to tissue 
culture polystyrene controls. As fibroblasts proliferated to higher density, some detachment 
of dense cellular aggregates from the hydrogel surfaces occurred.  
The peptide AFD49 was then designed based on the self-assembly model proposed in 
Chapter 4. AFD49 underwent hydrogel formation and supported fibroblast growth at similar 
levels to AFD36. The effects of hydrogel equilibration prior to cell seeding and 
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requirements for serum components for cellular attachment to the hydrogels were also 
investigated. AFD49 hydrogels also supported the proliferation of embedded fibroblasts 
over several weeks, demonstrating these peptide hydrogels potential as 3D tissue 
engineering matrices. The growth of induced pluripotent stem cells (iPSCs) was 
characterised on AFD49 hydrogels to test the applicability of peptide gels as substrates for 
alternate cell types. However non-functionalized AFD49 hydrogels showed poor iPSC 
attachment and required coating with Matrigel to achieve iPSC attachment and 
proliferation. Finally, the ability of peptide hydrogels to incorporate and release the 
hydrophobic drug all-trans retinoic acid was demonstrated. AFD36 and AFD49 peptide 
hydrogels are promising candidates for future tissue engineering, wound healing and drug 
delivery applications. 
5.2 Experimental 
 Materials 5.2.1
All reagents used were of the highest grade available. Water was purified using an Elga 
Purelab Classic and had a resistivity of >18.2 MΩ.cm. Sodium bicarbonate (≥99.5%) was 
purchased from Sigma-Aldrich. Peptides AFD36 (acetate salt, Ac-LKELAKV LHELAKL 
VKEALHA-CONH2, FW 2395) and AFD49 (acetate salt, Ac-LKELAKL LHELAKL 
LHELAKL-CONH2, FW 2465) were synthesised and purified by Biomatik (Wilmington, DE). 
The final purity was >95% in each case. 
 Gel rheology 5.2.2
Rheological measurements were carried out at 23 °C on a Thermo Scientific Haake MARS 
III stress-controlled rheometer using parallel plates (35 mm titanium) at a gap of 500 μm; 
the top plate had emery paper attached to limit slip. To prepare a gel, 500 μL 2.8 mM 
AFD36 pH 3 was mixed with 500 μL 25 mM NaHCO3, 2 × Dulbecco’s Modified Eagle 
Medium (DMEM; Gibco, Life Technologies, Carlsbad, CA) and loaded onto the lower plate 
using a micropipette, after which the upper plate was lowered. To limit evaporation, drops 
of water were placed in the solvent trap around the outer edge of the lower plate and a 
hood was lowered to cover the plates; the water drops were not in contact with the sample. 
A transient oscillatory test was used to capture development of structure as the pH rose 
with loss of CO2 from the sample, permitting gelation. The angular frequency was set to 
6.28 rad/s for quick measurements and the oscillatory shear stress was set to 0.1 Pa, 
which gave strain less than 0.005. Relative to the final gel, an oscillatory shear stress of 
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0.1 Pa was well within the linear viscoelastic region. The oscillation time test was run for 
3600 seconds and measurements commenced within 5 minutes of peptide mixing. 
An oscillatory stress sweep at an angular frequency of 6.28 rad/s was then run on the 
same sample, to determine the linear viscoelastic region. Using an oscillatory shear stress 
of 0.1 Pa, an oscillatory frequency sweep was also run from 0.29 to 19.9 rad/s. 
 Ultraviolet-visible absorption spectroscopy 5.2.3
Ultraviolet-visible absorption spectroscopy spectra were recorded on an Agilent Cary 4000 
spectrometer in 1-10 mm quartz cuvettes. 
 Electronic circular dichroism 5.2.4
ECD measurements were collected and mean residue ellipticity calculated as described in 
Chapter 2. 
 Peptide charge predictions 5.2.5
The net charge on the peptide was calculated as described in Chapter 2. 
 AFD36 treatment for cell culture 5.2.6
To remove chemical contaminants, solutions of AFD36 were stirred with 8 M urea and 3 
mg mL-1 activated charcoal for 24 hours. Charcoal was removed by centrifugation at 
20,000 g for 45 minutes and filtering (0.2 μm). The solution was then dialysed against 0.1 
M NaCl (24 h) and water (2 × 24 h). Recovered peptide (2.8 mM) was adjusted to pH 3 
and sterile-filtered (0.20 μm) then stored at -80 °C until use.  
Samples of treated peptide were lyophilized and the peptide content of the solid was 
determined by quantitative amino acid analysis (Australian Proteome Analysis Facility, 
Sydney). Similar to the Het2-6 concentration determination described in Chapter 2, the 
concentration of AFD36 was in some cases estimated by measurement of ellipticity at 222 
nm using a mean residue ellipticity of -27,500 deg cm2 dmol-1 at a peptide concentration of 
close to 1 mM in 10 mM MES buffer, pH 6.0.  
 AFD49 treatment for cell culture 5.2.7
AFD49 peptide solutions were dialysed against either 0.1 M NaCl pH 3 (24 h) then 1 mN 
HCl (8 h then 16 h; Method 1) or 0.1 g L-1 activated charcoal in water (3 × 24 h; Method 2). 
Recovered peptide (7.5 mM in both cases) was adjusted to pH 3 and sterile-filtered (0.20 
μm) then stored at -80 °C until use. 
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Samples of treated peptide were lyophilized and the peptide content of the solid was 
determined by quantitative amino acid analysis (Australian Proteome Analysis Facility, 
Sydney). The concentration of AFD49 was in some cases estimated by measurement of 
ellipticity at 222 nm using a mean residue ellipticity of -27,500 deg cm2 dmol-1 at a peptide 
concentration of close to 1 mM in 10 mM MES buffer, pH 6.0. 
 Protease digestion of peptide hydrogel 5.2.8
Trypsin cleavage samples were prepared at a final composition of 0.5 mM AFD36, 10 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0.035% (w/v) trypsin (from 
Trypsin-EDTA (Gibco, Life Technologies)) at pH 7.1 and incubated at 37 °C.  
 Fibroblast cell culture 5.2.9
NIH/3T3 cells (CRL-1658, ATCC) were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% (v/v) newborn calf serum (except where indicated; 
Ausgenex, Australia). Cultures were kept at 37 °C in a humidified 5% CO2 incubator. 
To prepare gels for cell culture, 50 μL acidic peptide solution was mixed thoroughly with 50 
μL of either 25 mM NaHCO3 (for 2.8 mM AFD36), 10 mM NaHCO3 (for 2 mM AFD49), 20 
mM NaHCO3 (for 4 mM AFD49), or 35 mM NaHCO3 (for 7.5 mM AFD49), 2 × DMEM 
(initially bicarbonate free) in individual wells of a 48-well tissue culture plate. Samples were 
allowed to gel for 1 h at RT then transferred to an incubator and equilibrated in 500 μL 
media as indicated in text before seeding with NIH/3T3 cells at 104 cells per well. Control 
wells contained NIH/3T3 cells seeded onto tissue culture polystyrene (TCPS) alone that 
was not equilibrated with media except where indicated in text. Fibroblasts were seeded 
on either hydrogel or TCPS surfaces in DMEM supplemented with 10% (v/v) newborn calf 
serum except where indicated in text. 
To prepare layered AFD49 gels for 3D cell culture, lower gels were cast and seeded with 
NIH/3T3 cells as above with no pre-soaking. Cells were also seeded onto bare TCPS for 
controls. After 1 day, equal volumes of warmed (37 °C) acidic 4 mM AFD49 and 20 mM 
NaHCO3, 2 × DMEM (initially bicarbonate free) were mixed thoroughly and 100 μL of this 
gelling solution was immediately added on top of cells on either TCPS or AFD49 gels. This 
was then allowed to gel in an incubator for 30 minutes before complete media was added. 
Cell growth was quantified using AlamarBlue (Life Technologies) at times indicated in text. 
Fluorescence readings used a Tecan Infinite M200 plate reader with λex 560 nm and λem 
590 nm. Cell-free wells were prepared either with or without hydrogels and fluorescence 
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values for these control wells containing medium were subtracted from the values of the 
relevant cell-containing wells. Statistical analyses used Student’s t-test, with differences 
considered significant for p values of <0.05. 
 Cytotoxicity of free peptide assay 5.2.10
NIH/3T3 cells were seeded into wells of a 24-well plate at 4 x 104 cells per well in 1 mL of 
media and allowed to adhere for 24 hours. At this point the media was removed and was 
replaced with 1 mL of media which had been incubated with either bare TCPS or 3 mM 
AFD49 hydrogels (prepared as above; n = 3 for each) for 24 hours in wells of a 24-well 
plate. The cells were then allowed to proliferate for 48 hours before growth was quantified 
using AlamarBlue (as above).  
 Induced pluripotent stem cell culture 5.2.11
Human induced pluripotent stem cells (iPSCs) were generated as wild-type nonviral cells 
by episomal reprograming.10 The cells were transfected using the EoS lentiviral vector11 to 
express enhanced green fluorescent protein (EGFP) as a reporter for pluripotency and 
adapted to single-cell culture. Cells were maintained on Matrigel (BD Biosciences, San 
Diego, CA) coated TCPS in conditioned DMEM/F12 culture medium prepared as 
described in Xu et al.12 and supplemented with 20% KnockOut Serum Replacement, 0.1 
mM nonessential amino acids, 2 mM GlutaMAX, 0.1 mM β-mercaptoethanol and 85 ng 
mL-1 human basic fibroblast growth factor (all from Invitrogen, Life Technologies, Carlsbad, 
CA). Cultures were kept at 37 °C in a humidified 5% CO2 incubator. Rho-associated 
kinase (ROCK) inhibitor (Y27632; ATCC) was included in the culture media at 10 µM for 
the first 24 hours following cell passaging to increase dissociated iPSC survival rates and 
help maintain pluripotency.13, 14 Subsequent media changes occurred every day and did 
not include ROCK inhibitor. 
Peptide hydrogels were prepared as for fibroblast cell culture in wells of a 48-well plate 
and then equilibrated in serum-free DMEM/F12 media as indicated in text. TCPS and 
peptide hydrogel surfaces were coated with Matrigel (BD Biosciences, Massachusetts) 
where indicated by soaking for 1-2 days with 150 µL of Matrigel prepared at 0.3 mg mL-1 
final protein concentration in serum-free DMEM/F12. Phase contrast and fluorescence 
images were collected each day following seeding. 
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 Recombinant vitronectin fragment 5.2.12
The recombinant N-terminal somatomedin B (SMB) domain of vitronectin contained amino 
acids 1-54 of mature vitronectin and a C-terminal six histidine tag for purification (H2N-
MDQESCKGRCTEGFNVDKKCQCDELCSYYQSCCTDYTAECKPQVTRGDVFTMLEHHH
HHH-COOH). This protein fragment was produced in E. coli and recovered as per 
previously described methods.15 Recombinant vitronectin SMB domain was mixed into 
acidic AFD49 stocks at concentrations as indicated in text prior to gel formation. 
 Microscopy 5.2.13
Phase-contrast and fluorescence images were collected utilising an Olympus IX50 
microscope with standard 4',6-diamidino-2-phenylindole (DAPI), Tetramethylrhodamine 
(TRITC) and Fluorescein isothiocyanate (FITC) filter sets. Cell images were taken at 4 × or 
10 × magnification. Images were processed utilising ImageJ software. 
Confocal microscopy was conducted on a Zeiss LSM 710 microscope. Fluorescein 
imaging used a 488 nm laser for excitation and λem 493 – 523 nm, while propidium iodide 
imaging used a 514 nm laser for excitation and λem 548 – 666 nm. Z-series of equidistant 
x-y scans at 5 µm (Figure 5-16) and 3 µm (Figure 5-18) intervals were acquired and 
processed utilising Zeiss Zen 2012 software. 
Live-dead staining methods were adapted from the methods of Jones and Seft (1985)  and 
the protocol of Marker Gene Technologies (Eugene, Oregon) live:dead/cytotoxicity assay 
kit (product M0795). Briefly, in a 48-well plate, cells were rinsed 2 × with 500 μL phosphate 
buffered saline (without calcium or magnesium; PBS; Lonza) then incubated with 150 μL of 
2 μM fluorescein diacetate (FDA; Sigma Aldrich), 4 μM (Section 5.3.4) or 1.5 μM (other 
experiments)  propidium iodide (PI; Sigma Aldrich) in PBS for imaging. 
To estimate the proportion of cells adopting spread morphologies on TCPS or hydrogel 
surfaces, cells were visually assessed and categorised as either rounded or spread. Cells 
of each type were counted with >150 cells assessed per sample type. 
 All-trans retinoic acid analysis 5.2.14
All-trans retinoic acid (ATRA) was added to peptide solutions by pipetting small volumes of 
an ATRA stock in dimethyl sulfoxide (DMSO) into the lid of an Eppendorf tube that 
contained AFD49 solution without mixing the two solutions. The Eppendorf tube was then 
closed and vortexed for 60 seconds to achieve rapid and even mixing. Final DMSO 
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content was 1% (v/v). The solution was then centrifuged at 16,000 g and the supernatant 
recovered. 
ECD spectra of ATRA-AFD49 solutions were recorded from 450-250 nm in a 1 mm quartz 
cuvette. 
To prepare gels (n=3) for ATRA release experiments, 50 μL acidic ATRA-AFD49 solution 
(2 mM peptide) was mixed thoroughly with 50 μL of 10 mM NaHCO3, 2 × DMEM (initially 
bicarbonate free) in wells of a 48-well plate. Samples were allowed to gel for 30 min at RT 
and then 500 μL cell culture media (DMEM supplemented with 10% (v/v) newborn calf 
serum) was added on top and the gels were incubated at 37 °C. Media was changed daily. 
Samples for retinoic acid measurements were diluted 1:10 with 0.1% formic acid (FA) in 
acetonitrile for LCMS analysis. LCMS used a Waters 2695 separations module with a 
Waters 2489 UV detector (Waters Corporation, Milford, MA). Samples were applied to a 
Kinetex 2.6 µm C18 100 Å column (Phenomenex) at a flow rate of 1 mL min-1, using a 
linear gradient of 60-100% (v/v) buffer B over 30 min. Buffer A was 0.1% (v/v) FA and 
buffer B was 0.1% (v/v) FA in acetonitrile. Eluate was injected directly into a Quattro micro 
API tandem quadrupole system in positive ion mode. Retinoic acid species were quantified 
by integration of absorption peak areas (monitored at 350 nm) using standards of all-trans 
retinoic acid and 13-cis retinoic acid. 
5.3 Results and Discussion 
 Mechanical characterisation of an AFD36 hydrogel 5.3.1
As discussed in Chapter 1, it has been shown that cell growth and function are impacted 
by the mechanical properties of the underlying substrate.17-20 It was therefore appealing to 
characterise the mechanical properties of AFD36 hydrogels.   
Oscillatory shear rheology was used to characterise the mechanical properties of AFD36 
hydrogels. As discussed in Section 4.3.12, peptide hydrogels prepared using addition of 
NaOH showed non-uniform gelation. Preliminary rheological studies of peptide hydrogels 
prepared using NaOH addition showed poor reproducibility. This was likely due to rapid 
local gelation on base addition, while the remaining peptide solution remained ungelled. 
This is consistent with rapid local network formation on pH adjustment by addition of 
NaOH. Hydrogels prepared in this manner were not investigated further due to this inability 
to produce a homogenous material for meaningful analysis. 
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An even change in pH and consequent homogenous gelation occurred on addition of 
bicarbonate in Dulbecco’s modified Eagle medium (DMEM) to an acidic solution of AFD36, 
with similar kinetics to when bicarbonate alone was used (Chapter 4, Section 4.3.12). This 
allowed meaningful analysis of the mechanical properties of a homogenous peptide 
hydrogel as would be used as a cellular scaffold. The storage (G′) and loss (G″) moduli of 
a gelling AFD36 solution (0.35 % (w/v)) were recorded using oscillatory shear rheology as 
the pH rose with loss of CO2 from the sample following bicarbonate addition, allowing 
observation of the rate of network formation (Figure 5-1A). 
A viscoelastic solid (G′ > G″) was formed in the time taken to mix and load the sample and 
structure development then followed approximately first order kinetics. After 60 minutes 
the value of G′ was 350 Pa, indicating mechanical properties similar to soft tissues such as 
brain and lymph node.21 Few hydrogels based on coiled coils have been reported and only 
the hSAF peptides designed by the Woolfson group have been investigated using 
rheology.3 Hydrogels formed by hSAF peptides had higher mechanical strength than the 
AFD36 gel characterised here, however the hSAF gels were prepared at almost 3-fold 
higher peptide concentration, which would greatly increase gel strength.  Comparison of 
AFD36 hydrogels with previously reported RAD16-I and MAX1 β-sheet peptide hydrogels 
showed comparable strength at similar or lower weight concentrations (Table 5-1).22-24  
After one hour, the gel formed showed moderate frequency dependence of G′ and G″ 
(Figure 5-1B). However, no cross-over point is observed, with G′ being greater than G″ by 
at least one order of magnitude for all frequencies tested. The frequency dependence of G′ 
and G″ shown here is similar to that previously reported for hydrogels formed by self-
assembling β-sheet peptides.23, 25 This dependency likely relates to the semi fluid-like 
properties of these physically cross-linked gels. At higher frequencies there is less time for 
the network to rearange and relax, which results in a more rigid material. 
At the completion of testing, visual observations of pH-dependent colour change showed 
the peptide sample to be at lower than physiological pH, likely due to limitations to the loss 
of CO2 at the plate edge. The results obtained are thus likely to represent a low-end 
estimate of the rate of gelation and the final gel strength. 
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Figure 5-1. Rheological characterisation of a 1.4 mM (0.35 % (w/v)) AFD36 hydrogel A) over 
time during gelation (x-axis is time from measurement initialization), and B) as a function of 
frequency (two samples). In both plots G′; triangles, G″; squares. 
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Table 5-1. Table of previously reported self-assembling peptide hydrogels referenced in this chapter 
Peptide Class 
Peptide 
concentrationa 
G′b Cell typec 
2D or 3D 
culture 
Recognition motifd 
hSAFAAA3 α-helical 0.9 1500 - - - 
hSAFAAA-W3 α-helical 0.9 - 
PC12 rat adrenal 
pheochromocytoma  
2D - 
RADA16-123 β-sheet 0.5, 1, 2 12, 37, 60 Murine neuronal stem cells 3D 
Unmodified as 
well as RGD and 
two bone marrow 
homing peptides 
MAX122 β-sheet 0.7, 1, 1.4, 2 
250, 1300, 
1600, 4000 
- - - 
MAX125 β-sheet 
2 (20, 150 and 400 
mM NaCl) 
100, 300, 
3000 
- - - 
MAX126 β-sheet 2 10000 NIH/3T3 murine fibroblasts 2D - 
MAX7CNB27 β-sheet 2 1000 NIH/3T3 murine fibroblasts 2D - 
MAX824 β-sheet 0.5 500 C3H10t1/2 murine stem cells 3D - 
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Fmoc-RGD28 Fmoc - - 
Human adult dermal 
fibroblasts 
3D RGD 
PAs29 
Alkyl-tail 
PA 
N/A 100 
NIH/3T3 murine fibroblasts, 
MDA-MB-231 human breast 
carcinoma 
3D RGD 
P11-430 β-sheet 3 - 
Primary human dermal 
fibroblasts 
3D - 
P11-8/12/1631 β-sheet 2 - L929 murine fibroblasts 3D - 
Q1132 β-sheet 4.5 - 
C3H10t1/2 murine stem cells, 
NIH/3T3 murine fibroblasts 
3D 
Unmodified  and 
RGD 
a Reported peptide concentration used in % w/v 
b Storage modulus reported for peptide hydrogel in Pa (where G′ was not reported in text, values are estimated from plotted rheological curves) 
c Cell type reported to be successfully cultured on or in the peptide hydrogel 
d Recognition motif incorporated within the peptide sequence where relevant 
188 
 
 Chemical contaminants 5.3.2
As discussed in Chapter 1, peptide hydrogels are promising materials for use as cellular 
scaffolds. It was therefore of interest to characterise mammalian cell growth on AFD36 
hydrogels. Initial experiments using hydrogels prepared from AFD36 peptide received as a 
TFA salt showed these gels were unable to support mammalian cell growth, with high 
levels of cell death observed (not shown). It was thought that this may be due to the 
toxicity of the residual TFA present in the solid.31, 33 In an attempt to overcome this issue, 
peptide AFD36 was purchased as an acetate salt. The level of TFA remaining in the 
peptide solid was 0.16% (w/w) (determined by the manufacturer), which once made up as 
a hydrogel is below the concentration reported to be detrimental to cell growth.31  
However, hydrogels prepared from AFD36 peptide received as an acetate salt were also 
unable to support mammalian cell growth (not shown). Ultraviolet-visible spectroscopy of 
as-received peptide indicated the presence of strongly absorbing species, with maxima at 
262, 285 and 296 nm (Figure 5-2). These spectra resembled those of the 
Fluorenylmethoxycarbonyl protecting group,34, 35 which is an aromatic protecting group 
used during solid-phase peptide synthesis. The presence of this contaminant in received 
peptide was suprising, given that the peptide had been purified by reversed-phase 
chromatography. The presence of this contaminant in purified peptide material may reflect 
binding of the aromatic molecule by the peptide, or introduction of the contaminant post-
purification. Similar chemical contaminants were observed in several batches of peptides 
of related sequence from different suppliers, suggesting an inability to fully purify the 
relatively hydrophobic AFD peptides from chemical contaminants using standard 
chromatography methods. 
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Figure 5-2. Absorbance spectra of AFD36 solutions at steps during purification; as-received 
peptide (solid line), peptide following urea and charcoal treatment (dotted), dialysed product 
(dashed). Spectra normalised to 1 mM peptide. All spectra collected in 10 mm path length cuvette. 
In an attempt to remove chemical contaminants, AFD36 peptide was mixed with a 
suspension of activated charcoal in the hope that this would bind aromatic compounds. 
Urea was also added at 8 M to destabilise the coiled coil to allow removal of contaminants 
bound in the hydrophobic core. A decrease in absorbing species was observed when 
charcoal was removed via centrifugation and filtering (Figure 5-2). The peptide solution 
was then dialysed against 0.1 M NaCl, to exchange any remaining TFA counterions, 
followed by water. The recovered peptide contained much lower levels of absorbing 
contaminants, with A260 values of ca. 10% of initial (Figure 5-2). This purification method 
gave peptide that was capable of supporting mammalian cell growth once gelled (Section 
5.3.3). 
While previous studies have highlighted the effects of residual TFA in synthetically 
produced peptides,25, 26 to the candidates knowledge, no studies have reported the 
presence of other chemical contaminants in peptide solids that effect cellular growth. The 
persistence of chemical contaminants in peptide material may relate to strong interactions 
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between the hydrophobic peptides and contaminant aromatic molecules, preventing 
separation via chromatography. This binding may be enhanced if the peptide is not fully 
denatured during chromatographic purification and encapsulates the hydrophobic chemical 
contaminants. Future studies evaluating the use of peptide hydrogels as cellular scaffolds 
will need to consider the presence of such contaminants. 
 Cell Growth on AFD36 5.3.3
AFD36 hydrogels prepared by mixing an acidic peptide solution with bicarbonate in DMEM 
were stable to repeated addition and removal of cell culture media, as required for tissue 
culture experimentation.  Furthermore, the cell culture media above the gel provided 
additional buffering capacity and maintained gelling conditions. Common to many reported 
studies of cell growth on peptide hydrogels is equilibration of gels with culture media prior 
to cell seeding.26, 27, 36-38 To assess the ability of AFD36 hydrogels to support mammalian 
cell growth, NIH/3T3 cells were cultured for 4 days on either uncoated tissue culture 
polystyrene (TCPS) or AFD36 gels pre-equilibrated for 2 × 2 days in serum-free DMEM. 
Cell growth was quantified by AlamarBlue assay at each day, with cell images recorded at 
day 3 (Figure 5-3). The fibroblasts proliferated well on AFD36 hydrogels, with cell growth 
at 68% of TCPS levels at day 4. This level of 3T3/NIH fibroblast growth is similar to that 
previously reported on MAX β-hairpin peptide gels, although in these systems no pre-
treatment of the peptide was required and hydrogels were only equilibrated with serum 
free media overnight.26, 27 Table 5-1 lists several hydrogels formed by self-assembling 
peptides which have been used for cell culture including the types of cells successfully 
cultured for comparison. 
The fibroblasts formed spread morphologies on AFD36 gels, similar to the control TCPS 
surface. Adhesion and spreading may be due to non-specific protein adsorption from 
serum onto the surface of the hydrogels, providing cellular attachment points.39 This is 
further investigated in Section 5.3.10. The proliferation of fibroblasts at levels similar to 
TCPS indicate that the AFD36 gels are not strongly toxic towards NIH/3T3 fibroblasts and 
suggests that the peptide gels may be suitable biomaterials for tissue engineering 
applications.  
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Figure 5-3. Growth of NIH/3T3 fibroblasts on AFD36 gels and TCPS controls. Representative 
images of cells cultured on A) TCPS control surface or B) AFD36 hydrogel at 3 days (scale bars 
100 µm). C) Cell growth measured via AlamarBlue fluorescence assay on TCPS (black bars) and 
AFD36 hydrogels (grey bars) at 1-4 days ±SD (n=3).   
* p values ≤ 0.05, relative to the control, as determined by Student’s T-test. Peptide gels were 1.4 
mM AFD36 final. 
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 Long term growth on AFD36 5.3.4
To assess the AFD36 peptide hydrogel’s potential as a substrate for long-term cell growth, 
NIH/3T3 cells were cultured on either TCPS or AFD36 hydrogels pre-equilibrated for 6 
days (one media change at day 2) in serum-free DMEM. Cell growth and morphology was 
observed via phase contrast microscopy at days 1, 7, 10, 14 and 18 (Figure 5-4).  
At 1 day fibroblasts were attached and had adopted a spread morphology on both TCPS 
and peptide hydrogels. At 7 days, fibroblasts grown on TCPS had reached confluence and 
higher magnification images of these fibroblasts were not collected at longer time points. 
At 7 days, fibroblasts grown on AFD36 hydrogels had begun to form localised islands of 
higher cell density. This “clumping” of fibroblasts on hydrogels increased with time, forming 
clusters at day 10 and dense balls at day 14. At days 14 and 18 it can be seen that in 
addition to the high-density cell aggregates, fibroblasts were proliferating and re-covering 
the gel surface that fibroblasts had previously receded from. The apparent decrease in 
number of cell aggregates at day 18 is likely due to loss of detached aggregates during 
media changes. 
Live-dead staining at day 21 was used to assess whether the observed clumping of cells 
corresponded with cell death (Figure 5-5). The washing procedure for staining resulted in 
the loss of some less attached fibroblast clusters on peptide hydrogels. Few dead cells 
were seen on the TCPS surface, however several dead floating cells were observed (not 
shown). This may be due to a loss of TCPS surface adhesion following cell death. On 
peptide hydrogels some cell death was seen in the dense cell aggregates; however the 
majority of fibroblasts in these masses were alive, suggesting these are not necrotic 
masses of cells. The presence of dead cells on hydrogel surfaces after washing also 
indicates that with the exception of the larger cell-agregates, cells may be partially 
embedded in the hydrogel material and resist detachment. 
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Figure 5-4. Representative images of NIH/3T3 fibroblasts grown on AFD36 hydrogels and TCPS 
controls. Days cultured as indicated (scale bars 100 µm). Peptide gels were 1.4 mM AFD36 final. 
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Previous experimentation has shown that culture of fibroblasts inside collagen40 and 
peptide28 gels caused contraction of these soft physically cross-linked materials. While no 
macroscopic contraction of peptide hydrogels was seen in this experiment, it may be 
possible that contraction of surface material due to cytoskeletal forces could result in the 
clustering of cells observed here. Such an effect would be enhanced as fibroblasts 
proliferate and cell density increases, resulting in increased numbers of cell-cell 
interactions leading to cell clustering. Additionally, fibroblasts may initially grow well on 
hydrogels, but later deposit their own ECM and form better attachments to this material 
and each other than to the hydrogel surface, resulting in detachment of high-density 
clusters of cells. The embedding of cells within a hydrogel matrix to give cells a three-
dimensional environment may overcome cellular detachment. 
 
Figure 5-5. Live-dead staining of NIH/3T3 fibroblasts grown for 21 days on A) TCPS or B-D) 
AFD36 hydrogels (scale bars 100 µm). 
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Characterisation of NIH/3T3 fibroblast growth on peptide hydrogels has generally been 
reported over shorter time periods of less than 1 week.26, 27, 29 The progressive aggregation 
and detachment of fibroblasts shown here may therefore relate to effects only seen at 
longer culture times, when cells have begun to remodel the hydrogel surface or produce 
their own ECM. There have also been few reports of fibroblast growth on peptide 
hydrogels at high cell density.26 In previous studies of high cell-density culture on peptide 
hydrogels no cellular aggregation and detachment was reported. However the mechanical 
properties of the peptide hydrogel in this case was much higher than for AFD36 hydrogels 
(Section 5.3.1), which may have prevented the contraction of surface material leading to 
cell clustering. The generality of this cell clustering and progressive detachment will need 
to be determined for alternate cell lines and hydrogel systems. 
 Trypsin digestion 5.3.5
NIH/3T3 fibroblast cells grown on AFD36 hydrogels were not detached by standard trypsin 
dissociation methods. One potential reason for this is the trypsin enzyme binding to 
cleavage sites within the peptide hydrogel and slowly digesting the peptide scaffold. 
Trypsin cleaves polypeptides C-terminal to lysine and arginine residues,41 and given the 
presence of four lysine residues within AFD36 may be expected to digest this peptide. 
During the design of the AFD peptides in Chapter 4, optimisation of the sequence 
instability index was used in an attempt to increase resistance to protease digestion.42 It 
was therefore of interest to assess trypsin digestion of the peptide hydrogel. A mixture of 
AFD36 and a commercial trypsin preparation was made at a gelling concentration of 
peptide and a final trypsin concentration similar to those recommended for cell dissociation 
by the manufacturer. The mixture gelled and was incubated at 37 °C. Gel breakdown 
occurred after ca. 18 hours. The helical secondary structure of AFD36 during digestion 
was monitored using ECD. Figure 5-6 shows the change in helical structure as measured 
at 222 nm over the first 2 hours. The helical secondary structure of AFD36 is degraded 
over time, with 63% remaining after 2 hours and only 10% at 24 hours (not shown). 
Decreasing helical structure shows trypsin to be capable of digesting AFD36, although 
loss of gel structure required much longer than the gels would be exposed to in normal cell 
culture experiments. Furthermore, in this digestion experiment the trypsin was mixed 
evenly through the gel, whereas in tissue culture experiments only the surface of the gel 
would initially be exposed to enzymatic degradation. The observed lack of cell detachment 
on treatment with trypsin may therefore be due the enzyme digesting AFD36 rather than 
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dissociating cells. Additionally, serum proteins and trypsin inhibitor from the culture media 
may remain in the hydrogel volume during washing steps and further decrease the efficacy 
of trypsin in detaching cells for recovery. The lack of cellular detachment from peptide 
hydrogels on treatment with trypsin indicates that the peptide hydrogels are not amenable 
to cell culture where cells are recovered via trypsinization. However, the use of alternate 
dissociation agents or dissolution of the hydrogel via pH adjustment may be applicable in 
some circumstances. Furthermore, AFD36 peptide hydrogels may be useful as matrices 
for toxicological assays or in vivo applications where the recovery of cells is not required. 
Further experiments are required to determine the susceptibility of peptide hydrogels to 
digestion by proteases secreted by mammalian cells. However, if the gels are susceptible 
to digestion at low levels, as appears likely, this may be an advantage in applications 
where cells are injected into the body encapsulated in a peptide hydrogel. In this case 
digestion of the gel over time by secreted proteases43 would allow for progressive 
replacement with native ECM, potentially resulting in enhanced tissue regrowth.44 Of note 
 
Figure 5-6. Digestion of a 0.5 mM (0.12% (w/v)) AFD36 gel by trypsin. Helical secondary 
structure monitored via ECD at 222 nm. 
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is that a high protease concentration was used in this experiment, and therefore 
degradation of AFD36 hydrogels may be expected to be slower in in vivo environments 
than is observed here. 
The design process used for peptide AFD36 included sequence optimisation for in vivo 
stability using the instability index. It may be of interest in the future to compare the 
proteolytic susceptibility of hydrogels formed by alternate sequences that assemble 
similarly but possess different instability index values. This would allow for validation of the 
use of such an index in designing peptides for in vivo applications. Furthermore, if the 
instability indices of designed peptide sequences were shown to be predictors for the rate 
of hydrogel degradation, this may offer a way to design hydrogels with pre-determined 
degradation rates as required for clinical applications. 
 Peptide design 5.3.6
The peptide AFD49 (Figure 5-7) was designed based on the self-assembly model 
proposed in Chapter 4, to further explore the relationship between sequence and self-
assembly for gel formation. This design maintains the same charged residue composition 
as AFD36 of four lysine, three glutamate and two histidine residues. This is predicted to 
 
Figure 5-7. Comparison of heptad based helical wheel projections of peptides AFD36 and 
AFD49. Sequence changes are highlighted in red. 
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give a charge of +1 at pH 7.0,45 which is associated with gel formation (Chapter 4). In 
AFD49 the charged residues are arranged to have a higher degree of heptad repetition 
than AFD36, with only glutamate at position c, lysine at position f and a mixture of lysine 
and histidine residues at position b.  
The hydrophobic residue composition of AFD49 included a higher proportion of leucine 
residues compared to AFD36 and AFD19. This choice was driven by the hydrophobicity 
and high helix propensity of leucine.46, 47 The hydrophobic residues were arranged to 
maintain the expanded hydrophobic face for coiled-coil assembly while providing a higher-
degree of heptad repetition, with only leucine residues in positions a, d and g, and alanine 
residues at position e. The high degree of heptad repetition in AFD49 may reduce 
differences in peptide-peptide interactions between in-register and offset helices, 
potentially stabilising out-of-register arrangements and enhancing fibril formation 
(discussed in Chapter 4; Section 4.3.8). The final sequence of AFD49 (Ac-LKELAKL 
LHELAKL LHELAKL-CONH2, FW 2465), possesses a GRAVY value of 0.338, which is 
higher than AFD36 but lower than AFD19 and predicted sequence solubility. The instability 
index of AFD49 is -6.65, which is lower than both AFD19 and AFD36 and places it well 
below the threshold value of 40 thought to divide proteolytically stable from unstable 
polypeptides.42  
 AFD49 characterisation 5.3.7
Similarly to AFD19 and AFD36, as-received AFD49 peptide dissolved in water to give an 
acidic solution. Titration of a 0.1-0.5% (w/v) solution of AFD49 with NaOH gave similar 
results to those of AFD36, with gelation occurring at pH 7.0, where the molecular charge is 
predicted to approach +1, and precipitation observed above pH 10, where the predicted 
molecular charge approaches zero. ECD of AFD49 in both ungelled (pH 2.8) and gelled 
(pH 7.0) states shows a spectrum with a double minimum at 208 and 222 nm and a 
maximum at 192 nm indicating α-helix formation (Figure 5-8). The mean residue ellipticity 
at 222 nm for gelled and ungelled samples were -33,300 and -31,900 deg cm2 dmol-1 
respectively. These values indicate AFD49 to be in an almost fully helical conformation in 
both states.48 The slightly lower helicity at acidic pH likely reflects increased electrostatic 
repulsion destabilising helix folding due to higher molecular charge under acidic 
conditions. The observed hydrogel formation and secondary structure of AFD49 is 
consistent with this peptide self-assembling similarly to peptide AFD36. This is consistent 
with the self-assembly model proposed in Chapter 4, whereby amphiphilic α-helices with 
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self-similar heptad repeats assemble into staggered coiled coils due to permissive helix 
offsetting. The success of this new peptide design also demonstrates the tolerance of the 
self-assembling system for modification of gelling sequences. This potentially enables 
future designs to incorporate sequence modifications for specific property or functionality 
requirements.  
In contrast to AFD36 (Section 5.3.2), as-received AFD49 peptide did not contain strongly 
absorbing species (Figure 5-9). Chemical contaminants were therefore thought to be at 
lower levels in this peptide solid. Similar to the AFD36 solid used for cell culture 
experiments (Section 5.3.3), this peptide was purchased as an acetate salt and the level of 
TFA remaining in the peptide solid was 0.2% (w/w) (determined by the manufacturer), 
which once made up as a hydrogel is below the concentration reported to be detrimental to 
cell growth.31 Two methods were assessed for their ability to remove any remaining 
contaminants from AFD49. Peptide solutions were dialysed against either 100 mM NaCl 
 
Figure 5-8. ECD spectra of self-buffered AFD49 (1.6 mM) at 20 °C in gelled (solid line, pH 
7.0) and non-gelled (dashed, pH 2.8) states. 
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pH 3 (24 h) then 1 mN HCl (8 h then 16 h; Method 1) or 1 g L-1 activated charcoal in water 
(3 × 24 h; Method 2; Figure 5-9). 
To compare the ability of the two methods to give peptide material able to support 
mammalian cell growth, NIH/3T3 fibroblasts were cultured for 3 days on either TCPS or 
AFD49 gels prepared from peptide recovered after treatment with Method 1 or 2 and pre-
equilibrated for 16 hours in cell culture media. At day 3 cell growth was quantified by 
AlamarBlue assay and cell images were taken (Figure 5-10). No statistical difference in 
cell growth was seen between hydrogel samples, with cell growth at 35-38 % of TCPS 
levels. This indicated material recovered from both methods was similarly able to support 
cell growth, potentially in part due to lower contaminant levels in the initial solid, and were 
therefore both utilised in subsequent experimentation. The fibroblasts adopted spread 
morphologies on all AFD49 gels, similar to the control TCPS surface. However some 
clusters of cells were observed on the AFD49 gels, similar to those observed on AFD36 
 
Figure 5-9. Absorbance spectra of AFD49 stock solutions before (solid line) and after dialysis 
using Method 1 (dotted) and Method 2 (dashed). Spectra normalized to 1 mM peptide and 10 mm 
path length. 
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gels (Section 5.3.4). The level of cell growth on AFD49 hydrogels compared to TCPS 
controls was lower than that seen for AFD36 hydrogels (Section 5.3.3). However the 
shorter hydrogel equilibration in cell culture media prior to cell seeding on AFD49 may 
have affected the rate of cell growth, as is investigated in Section 5.3.9. 
Similar experiments to those comparing the batches of treated AFD49 were used to 
investigate the growth of 3T3/NIH fibroblast on hydrogels of varied final AFD49 peptide 
concentration (not shown). No significant difference was seen between final peptide 
concentrations of 1-2 mM. This suggests that at the peptide concentrations investigated 
here, the differences in mechanical properties and residual contaminant concentrations 
are not sufficient to influence fibroblast proliferation. 
 
Figure 5-10. Growth of NIH/3T3 fibroblasts on AFD49 gels and TCPS controls. A) Cell growth 
measured via AlamarBlue fluorescence assay on TCPS and AFD49 hydrogels at 3 days ±SD 
(n=3). Representative images of cells cultured on B) TCPS; or AFD49 hydrogels prepared from 
peptide dialysed using either C) Method 1 or D) Method 2 (discussed in text) (scale bars 100 
µm). Peptide gels were 3.75 mM AFD49 final. 
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 Cytoxicity of peptide released from hydrogels 5.3.8
One potential reason for the lower level of proliferation seen on peptide hydrogels 
compared to TCPS alone is the potential continual release of “free peptide” from the 
dynamic network of peptide fibrils. If this low level of unassembled peptide in the media 
were cytotoxic to the cells it may partially explain the lower level of proliferation seen on 
hydrogels compared to TCPS alone. To investigate this, NIH/3T3 cells were seeded in 
empty wells and allowed to adhere to TCPS. After 1 day the media was removed and then 
replaced with cell culture media which had been incubated with either TCPS or AFD49 
hydrogel (n = 3 for each) for 1 day. Cell growth was quantified by AlamarBlue assay after 2 
days. These results showed no statistical difference in growth between cells growing in 
media incubated with TCPS or AFD49 hydrogels (not shown). This indicates that if free 
peptide is slowly released from peptide hydrogels, it is not cytotoxic to NIH/3T3 cells under 
the conditions tested here. While futher studies will be required to investigate the effects of 
free peptide at varied concentrations, different growth and incubation times, and for 
different cell types, this preliminary experiment is promising for future application of AFD49 
hydyrogels as cell scaffold materials and therapeutic delivery vehicles. Alternate reasons 
for the lower level of growth on hydrogels compared to TCPS may relate to the inherent 
propensity for NIH/3T3 fibroblasts to proliferate on soft materials compared to TCPS, a 
factor which would need to be explored for alternate cell lines. 
 Effect of length of equilibration time for AFD49 gels 5.3.9
Given the lower level of cell growth observed on AFD49 gels when pre-equilibrated for 
only 16 hours (Section 5.3.6) compared to growth on AFD36 gels when pre-equilibrated for 
2 × 2 days (Section 5.3.3), it was of interest to further assess the effect of the length of gel 
pre-soaking time. To investigate this, NIH/3T3 cells were cultured for 3 days on either 
uncoated TCPS or AFD49 gels that were either washed for 1 hour or pre-equilibrated for 1 
or 2 × 1 days in cell culture media prior to cell seeding. Cell growth was quantified by 
AlamarBlue assay at day 3 (Figure 5-11).The fibroblasts proliferated more on hydrogels 
that had been equilibrated for longer in cell culture media. At 3 days, growth on AFD49 
hydrogels equilibrated for 2 × 1 days is not significantly different from levels on TCPS and 
more than double that on gels that were seeded after only washing the surface. These 
results show the importance of pre-soaking time for peptide hydrogels.  
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There are two potential reasons for the observed increased proliferation following pre-
equilibration of hydrogels with media. Although AFD49 was received as an acetate salt, no 
absorbing species were observable via absorption spectroscopy and the peptide was 
further treated by dialysis (Section 5.3.6); there is still the potential for chemical 
contaminants to remain in the peptide solution at trace levels and reduce proliferation as 
the gels degrade. If contaminants are able to diffuse out of the gel and affect cell growth, it 
may be expected that they could be removed via pre-soaking with cell culture media. 
While the results of Section 5.3.8 suggest that media incubated with hydrogels is not itself 
 
Figure 5-11. NIH/3T3 fibroblast growth on TCPS and AFD49 gels equilibrated in cell culture 
media for varying times as indicated, measured via AlamarBlue fluorescence assay at 3 days ±SD 
(n=3). Peptide gels were 3.75 mM AFD49 final. 
 * p values ≤ 0.05, as determined by Student’s T-test. 
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cytotoxic to fibroblasts, factors such as the proximity of cells to the contaminants being 
leached from the hydrogel and the length of time hydrogels are pre-soaked may play a 
role. Alternatively, the presence of serum in the equilibration media may enhance 
subsequent cell growth by increasing the levels of surface adsorbed proteins, or by the 
accumulation of metabolic factors such as growth factors within the gels. This is further 
investigated in Section 5.3.10. 
 Presence of serum in pre-soaking media 5.3.10
The results of Section 5.3.9 indicated the benefits to cell growth of equilibrating AFD49 
hydrogels with cell culture media prior to cell seeding. To separate the effects of 
contaminant removal and accumulation of components from media serum, NIH/3T3 cells 
were cultured for 3 days on either TCPS or AFD49 gels that were pre-equilibrated in 
DMEM with or without serum for 3 × 1 days. Growth on these surfaces was compared to 
control TCPS and AFD49 gels that were not pre-equilibrated. Cell images were recorded 
and cell growth was quantified by AlamarBlue assay at day 3 (Figure 5-12). 
Cell growth on AFD49 gels pre-equilibrated with serum-free media was more than double 
that on gels that were not pre-equilibrated, with growth increased by a further 12% when 
serum was included in the soaking media. On TCPS the effect of equilibrating with serum-
free media was not statistically significant; however the inclusion of serum in the soaking 
media increased growth by 32%. Fibroblasts adopted spread morphologies on both 
surfaces for all conditions tested. While the surfaces not pre-equilibrated with serum-
containing media will not initially be coated with serum proteins, protein may adsorb to the 
surface from the growth media after cell seeding and provide cellular attachment sites. Cell 
growth on AFD49 gels pre-equilibrated for 3 × 1 days with serum-free media was 67% of 
that on non-equilibrated TCPS at 3 days. This is comparable to growth on AFD36  
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Figure 5-12. Growth of NIH/3T3 fibroblasts on AFD49 gels and TCPS controls using different 
equilibration conditions. Representative images of cells cultured for 3 days on A) AFD49 
hydrogels or B) TCPS control surfaces pre-equilibrated with media as indicated (scale bars 100 
µm). C) Cell growth measured via AlamarBlue fluorescence assay on AFD49 hydrogels (black 
bars) and TCPS (grey bars) at 3 days ±SD (n=3). Peptide gels were 3.75 mM AFD49 final. 
* p values ≤ 0.05, relative to samples of same substrate material, as determined by Student’s T-
test.  
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hydrogels pre-equilibrated using similar conditions (Section 5.3.3), indicating the two 
peptide hydrogels to support similar levels of fibroblast growth. 
The increase in fibroblast proliferation on AFD49 hydrogels pre-equilibrated with serum-
free media indicates that soaking may further remove residual chemical contaminants. As 
the gels are initially cast containing DMEM, it is not expected for components of this basal 
media to diffuse into the gel and accumulate. The increase in cellular proliferation on both 
TCPS and AFD49 hydrogels following pre-equilibration with serum-containing media 
compared to serum-free media likely reflects the benefits to early cell growth of the pre-
adsorption of serum proteins to the surfaces. In the case of the hydrogels this may be 
further enhanced by the accumulation of metabolic factors from the serum within the 
hydrogel volume.  
The benefits to cell growth demonstrated by equilibration of hydrogels in serum-free media 
suggest that low levels of chemical contaminant remain in the peptide material after 
dialysis. The ability to remove these contaminants by equilibrating peptide hydrogels is 
somewhat surprising, given that equilibration media is only at a five-fold excess compared 
to gel volume, while dialysis is conducted at an approximately hundred-fold larger excess 
of external dialysis volume to peptide solution. This may reflect differences in solubility of 
the contaminant under the conditions used for dialysis compared to equilibration due to 
solution pH or ionic strength. Furthermore, equilibration is conducted at 37 °C, which may 
increase contaminant solubility compared to room temperature dialysis conditions. Another 
contributing factor may be slow diffusion of material from peptide solutions under gelling 
conditions during dialysis due to a lower surface area to volume ratio than when gels are 
cast in wells for cell culture experiments. Future studies may be able to overcome 
contaminant issues by investigating alternate dialysis conditions. This may include further 
investigating the effects of dialysis solution pH, ionic strength and temperature, as well as 
varying peptide solution surface area to volume ratios by using different dialysis cassette 
volumes. The results of Sections 5.3.9 and 5.3.10 demonstrate the importance of 
appropriate selection of pre-equilibration conditions for both peptide hydrogels and TCPS 
controls. These conditions may vary across different cell lines and applications but should 
be further explored and optimised for each case. 
 Fibroblast attachment without serum 5.3.11
Given the lack of cellular recognition motifs in the AFD49 peptide, it was thought that 
fibroblast attachment may be mediated via serum proteins adsorbed to the hydrogel 
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surface. To investigate the requirement for serum proteins for fibroblast attachment, 
NIH/3T3 fibroblasts were cultured for 1 day on either TCPS or AFD49 hydrogel surfaces 
that had been pre-equilibrated for 1 day in either serum-free or serum-containing media. 
On each type of surface, fibroblasts were seeded in either serum-free or serum-containing 
media and images of cell attachment were recorded at 1 day (Figure 5-13).  
As fibroblasts do not detach from hydrogel surfaces even on cell death (Section 5.3.4) it 
was not possible to assess the level of attachment to different surfaces by counting 
detached cells that were washed off. In the absence of this metric, the level of cellular 
spreading was used as a measurement of cell-substrate interactions. To assess the level 
of cellular spreading on each surface type, fibroblasts were visually assessed and 
classified as having either a rounded or spread morphology. Comparison of the numbers 
of each type allowed for an estimate of the levels of cells adopting spread morphologies on 
each surface. 
Approximately 90 % of fibroblasts adopted a spread morphology on AFD49 or TCPS 
surfaces when serum was included in the cell-seeding media, regardless of pre-
equilibration conditions (Figure 5-13A). However, when serum-free media was used for 
cell-seeding, fibroblast spreading on TCPS surfaces was only 60%, regardless of pre-
equilibration conditions. On AFD49 hydrogels pre-equilibrated in the absence of serum, 
only 20% of cells adopted spread morphologies when serum-free medium was also used 
for cell-seeding. However, pre-equilibration with serum-containing media increased the 
level of spreading to 90%, even when serum-free media was used for cell seeding.  
The higher level of cell spreading on surfaces in serum-containing media illustrates the 
benefits of the presence of serum components for cell-substrate interactions on peptide 
hydrogels and TCPS, likely due to the lack of cellular recognition motifs on both bare 
surfaces. In the case of fibroblasts seeded on peptide hydrogels in the absence of serum, 
the pre-equilibration of gels with serum-containing media was sufficient for fibroblast 
spreading to occur at levels similar to controls where cells were seeded in serum-
containing media. This implies that adsorption of serum components to peptide hydrogels 
may decorate these surfaces with sufficient cellular recognition sequences to achieve cell 
spreading in the absence of specific integrin sequences within the peptides themselves. 
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Figure 5-13. The effects of serum on spreading of NIH/3T3 fibroblasts on TCPS or AFD49 
surfaces. Representative images of cells after 24 hours when they were added in A) serum-
containing media, or B) serum-free media to surfaces pre-equilibrated as indicated. (scale bars 
200 µm). Peptide gels were 1 mM AFD49 final. 
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Cell spreading may also be enhanced by accumulation of other serum components within 
the hydrogel volume that increase fibroblast interactions with the substrate. The similar 
levels of spreading on TCPS surfaces when cells were seeded in serum-free media, 
regardless of pre-equilibration conditions, indicates that for these surfaces, the presence of 
serum components in the seeding media is more important than in equilibration media. 
This may reflect the influence of other soluble serum components in promoting 
attachment. 
 Fibroblast attachment in the presence of free RGD 5.3.12
As discussed in Chapter 1, arginine-glycine-aspartic acid (RGD) is an oligopeptide 
sequence found across many ECM components such as fibronectin,49 laminin,50 collagen51 
and vitronectin.52 It is implicated in cellular recognition and attachment through integrin 
binding. The inclusion of free cyclic-RGD peptides in growth media is expected to inhibit 
cellular recognition and binding of proteins containing this sequence.37, 38  To investigate 
whether the attachment of fibroblasts to hydrogel surfaces proceeded through integrin 
recognition of RGD sequences, NIH/3T3 fibroblasts were grown in serum-containing 
media for 1 day in the presence or absence of 100 μM free cyclic-RGD 
(c[RGDfK(Biotin)])53, 54 on TCPS or AFD49 hydrogels pre-equilibrated for 1 day in serum-
free media. Cell images were recorded after 1 day (Figure 5-14). Fibroblast attachment 
and spreading occurred on all surfaces, irrespective of the presence of cyclic-RGD. On 
AFD49 hydrogels in the presence of cyclic-RGD, the cellular morphology was slightly less 
extended, potentially relating to a lower level of attachment and spreading. Interestingly, 
the fibroblasts incubated with cyclic-RGD did not proliferate and adopted rounded 
morphologies and underwent cell death in the days after initial attachment. Previous 
studies have implicated soluble RGD-containing peptides in cell-cycle arrest and apoptosis 
via integrin signalling pathways, an effect that may be active here.55, 56 The lack of 
attachment inhibition is likely due to alternate integrin recognition sites being involved in 
fibroblast adhesion on serum-adsorbed surfaces57 and is consistent with the absence of 
integrin recognition sequences within the AFD49 peptide. Future studies may involve using 
varied concentrations of cyclic-RGD to determine the concentration dependence of 
attachment inhibition and cellular proliferation. 
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 Effects of hydrogel pre-equilibration on fibroblast attachment and 5.3.13
proliferation 
The results of Sections 5.3.9-5.3.12 demonstrate the importance of equilibration of peptide 
hydrogels prior to cell seeding. The benefits of equilibration to proliferation is cumulative, 
with longer pre-equilibration times resulting in increased proliferation (Section 5.3.9). The 
exact reason for enhanced proliferation has not yet been determined; however it appears 
to be a combination of the removal of residual chemical contaminants and the deposition 
of serum components on or in the hydrogels (Section 5.3.10).  
Fibroblast attachment to peptide hydrogels was dependent on the presence of serum 
components either in the pre-equilibration media or in the cell-seeding media (Section 
5.3.10), and was not affected by the presence of free cyclic-RGD peptides (Section 
5.3.12). This is consistent with the lack of designed integrin recognition sites within the 
 
Figure 5-14. Effect of free cyclic-RGD on NIH/3T3 fibroblast adhesion to TCPS and AFD49. 
Fibroblasts incubated on TCPS in A) culture media, B) 100 µM cyclic-RGD in culture media, or 
on AFD49 in C) culture media, D) 100 µM cyclic-RGD in culture media. (scale bars 100 µm). 
Peptide gels were 2 mM AFD49 final. 
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hydrogel forming peptides, and involvement of adsorbed serum proteins in providing 
cellular attachment points. As discussed in Chapter 1, many peptide hydrogel scaffolds 
require functionalization with cell recognition motifs to support cellular attachment, and to 
the candidates knowledge only the MAX peptide system has been reported to support 
cellular attachment in the absence of recognition motifs or adsorbed serum proteins,26 
although the mechanism for this is not clear. Cellular attachment in the absence of serum 
proteins is not a requirement for most tissue engineering applications, as serum will 
typically be supplied in the cell culture media. AFD36 and AFD49 hydrogels are therefore 
potential cell scaffold materials for these applications.  
To the candidates knowledge no detailed reports have been made on the effects of pre-
equilibration of peptide hydrogels on cellular proliferation. However, there is the potential 
for the effects of pre-equilibration conditions on proliferation rates to be common to a 
range of hydrogel systems, especially those in which chemical contaminants are present. 
Accounting for these effects during material preparation will thus be required to allow direct 
comparison between cell proliferation on different hydrogel systems. Furthermore, if AFD 
peptide hydrogels are utilised in future in vivo applications, the effects of pre-treating 
peptide material will need to be assessed. 
 Culture of encapsulated fibroblasts 5.3.14
As discussed in Chapter 1, the culture of cells within a 3D environment can provide 
models that better mimic the functions of living tissue.58 The effects of encapsulating cells 
within a 3D peptide hydrogel were therefore of interest. As a first test, fibroblasts were 
mixed directly into a gelling AFD49 peptide solution. However, encapsulated cells did not 
proliferate (not shown), likely due to the transient acidic conditions that occur during 
gelation causing cell death. The growth of fibroblasts inside layered AFD49 hydrogels was 
then tested as an alternate method to reduce the exposure of cells to acidic conditions. 
One benefit of this layered approach is that cells are initially found in a single plane. 
Therefore cells visualised outside of this plane give an indication of cellular migration into 
the peptide scaffold. 
NIH/3T3 fibroblasts were allowed to adhere overnight on either TCPS or AFD49 hydrogels. 
Fibroblasts were then either allowed to continue growing in 2D, or had a gelling peptide 
solution cast on top to encapsulate the cells in a 3D environment. Cell images were taken 
at 4 and 6 days after seeding (Figure 5-15). Fibroblasts on TCPS surfaces that were not 
covered by a peptide hydrogel proliferated and reached confluence by 6 days (Figure 
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5-15A). Those on 2D AFD49 hydrogels also proliferated, with some dense clusters forming 
by 6 days (Figure 5-15C). Fibroblasts on TCPS with AFD49 gels cast on top underwent a 
high degree of cell death, with only small local areas of viable cells (Figure 5-15B). The 
remaining fibroblasts were viable and continued to proliferate, however growth was slow 
and they maintained a flat morphology, with cells appearing less raised than those on 
TCPS alone, possible due to the presence of gel material above them. The fibroblasts 
encapsulated inside layered AFD49 hydrogels proliferated, although at a much lower level 
than those on 2D hydrogel surfaces (Figure 5-15D). At 6 days some of the encapsulated 
cells were also visualised in slightly different focal planes, indicating some vertical 
distribution of cells. The encapsulated cells also adopted a more spindle-like morphology, 
with some cellular protrusions forming. 
The high degree of cell death on TCPS surfaces with hydrogels cast on top may be a 
consequence of the mildly-acidic gelling solution causing cell death and detachment. The 
lack of extensive cell death observed inside the layered hydrogels upon encapsulation 
may be due to the base hydrogel providing sufficient buffering capacity to protect the 
fibroblasts from the acidic environment during gelation. The slower growth of fibroblasts 
encapsulated within hydrogels is likely a consequence of limited nutrient diffusion through 
the gel compared to on a flat exposed surface. Furthermore, for proliferation to occur, the 
surrounding hydrogel may need to be degraded or moved to make space for new cells. 
At 7 days after seeding, confocal microscopy and live-dead staining was utilised to image 
the fibroblasts encapsulated in peptide hydrogels in 3D (Figure 5-16). The fibroblasts had 
formed small local clusters of spindle-shaped cells with some extending long processes 
into the hydrogel. The local clusters may be due to proliferation of individual cells forming 
clusters, or alternately, migrating cells may contact each other and adhere to form clusters. 
Side-on views of the fibroblasts show a general slope to the plane in which the cells are 
found. This is likely due to the uneven surface of the initial bottom hydrogel due to 
meniscus effects when it was cast. Side-on views of the fibroblasts also show some 
spreading of cells in the z-axis by ca. 20-30 µm, which is larger than the observed average 
fibroblast diameter of ~ 10 µm, potentially indicating the fibroblasts are  beginning to grow 
into the 3D environment.  
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Figure 5-15. Effects of hydrogel encapsulation on NIH/3T3 fibroblast growth. NIH/3T3 fibroblasts 
cultured A) on TCPS, B) on TCPS with AFD49 hydrogel cast on top, C) on AFD49 hydrogel, D) on 
AFD49 hydrogel with second gel cast on top. (scale bars 100 µm) Peptide concentration was 2.1 
mM in the base gels and 2 mM in the top layered gels. 
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The morphology of fibroblasts embedded in AFD49 hydrogels is similar to those of primary 
fibroblasts cultured in 3D environments inside degradable PEG40 and peptide28 hydrogels. 
Previous research has indicated the necessity for cell-mediated proteolytic degradation of 
chemically cross-linked hydrogel networks to allow remodelling of fibroblasts’ extracellular 
environment to create sufficient space for cellular proliferation.40, 59, 60 However these 
studies were completed at higher concentrations of scaffold material than used in the 
peptide hydrogels reported here. While proteolytic degradation (Section 5.3.5) of the 
peptide network may be involved in cellular proliferation, the low solid content and non-
covalent nature of the crosslinks of AFD49 hydrogels likely provide a sufficiently low 
density and deformable network for proliferation to occur even in the absence of proteolytic 
action.  
Due to the slow growth of encapsulated fibroblasts it was of interest to observe cell growth 
over longer times. Cell images were recorded at days 11, 19 and 28 (Figure 5-17). 
Fibroblasts proliferated over time, with increasingly large clusters of cells forming with 
large numbers of long processes. At these longer times, more fibroblasts were in different 
focal planes, indicating growth in 3D. The growth rate of fibroblasts encapsulated in 
AFD36 hydrogels appears qualitatively similar to rates previously reported for 
encapsulated fibroblasts in β-sheet peptide30, 31 and synthetic polymer40 hydrogels. 
However the growth rate appeared slower than that reported for cells encapsulated within 
peptide microgels that had a larger surface area to volume ratio that may increase nutrient 
diffusion to the cells.32 
Confocal microscopy and live-dead staining at day 42 were used to visualise the long-term 
growth of fibroblasts encapsulated inside AFD49 hydrogels in 3D (Figure 5-18). At this 
time point, fibroblasts had proliferated to give a large network of cells within the gel. The 
number of cells with spindle morphologies had decreased compared to earlier times, 
potentially due to cells forming larger assemblies where cell-cell interactions limit the 
potential for long process formation. While the majority of the fibroblasts are found in the 
plane of the initial hydrogel surface, side-on views show cells to have extended up to ca. 
160 µm into the gel. This indicates that while fibroblasts encapsulated within AFD49 
hydrogels proliferate slower than on a 2D hydrogel surface, they form 3D networks 
extending into the peptide hydrogel. This makes this material a promising candidate for 
future use in areas such as wound healing and therapeutic models where the cell 
microenvironment and the ability of cells to invade the hydrogel material may be of 
importance.  
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Figure 5-16. Confocal microscopy of live-dead staining of NIH/3T3 fibroblasts in layered AFD49 
hydrogels at day 7. Images A) top-down, B) and C) side-on. (green, live; red, dead). Peptide 
concentration was 2.1 mM in the base gels and 2 mM in the top layered gels. 
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Figure 5-17. Representative images of NIH/3T3 fibroblast growth encapsulated in AFD49 
hydrogels at longer times. (scale bars 100 µm). Peptide concentration was 2.1 mM in the base gels 
and 2 mM in the top layered gels. 
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Figure 5-18. Confocal microscopy of live-dead staining of NIH/3T3 fibroblasts in layered 
AFD49 hydrogels at 42 days. Images A) top-down, B) and C) side-on. (green, live; red, dead). 
Peptide concentration was 2.1 mM in the base gels and 2 mM in the top layered gels. 
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 Induced pluripotent stem cell growth on AFD49 gels 5.3.15
There has been recent interest shown in induced pluripotent stem cells (iPSCs) for  
applications such as toxicity assays61 and regenerative medicine.62 Culture of iPSCs often 
utilises a feeder-cell layer to assist in cell proliferation and maintaining their pluripotent 
state.63 Recent advances have enabled the replacement of feeder-cell layers with 
substitute extracellular matrices such as MatrigelTM.12, 63 While this greatly simplifies the 
culture of iPSCs, there still remain issues with these naturally-derived materials such as 
batch-to-batch variability, risk of viral contamination and a lack of the ability to modulate 
their characteristics.58, 63, 64 Given the demonstrated ability of AFD49 hydrogels to support 
mammalian cell growth (Sections 5.3.3-5.3.14), it was of interest to assess the ability of 
this defined and non-naturally-derived material to support the culture of iPSCs.  
Previous studies have demonstrated the functionalization of surfaces with recombinant 
vitronectin to be sufficient for the attachment and proliferation of human embryonic stem 
cells (hESCs).65 More recent work has shown that surfaces functionalised with the N-
terminal somatomedin B (SMB) domain of vitronectin, which contains an RGD sequence, 
are capable of supporting hESC attachment and maintenance in long-term culture.15 In an 
attempt to functionalise AFD49 hydrogels for enhanced iPSC attachment and proliferation, 
the SMB vitronectin fragment was included in hydrogels at the time of gelling at final 
concentrations of 10, 20 and 50 ug mL-1. If evenly distributed throughout the hydrogels this 
would result in spacing between RGD ligands of 105, 84 and 62 nm respectively, which is 
within the range reported to be required for the attachment of human mesenchymal stem 
cells66 and primary human fibroblasts.67 Non-specific incorporation of the vitronectin 
fragment into peptide fibrils during gelation was hoped to be sufficient to give 
functionalization for cellular attachment. The iPSC line utilised in this experiment was 
transformed using the EOS lentiviral vector11 and maintained in single cell culture. The 
reporter system engineered into this vector means that viable pluripotent cells express 
enhanced green fluorescent protein (EGFP), allowing for simple visual assessment of the 
maintenance of viable and undifferentiated cells. 
To assess the ability of AFD49 hydrogels to support iPSC growth and the effect of 
vitronectin fragment incorporation, iPSCs were cultured for two days on either Matrigel 
coated TCPS or AFD49 gels with varied amounts of vitronectin fragment that were pre-
equilibrated for two days in serum-free media. Images of iPSCs on all surfaces were taken 
each day (Figure 5-19). Similar to experiments with fibroblasts, rounded iPSCs on 
hydrogels were resistant to being washed off and were likely partially embedded in the soft 
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material. Similar to Section 5.3.11, the number of cells adopting a spread morphology was 
used to assess cell-substrate interactions. At day 1, ~ 40% of iPSCs on Matrigel coated 
TCPS had adopted spread morphologies. On gels of AFD49 alone this value was only ~ 
20%. Incorporation of the vitronectin fragment did not increase the level of attachment of 
iPSCs on peptide hydrogels with ~ 10% of cells adopting spread morphologies on all 
vitronectin fragment containing gels. The cells expressing EGFP generally also had spread 
morphologies, indicating that the rounded cells are likely undergoing cell death. At day 2 
the iPSCs on the Matrigel coated TCPS surface had proliferated, with EGFP expressing 
cells forming adherent clusters. iPSCs on all peptide hydrogels adopted rounded 
morphologies and the number of EGFP expressing cells decreased, likely indicating cell 
death.  
The low level of cell spreading followed by cell death on all peptide hydrogels indicated 
AFD49 hydrogels are not suitable for the culture of iPSCs, even with the incorporation of 
the vitronectin fragment. The initial spread morphology of some iPSCs on peptide 
hydrogels at day 1, followed by iPSCs rounding up and undergoing cell death is 
unexpected, but may be due to the cells taking some time to respond to the new substrate 
following their previous culture on Matrigel coated TCPS. Alternately, the soft peptide 
hydrogel material may be too weak to support the cytoskeletal forces of iPSCs, and 
following initial attachment, the iPSCs then contract to form rounded cells that do not 
further proliferate and in some cases completely detach from the surface. In an attempt to 
increase mechanical strength of the hydrogels, a separate experiment assessed iPSC 
spreading and proliferation on AFD49 hydrogels where peptide concentration was varied 
from 1-3.75 mM. This did not increase cellular spreading at longer than 1 day (unpublished 
data), indicating that altering the mechanical properties within the range tested did not 
enhance the ability of the peptide hydrogels to support iPSC culture. 
Another possibility is that the peptide itself is cytotoxic to the iPSC cells, and causes cell 
death on longer exposure, however the lack of cytotoxicity to fibroblasts in previous 
experiments makes this unlikely. The removal of Rho-associated kinase (ROCK) inhibitor 
from the culture media after 24 hours was also a potential influence in the higher degree of 
cell death during the second day of culture; however experiments in which the ROCK 
inhibitor was maintained in the media past the first 24 hours showed no decrease in cell 
death (not shown).  
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The lower level of cellular spreading on hydrogels containing the vitronectin fragment 
compared to unfunctionalised hydrogels was unexpected. This may be due to the 
vitronectin fragment not being incorporated into the fibrils during self-assembly and 
remaining free in the gel volume. As discussed for the free cyclic-RGD peptide (Section 
5.3.12), free vitronectin fragment may bind to receptors on the iPSCs and lower cellular 
attachment to other surface adsorbed proteins. While the hydrogels were equilibrated with 
media prior to cell seeding, the soaking media was at a five-fold excess to gel volume, and 
therefore there still remains the potential for low levels of this protein fragment to remain 
within the gel volume and effect cellular attachment. 
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Figure 5-19. Growth of iPSCs on AFD49 hydrogels and Matrigel coated TCPS controls. A) 
Matrigel coated TCPS, B) AFD49 hydrogels, C) AFD49 hydrogels cast with 10 µg mL-1 
vitronectin fragment, D) AFD49 hydrogels cast with 20 µg mL-1 vitronectin fragment, E) AFD49 
hydrogels cast with 50 µg mL-1 vitronectin fragment. Each fluorescence image (green, EGFP 
fluorescence) is of the same location as the phase contrast image above. (scale bars 100 µm). 
Hydrogels were 2 mM AFD49 final. 
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 iPSC growth on Matrigel coated hydrogels 5.3.16
Preliminary experiments investigating the ability of AFD49 hydrogels to support iPSC 
growth showed a low level of cells initially adopting spread morphologies followed by 
iPSCs adopting rounded morphologies and in some cases detaching and undergoing cell 
death. The presence of the SMB vitronectin fragment in the hydrogels did not enhance 
iPSC spreading (Section 5.3.15). From initial experiments it was unclear whether iPSC 
detachment and death resulted from one of several factors such as potential cytotoxicity, 
unfavourable mechanical properties or a lack of appropriate cellular recognition motifs. As 
a test of the effects of functionalization, iPSC growth was assessed on AFD49 gels coated 
with Matrigel. 
iPSCs were cultured for 6 days on Matrigel coated TCPS and AFD49 gels with images 
taken at days 1, 2, 4 and 6 (Figure 5-20). At day 1 iPSCs were well attached with spread 
morphologies and only limited numbers of rounded cells on both AFD49 and TCPS 
surfaces. At day 2 the iPSCs had proliferated to form sheets of cells on both surfaces. On 
TCPS these sheets were better spread than on hydrogel surfaces, where the iPSCs had 
formed areas of high cell density with sparse areas between. The majority of iPSCs on 
both TCPS and AFD49 surfaces maintained EGFP expression, indicating viability and 
pluripotency. However, small numbers of iPSCs in areas of high cell density lost EGFP 
expression and were likely undergoing differentiation. At day 4, iPSCs on TCPS had 
reached confluence, with a small number of cells forming cell aggregates and detaching 
from the surface at day 6. The majority of cells at days 4 and 6 on TCPS maintained 
expression of EGFP, indicating viability and pluripotency. At day 4, iPSCs cultured on 
AFD49 had formed dense cell masses that began to detach from the hydrogel surface. At 
day 6 iPSCs had detached from the hydrogel surface and formed rounded cellular 
aggregates that had diameters of 150-250 µm and resembled spheroids of hESCs and 
iPSCs in suspension culture.68 Interestingly, EGFP expression was maintained by iPSCs 
in these spheroids, suggesting that iPSCs in the spheroids may still be viable and 
pluripotent.
224 
 
 
Figure 5-20. Growth of iPSCs on Matrigel coated surfaces. A) and B) TCPS, C) and D) AFD49 hydrogels. Each fluorescence image (B and D; Green, 
EGFP fluorescence) is of the same location as the phase contrast image above (A and C). (scale bars 100 µm). Hydrogels were 2 mM AFD49 final.
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Matrigel coating of AFD49 hydrogels is sufficient to promote iPSC attachment, spreading 
and proliferation over several days. This suggests that AFD49 hydrogels are not directly 
cytotoxic to iPSCs, and furthermore the mechanical properties of these gels are able to 
support iPSC cytoskeletal forces, at least at low cell density. Matrigel functionalization of 
hydrogels is not optimal for future work as it does not avoid this naturally-sourced material. 
However, future experimentation may elucidate appropriate recognition motifs for 
functionalization of AFD49 hydrogels to achieve a defined matrix capable of supporting 
iPSC culture. The detachment of iPSCs at days 4 and 6 appears mechanistically similar to 
the detachment of fibroblasts noted previously (Sections 0). This may relate to the iPSCs 
forming strong cell-cell attachments as the density of cells increases, which eventually 
overcome the attachment to the hydrogel surface. This may be coupled with iPSCs 
generating their own ECM over time, which detaches from the hydrogel surface. 
Additionally, AFD49 gels likely possess similar proteolytic degradability (Section 5.3.5) and 
low mechanical strength (Section 4.4.14) to AFD36 gels, which may allow for cells to 
progressively remodel and weaken the hydrogel surface, leading to detachment. Further 
experiments may focus on increasing the mechanical strength of peptide hydrogels 
through either covalent cross-linking or increasing peptide concentration. Embedding of 
iPSCs inside an appropriately functionalised peptide hydrogel may also be of interest, as 
this would prevent iPSCs from detaching from hydrogel surfaces. 
 Drug loading into peptide hydrogels 5.3.17
Vitamin A and its derivatives such as all-trans retinoic acid (ATRA; Figure 5-21A) play 
important roles in both embryonic development and adult cell differentiation.69 The 
influence of ATRA and its most common isomers 9-cis retinoic acid and 13-cis retinoic acid 
(Figure 5-21B) on cell maturation has resulted in its use in treatment of a number of clinical 
disorders such as certain leukaemias70 and acne.71 It is also of interest for stem-cell 
research, as it affects the differentiation of pluripotent cell lines.72, 73 Due to the 
hydrophobic and polyenic structure of retinoic acids, they possess low solubility in 
aqueous solutions and undergo isomerization under exposure to light, making them 
difficult to work with.74, 75 As discussed in Chapter 1, a potential delivery vehicle for 
hydrophobic molecules such as retinoic acids is the hydrophobic cavity formed in the core 
of higher-order coiled coils.9 For example, Guo et al.76 have shown the pentameric coiled-
coil domain of cartilage oligomerization matrix protein to bind ATRA within its hydrophobic 
core. It was therefore of interest to assess the ability of AFD49 to bind ATRA with the 
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potential for peptide hydrogels containing this retinoid to act as a slow-release reservoir for 
cell culture and possible clinical applications. 
LCMS allowed quantification of both all-trans retinoic acid and the most common isomer 
13-cis retinoic acid. The solubility of ATRA was measured to be ~ 5-10 µM in water or 
phosphate-buffered saline alone, while 290 µM ATRA was dissolved in an aqueous 
solution of 7.5 mM AFD49. This demonstrated the ability of AFD49 to solubilise this 
hydrophobic molecule. 
ATRA is non-chiral, and therefore will not generally exhibit a spectrum via circular 
dichroism. However, when bound in a chiral environment such as a protein binding site, 
induced circular dichroism may be observed at wavelengths close to the chromophore’s 
absorption maxima of 350 nm (in ethanol).77, 78 ECD spectra of a solution of ATRA 
solubilised by AFD49 were collected over 250-450 nm (Figure 5-22). Peptide secondary 
structure is generally measured over 190-260 nm, and in the wavelength range used for 
measurement of ATRA shows minimal contribution. Additionally, under the solution 
conditions used for this experiment AFD49 is in a fully helical state (Section 5.3.7), and no 
change in peptide secondary structure was observed on ATRA addition. 
 
Figure 5-21. Chemical structure of A) ATRA and B) 13-cis retinoic acid. 
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 ATRA solubilised by AFD49 gave a weak spectrum with maxima at 283 and 385 nm and a 
minimum at 329 nm, indicating some interaction with the peptide that did not change over 
time when the sample was kept in the dark. Upon exposure of the solution to room light for 
15 minutes the spectrum changed, with maxima at 293 and 372 nm and minima at 335 
and 427 nm. LCMS analysis showed a small amount of isomerization of ATRA, with 0.6 % 
of detected retinoic acid now in the 13-cis form. Exposure of ATRA samples to light also 
gave decreasing total amounts of retinoic acid isomers, indicating some degradation to 
alternate products not detected by the method used here. Continued exposure of the 
ATRA-AFD49 solution to room light gave further changes to the ECD spectra. After 17 
hours the spectra showed a single maximum at 307 nm and a minimum at 397 nm. LCMS 
analysis at this point in time showed 68% of the initial retinoic acid to remain in the all-
trans state, with 4% of the initial retinoic acid now present as the 13-cis isomer. Extremely 
low concentrations of 9-cis retinoic acid and an unassigned isomer were also detected. 
After 4 days of light exposure only ca. 1% of initial retinoic acid is present as either ATRA 
  
Figure 5-22. ECD of ATRA in AFD49 solution on exposure to room light. ATRA initial 
concentration was 290 µM, AFD49 concentration was 7.5 mM. Spectra collected at times as 
indicated by colour legend.  
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or 13-cis retinoic acid. No circular dichroism signal corresponding to retinoic acid was 
observed. This indicated near complete degradation of the retinoic acid under prolonged 
exposure to room light. The initial observation of increasing circular dichroism signal on 
exposure of ATRA to light indicates that it may be an isomer or other degradation product 
of ATRA that binds within a chiral environment of AFD49. Further studies using techniques 
such as nuclear magnetic resonance spectroscopy may determine the identity and precise 
binding location of this species within AFD49 coiled coils. Notably, ATRA was solubilised 
by AFD49, indicating it may be useful for drug-delivery applications.  
 ATRA release from peptide hydrogels 5.3.18
The release of ATRA from AFD49 hydrogels was investigated under conditions similar to 
those that would be used for tissue culture experiments. Gelation of an AFD49-ATRA 
solution on addition of bicarbonate containing 2 × DMEM proceeded with similar kinetics to 
when ATRA was omitted. No attempt was made to characterise the rheological properties 
of ATRA containing AFD49 hydrogels due to difficulties in handling this light sensitive 
compound. However, qualitatively the gels behaved similarly to hydrogels formed with the 
same concentration of peptide in the absence of ATRA. 
1 mM AFD49 hydrogels containing 29 µM ATRA were incubated in the dark at 37 °C in a 
48-well plate with culture medium for 3 days with media changes each day. The amount of 
ATRA in the recovered media was quantified at each day. After 1 day ATRA was 
measured in the soaking media at 4 µM, equating to 64% of the total loaded ATRA. At 2 
days only 1 µM ATRA was present in the soaking media, giving a cumulative release of 
82%. This increased to 87% at day 3, and no further release was observed when media 
was sampled on later days. At each day the concentration of retinoic acid isomers other 
than ATRA were too low to quantify using the LCMS method employed here.  
The total recovery of only 87% of loaded ATRA may correspond to degradation to low 
levels of isomers and other products not detected by the LCMS method employed here.79, 
80 Alternately, some ATRA may remain bound in the hydrophobic core of AFD49 coiled-coil 
fibrils. This experiment indicated successful loading and release of ATRA from AFD49 
hydrogels. However, the uncontrolled and rapid release of ATRA over the first 24 hours 
may be faster than is desirable for many applications relating to cell differentiation and 
potential cancer therapies where it is commonly used in the nM to low µM range over 
several days.73, 81, 82 Lowering the loaded concentration of ATRA may achieve the desired 
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low therapeutic concentrations over longer times, however the initial burst release seen in 
this trial may be unfavourable for some applications. 
The ability of hydrophobic molecules to bind within the coiled-coil core is dependent on 
factors such as their charge, molecular size, shape and hydrophobicity.9 Therefore, while 
this initial experiment demonstrates the ability for AFD49 hydrogels to be loaded with 
hydrophobic drugs for later release, alternate drug molecules may be investigated that 
could show enhanced binding and slower release rates. Alternately, it may be possible to 
redesign the peptide structure to better accommodate various hydrophobic molecules. In 
either case, more detailed structural information of the packing of hydrophobic molecules 
within coiled-coil fibrils will be required to allow directed peptide modifications and 
hydrophobic molecule selections. 
5.4 Conclusions 
In this chapter α-helical peptide hydrogels were investigated as cellular scaffolds and drug 
delivery vehicles. Oscillatory shear rheology results showed AFD36 hydrogels to possess 
soft-solid properties similar to soft tissues and previously reported β-sheet peptide 
hydrogels. This suggested the hydrogels to be suitable as matrices for mammalian cell 
growth. However, hydrogels formed from as-received peptide material were unable to 
support cell growth and caused cell death. Peptide solutions contained absorbing species 
proposed to be contaminants remaining from peptide synthesis. A purification method was 
developed that allowed removal of these contaminants and gave AFD36 peptide material 
able to support NIH/3T3 fibroblast growth at levels similar to TCPS. This highlights the 
potential for contaminants present in peptide materials to affect biological experiments, a 
factor that may be more widespread than is currently recognised. 
The long-term growth of NIH/3T3 fibroblast cells on AFD36 hydrogels showed cellular 
aggregation with eventual detachment that was attributed to cell-cell interactions 
overcoming cell-hydrogel attachments at higher cell densities. AFD36 was susceptible to 
trypsin digestion, with progressive loss of secondary structure over time and a loss of gel 
structure after 18 hours. While protease susceptibility will need to be further investigated 
using secreted proteases, low levels of proteolytic susceptibility of the hydrogel may be an 
advantage in wound-healing applications where gradual degradation of the gel and 
replacement with native ECM may enhance tissue regeneration. 
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The peptide AFD49 was then designed based on the self-assembly model proposed for 
AFD19 and AFD36. This peptide showed hydrogel formation under similar conditions to 
AFD36 and supported NIH/3T3 fibroblast growth. The pre-equilibration of AFD49 
hydrogels in cell culture media enhanced subsequent cell growth. This was attributed to a 
combination of the removal of residual contaminants that are detrimental to cell growth, 
and the deposition of serum components on or in the hydrogel. Extremely low fibroblast 
attachment to hydrogel surfaces occurred in the absence of serum, indicating that 
attachment to this material, which lacks cellular recognition motifs, is likely mediated by 
adsorbed serum components. The proliferation of fibroblasts encapsulated within AFD49 
hydrogels demonstrated these materials to be suitable as 3D cell scaffold matrices. This 
indicates AFD peptide hydrogels may have potential in wound healing applications, as well 
as demonstrating potential utility in applications such as toxicological assays, where the 
cellular microenvironment can affect drug susceptibilities.  
The culture of iPSCs on AFD49 hydrogels was investigated to determine the ability of 
these gels to support the growth of alternate cell types. Initial experimentation showed 
both unfunctionalised peptide hydrogels and hydrogels incorporating the SMB vitronectin 
domain to be unable to support iPSC attachment and proliferation. However, coating of 
gels with Matrigel gave sufficient functionalization for iPSC attachment and growth over 
several days. These experiments demonstrate that when appropriately functionalised, the 
peptide hydrogels may function as a substrate for iPSCs. However future experimentation 
will be required to determine appropriate specific recognition motifs to allow iPSC culture 
on a completely defined substrate. Similar to the results seen with 3T3/NIH fibroblasts, 
iPSCs showed detachment from peptide hydrogel surfaces at longer times. Increasing the 
mechanical strength of peptide hydrogels may overcome this cellular detachment at higher 
cell densities by providing a more rigid substrate. 
ATRA was solubilised by AFD49, demonstrating the potential for hydrophobic drug loading 
and delivery. The release of ATRA after loading into peptide hydrogels occurred rapidly 
over the first two days. This is likely too fast for most applications, however varying drug 
concentration may be able to influence release rates. Further screening of potential 
hydrophobic drugs as well as possibly redesigning hydrogel forming peptides will 
potentially increase the future utility of α-helical peptide hydrogel drug delivery systems. 
The results of this chapter indicate that the peptide hydrogels developed in Chapters 4 and 
5 support mammalian cell growth and solubilise hydrophobic molecules, thereby 
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demonstrating their potential in applications such as tissue engineering, wound healing 
and drug delivery. There are several directions for future research that may be of benefit 
for further developing this class of α-helical peptide hydrogel that are now discussed. 
5.5 Future directions 
 Characterisation of fibril forming peptides 5.5.1
As discussed in Chapter 4, future studies of the self-assembling AFD peptides may focus 
on further characterising the assembled state of AFD19, AFD36 and AFD49 peptides. This 
may focus on better determining the oligomerization state of the coiled coil formed by 
these peptides using techniques such as sedimentation equilibrium ultracentrifugation. 
Characterisation of coiled-coil fibrils by techniques such as higher resolution electron 
microscopy and X-ray scattering studies may also serve to better define the peptides 
assembled state and enhance the understanding of these peptides self-assembly. This 
may then allow for a more targeted peptide design process for future applications. 
5.1.1 Hydrogel forming peptides as cell scaffold materials 
The investigation of mammalian cell growth on peptide hydrogels reported in this thesis 
demonstrated the suitability of these materials as cell scaffolds. However, a full exploration 
of the many factors involved in the use of the peptide hydrogels as defined matrices for 
cell growth will require further studies. Future studies will likely involve investigation of the 
effects of hydrogel mechanical properties, as well as approaches for hydrogel 
functionalization to support more demanding cell types such as iPSCs. 
Chapter 5 demonstrated hydrogels formed by the peptides AFD36 and AFD49 to support 
the growth of NIH/3T3 fibroblasts. However at higher cell densities fibroblasts began to 
detach from the gel surface, likely in part due to the gels weak mechanical properties. 
Future studies may investigate methods for increasing the mechanical strength of peptide 
hydrogels. As discussed in Chapter 1, this may be achieved by increasing the peptide 
concentration to give a denser fibril network. Further rheological studies would be required 
to determine the precise relationship between peptide concentration and hydrogel 
mechanical properties. Alternately, chemical cross-linking of peptide hydrogels may be 
investigated to give a more rigid material. This could be accomplished by the addition of 
cross-linking agents such as glutaraldehyde, or the incorporation of cysteine residues to 
form disulfide cross-links. While chemical cross-linking may increase hydrogel mechanical 
strength and potentially enhance the utility of peptide hydrogels as tissue culture 
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substrates, these cross-links will impair the self-healing properties of peptide hydrogels. In 
applications where it is desirable for hydrogel material to be shear-thinned for injection, 
such chemical cross-links would therefore have to be formed in situ. Control over the 
mechanical properties of peptide hydrogels will be of use in future applications, and 
studies such as those outlined here will be required to assess the variety of methods 
available. 
The mechanism involved in cellular detachment from peptide hydrogels at higher cell 
densities may be of interest for future studies. For example, if the cells on the surface of 
hydrogels are producing their own ECM, which then detaches from the hydrogel surface, 
this may be visualised by immunostaining of ECM components.38 Such progressive 
replacement of peptide hydrogel with native ECM may be beneficial for wound healing 
applications, where native tissue would eventually replace the hydrogel. Additionally, a 
better understanding of the cellular behaviour on hydrogel surfaces may be obtained if 
cellular migration and detachment were visualised using time-lapse microscopy studies. 
This would provide a better understanding of the processes by which cells migrate on, and 
eventually detach from, hydrogel surfaces and potentially provide more general insights 
into cellular behaviour on such soft substrates. 
Layered AFD49 hydrogels were demonstrated to support the growth of encapsulated 
fibroblasts (Chapter 5). However, directly mixing cells into a gelling peptide solution gave 
high cell death, likely due to the transient acidic conditions. Future studies may determine 
improved methods for encapsulating cells within peptide hydrogels. This may involve 
titrating the starting peptide solution to a less acidic pH prior to inducing gelation and 
seeding cells, or increasing the bicarbonate concentration to achieve faster gelation and 
lessen the exposure of cells to acidic conditions. Alternately, it may be possible to mix cells 
into sheer-thinned peptide hydrogels, however obtaining a homogenous distribution may 
be challenging. Future work may explore these potential approaches for obtaining a 
homogenous distribution of cells through a hydrogel matrix. 
Non-functionalized AFD49 hydrogels were unable to support the growth of iPSCs (Chapter 
5). While coating the hydrogels with Matrigel was sufficient to provide iPSC attachment 
and proliferation, this is not optimal for future work as this does not avoid the naturally-
derived Matrigel. Future research may determine methods for peptide functionalization to 
give a defined substrate capable of supporting iPSC attachment and growth. This could be 
accomplished by the incorporation of an integrin recognition sequence containing peptide 
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into peptide hydrogels. The design of such a peptide may involve appending a recognition 
sequence via a flexible linker to the termini of a gel forming peptide to allow the recognition 
sequence to extend laterally from fibrils, similar to the structure proposed by Potekhin et 
al..83 An alternate approach to functionalization may involve covalent attachment of 
integrin-recognition sequence peptides to side-chains of hydrogel forming peptides. This 
may use similar chemistries to those used by the Woolfson group to synthesize branched 
fibril-forming peptides.84 This would allow for a variety of alternate integrin recognition 
sequences to be attached to a single hydrogel forming peptide without the need for 
peptide redesign. However, such an approach would be be incompatible with potential 
future bioproduction of hydrogel forming peptides. Future work may explore these two 
approaches for the functionalization of hydrogel forming peptides to better support the 
attachment and proliferation of more demanding cell types such as iPSCs. 
 Hydrogel forming peptides for therapeutic delivery 5.5.2
Results reported in Chapter 5 demonstrated the ability of AFD49 hydrogels to incorporate 
and release the hydrophobic therapeutic ATRA. While this proof of concept system 
showed rapid release of loaded therapeutic, future studies may investigate alternate 
hydrophobic molecules that may display slower release rates. It would also be beneficial to 
use techniques such as nuclear magnetic resonance spectroscopy to better determine the 
molecular structure of the AFD49-ATRA complex. This would enable targeted redesign of 
the peptide to alter interactions with this therapeutic. Future studies may also investigate 
the loading and release of therapeutic biomolecules such as antibodies from peptide 
hydrogels. While the results presented in this thesis demonstrate the potential for use of 
AFD49 hydrogels as therapeutic delivery vehicles, studies such as those outlined here will 
be required in the future to tailor release rates and expand the use of these materials to 
other therapeutics. 
 Bioproduction of hydrogel forming peptides 5.5.3
The results reported in Chapter 5 show potential utility of AFD49 hydrogels as both cell 
scaffold materials and therapeutic delivery vehicles. As discussed in Chapter 1.4, high-
value products such as pharmaceuticals and materials for biomedical applications may be 
feasibly produced using high-cost processes such as solid-phase peptide synthesis. With 
this in mind there is less of a requirement for the bioproduction of hydrogel forming 
peptides in comparison to surfactant peptides that find utility in large-scale applications. 
However, in the future it may be beneficial to reduce the costs associated with producing 
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these materials. This may be achieved using a bioproduction approach similar to that 
described in Chapters 2 and 3, applied to hydrogel forming peptides. A concatemer 
approach based on the peptide AFD49 will be presented here; although many similar 
approaches are easily envisioned and it is still difficult to predict which will be most 
successful. Notably, given that the target peptide AFD49 does not possess a high level of 
charge under physiological conditions, it is likely that a homoconcatemer approach rather 
than a heteroconcatemer (as used in Chapter 2) may be appropriate. Furthermore, it is 
proposed that by joining the peptides at their termini with linkers as well as constraining 
coiled-coil assembly to an antiparallel arrangement, gel formation during expression may 
be avoided and will only occur after concatemer cleavage. 
A concatemer approach similar to that described in Chapters 2 and 3 will utilise acid 
cleavage at aspartate-proline dipeptides to release product peptides following expression. 
As described in Chapter 3, if cleavage is allowed to continue to completion, removal of C-
terminal aspartate residues may be achieved. This could be accounted for in the design of 
a bioproduction method for a hydrogel forming peptide. One notable difference between 
synthetically produced and expressed peptides is capped vs uncapped termini 
respectively, which will effect the level of charge present on the peptide. A target peptide 
for expression based on AFD49 may therefore be uAFD49 (H2N-P LKELAKL LHELAKL 
LHELAKL-COOH, FW 2521). This peptide possesses the same helix-foming core as 
AFD49 with an N-terminal proline residue for cleavage as well as uncapped termini. This 
peptide sequence possesses a GRAVY value of 0.250 and an instability index of -5.89, 
suggesting a soluble and stable sequence, similar to AFD49. The predicted charge on 
uAFD49 approaches +1 as the pH is raised above 7.0, in line with requirements for gel 
formation under physiological conditions. The predicted pH for 0 net charge for uAFD49 is 
9.0, which while lower than AFD49, is still well outside the physiological range. Future 
experiments will be required to determine the gelation behaviour of this peptide, however it 
may be expected that such a peptide would undergo gelation similarly to the previous 
peptides AFD36 and AFD49. 
A linker sequence (L) similar to the one successfully used in Het2-6 (PGRGMD) could be 
used to link repeats of uAFD49 within a concatemer structure. In this case, it may be 
beneficial to substitute the cationic arginine with an anionic glutamate residue (PGEGMD) 
to increase negative charge at physiological pH and avoid pI values close to physiological 
conditions. Also similar to the approach used in Chapter 2, an N-terminal methionine-
aspartate dipeptide (M) would be required to initiate expression. This would result in a 
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concatemer with sequence (M-(uAFD49)-(L-(uAFD49))n) where n+1 is the total number of 
uAFD49 repeats. As described in Chapter 1, the number of peptide repeats is a factor 
which will likely need empirical optimization. Given the higher-order coiled coil proposed to 
be formed by AFD49, it seems likely that a concatemer of approximately 6 (n=5) repeats 
may be appropriate. For example, the sequence (M-(uAFD49)-(L-(uAFD49))5) has a 
predicted pI of 5.5, which while higher than Het2-6, is comparable to the majority of native 
bacterial proteins (Chapter 2). This sequence also has a GRAVY value of -0.159 and an 
instability index of -4.26, suggesting a soluble and stable sequence. The predicted charge 
at pH 7.0 of this sequence is -9.7, which is higher than Het2-6. However the computed 
Foldindex value for this sequence is +0.127, suggesting a stably folded sequence. A 
series of concatemers where the n value is varied between 4 and 6 may be investigated to 
determine the optimal value for expression. 
Following expression, heat and acid-mediated cleavage of the aspartate-proline dipeptides 
and subsequent removal of C-terminal aspartate residues could be used to produce the 
desired product peptide. Following cleavage it is likely that a chromatography approach 
may be required to recover product peptides. However, given the high-value potential 
applications of these materials this is likely to be a feasible approach. 
As stated above it is still difficult to accurately predict the success of bioproduction 
strategies due to the level of complexity involved. However a bioproduction strategy similar 
to that outlined here is one potential future route to achieving bioproduction of hydrogel 
forming designer peptides. 
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